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Abstract 
Rationale: The prevalence of low back pain and associated costs to society are high. 
Despite this, the number of studies investigating observational data on the quality 
and costs of care in routine health care services, such as chiropractic, is relatively 
small in comparison to the clinical trial evidence available on the effectiveness and 
cost-effectiveness of manual therapies for low back pain. 
Objective: To document the quality and cost of care in low back pain patients 
undergoing routine chiropractic care in the United Kingdom.  
Design: Prospective single cohort multi-centre study. 
Participants: A sample of 120 chiropractors and 421 patients. 
Methods: Following the development of a data collection instrument and a pilot 
study, patients suffering from low back pain were recruited by chiropractic clinics in 
the United Kingdom. Information was recorded using a patient self-report 
questionnaire at baseline prior to the initial consultation, and participants were 
mailed a follow-up questionnaire at three months. Health outcomes, patient 
experiences of the process and safety of care, and related costs in the intervening 
three month period were documented. 
Results: Four hundred and twenty-one patients formed the baseline sample, and 238 
(57%) of these returned the follow-up questionnaire at three months. Statistically 
significant change scores (p = 0.0001) were seen for the health status measures 
including the Roland-Morris Disability Questionnaire, Bournemouth Questionnaire, 
EuroQol-5D and bothersomeness scale. One hundred and sixty-eight of 238 (70%) 
patients reported a clinically significant improvement on the Perceived Global Effect 
scale, and 73 (31%) of these were considered recovered anytime during the study 
period using definitions of recovery (i.e. acceptable quality of life, no disability and 
no pain for a whole month). One hundred and twenty-nine (54%) of patients at 
follow-up rated chiropractic care for their low back condition as ‘very helpful’. The 
number of patients rating the process of care (i.e. time and explanations given by 
chiropractor as well involvement in decisions about care) as ‘very good’ ranged from 
157 to 168 (66% to 71% respectively of the patients at follow-up). One hundred and 
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twenty-five (52%) of patients at follow-up reported adverse events of care (i.e. 
worsening of their back pain, stiffness, soreness and/or general discomfort 
immediately or shortly after the chiropractic treatment visits); however, only 13 (5%) 
of these reported that they were unable to carry on with their usual activities and/or 
work as a result of these events. On average, the total cost of care was £481.83 (95% 
CI = 333.17 to 639.42) per patient. Lost productivity resulting from time away from 
work was the most important contributor to these costs (59.6%). The cost of 
chiropractic visits was the second most important contributor, which accounted for 
nearly one-third of total costs (32.8%). Other health care usage including general 
practitioner visits, medical procedures and diagnostic imaging were responsible for a 
small proportion of total costs ranging from 0.4% to 1.6%.  
Conclusions: This programme of research is the first prospective study conducted in 
routine chiropractic practice simultaneously documenting information about health 
outcomes and patient experiences and costs of care. Patients improved markedly 
within the first three months of care and expressed high satisfaction with the 
chiropractic treatment and consultation they received. Chiropractic care was 
relatively safe, with common yet benign adverse events that had little influence on 
activities of daily living. Taken overall, patients receiving chiropractic care reported 
improvement at arguably reasonable cost, suggesting this approach to the health care 
of patients with low back pain be considered in the wider context of health care 
delivery in the United Kingdom.  
 
 
 
 
 
 
 
iii 
 
Table of Contents 
 Page 
Abstract ......................................................................................................................................................... ii 
Table of Contents........................................................................................................................................... iv 
List of Tables ................................................................................................................................................. vii  
List of Figures ................................................................................................................................................ viii 
Abbreviations ................................................................................................................................................ ix 
Declaration .................................................................................................................................................... x 
Acknowledgements ....................................................................................................................................... xi 
Dissemination ................................................................................................................................................ xii 
LITERATURE REVIEW: CHAPTERS 1-3 1 
Preface ........................................................................................................................................................... 2 
CHAPTER 1 4 
PATIENT-REPORTED OUTCOME MEASURES IN LOW BACK PAIN 4 
1.1 Introduction  ................................................................................................................................... 4 
1.2 Health status measures ................................................................................................................... 5 
1.2.1 Condition-specific measures ................................................................................................. 5 
1.2.2 Health-related quality of life measures ................................................................................. 7 
1.2.3 Patient-specific measures ...................................................................................................... 8 
1.3 Low back pain recurrence and recovery measures ......................................................................... 9 
1.4 Conclusion ..................................................................................................................................... 11 
CHAPTER 2 13 
REPORTING IMPROVEMENT FROM PATIENT-REPORTED OUTCOME MEASURES 13 
2.1 Introduction .................................................................................................................................... 13 
2.2 Direct method of measuring improvement using Global Perceived Effect (GPE) scales ............... 15 
2.3 Indirect method of measuring improvement using health status measures ..................................... 18 
2.3.1 Determination of threshold of clinical improvement using change scores ............................ 18 
2.3.2 Considerations when using indirect methods to determine improvement ............................. 20 
2.4 Conclusion ..................................................................................................................................... 22 
CHAPTER 3 23 
ASSESSING COST AND PATIENTS EXPERIENCES OF CARE IN LOW BACK PAIN  23 
3.1 Introduction .................................................................................................................................... 23 
3.2 Costs of care ................................................................................................................................... 23 
3.2.1 Measuring costs .................................................................................................................... 23 
3.2.2 Analysing costs ..................................................................................................................... 25 
3.2.3 Conducting an economic evaluation ..................................................................................... 27 
3.3 Patient experiences of care ............................................................................................................. 29 
3.3.1 Patient experiences of the process of care ............................................................................. 29 
3.3.2 Patient experiences of the safety of care ............................................................................... 31 
3.4 Conclusion ..................................................................................................................................... 32 
RESEARCH PROGRAMMES: CHAPTERS 4 -7 33 
CHAPTER 4 34 
RESEARCH PLAN 34 
4.1 Background .................................................................................................................................... 34 
4.2 Aim ................................................................................................................................................ 34 
4.3 Objectives ...................................................................................................................................... 34 
4.4 Research questions  ........................................................................................................................ 36 
 
 
 
iv 
 
 Page 
CHAPTER 5 38 
DEVELOPMENT OF DATA COLLECTION INSTRUMENT 38 
5.1 Introduction .................................................................................................................................... 38 
5.2 Methods ......................................................................................................................................... 38 
5.3 Results ............................................................................................................................................ 39 
5.4 Discussion ...................................................................................................................................... 41 
5.5 Conclusion ..................................................................................................................................... 44 
CHAPTER 6 45 
PILOT STUDY 45 
6.1 Introduction .................................................................................................................................... 45  
6.2 Aims and objectives ....................................................................................................................... 45  
6.3 Methods ......................................................................................................................................... 46 
6.3.1 Selection of chiropractors ..................................................................................................... 46  
6.3.2 Procedures of pilot study ...................................................................................................... 46 
6.3.3 Procedures of data analysis ................................................................................................... 49  
Analysis of written notes ............................................................................................................. 49  
Analysis of patient data ............................................................................................................... 49  
6.4 Results ............................................................................................................................................ 49  
6.4.1 Issues pertaining to the data collection process and resulting changes ................................. 50  
6.4.2 Issues pertaining to the clarity of the documentation and resulting changes ......................... 50  
6.5 Conclusion ..................................................................................................................................... 53 
CHAPTER 7 54 
MAIN STUDY 54 
7.1 Introduction .................................................................................................................................... 54  
7.2 Methods ......................................................................................................................................... 54  
7.2.1 Study design ......................................................................................................................... 54  
7.2.2 Patient sample ....................................................................................................................... 54  
Sampling method ......................................................................................................................... 54  
Sample size .................................................................................................................................. 55  
7.2.3 Recruitment and sample of chiropractors ............................................................................. 56  
7.2.4 Data collection procedures .................................................................................................... 57  
7.2.5 The chiropractic intervention ................................................................................................ 59  
7.2.6 Ethics .................................................................................................................................... 59  
7.2.7 Quality check for data entry errors ....................................................................................... 59  
7.2.8 Data analysis ......................................................................................................................... 59  
Documentation of health outcomes, patient experiences and costs of care as well as              
evaluation of outcome reporting methods ................................................................................... 60 
Evaluation of data collection instrument .................................................................................... 62 
7.3 Results ............................................................................................................................................ 65  
7.3.1 Response rate ........................................................................................................................ 65  
7.3.2 Sample characteristics........................................................................................................... 68  
7.3.3 Health outcomes ................................................................................................................... 70  
7.3.4 Patient experiences of care.................................................................................................... 79  
7.3.5 Health care costs and usage .................................................................................................. 81 
Costs of care ............................................................................................................................... 81 
Health care usage ....................................................................................................................... 81 
7.3.6 Evaluation of data collection instrument ............................................................................... 84  
Responsiveness of health status measures ................................................................................... 84 
Criterion validity of patient-reported number of visits made to the clinic .................................. 85  
Construct validity of measuring complete recovery from low back pain using construct-             
specific questions ........................................................................................................................ 87  
Questionnaire feedback............................................................................................................... 88 
7.4 Discussion ...................................................................................................................................... 89  
CHAPTER 8 101 
CONCLUSIONS AND RECOMMENDATIONS 101 
References ..................................................................................................................................................... 103 
 
 
v 
 
 Page 
Appendix 1: Study documentation of pilot study .......................................................................................... 125  
Appendix 2: Study documentation of main study .......................................................................................... 150  
Appendix 3: Ethics approval letter ................................................................................................................ 175 
Appendix 4A: Distribution of age of patients at baseline .............................................................................. 176  
Appendix 4B: Distribution of change scores ................................................................................................. 176 
Appendix 4C: Distribution of continuous cost data ....................................................................................... 178  
Appendix 5: Hypothetical example of a QALY calculation assuming linear utility change over time .......... 180  
Appendix 6: Calculation of the accuracy between dichotomous measures using sensitivity and specificity . 181 
Appendix 7: Unit costs .................................................................................................................................. 182 
Appendix 8: Cut-off point determination using receiver operating characteristic ......................................... 183 
Appendix 9: Comparative analysis between the follow-up cohort and the validation sample ....................... 189 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
List of Tables 
 Page 
Table 2.1:  Seven point global perceived change scales ................................................................................ 16 
Table 2.2:  Distribution-based method: formula and threshold of clinical improvement .............................. 19 
Table 5.1:  Structure of data collection instrument ....................................................................................... 40 
Table 6.1:  Issues pertaining to the data collection process and resulting changes........................................ 51 
Table 6.2:  Issues pertaining to the clarity of the documentation and resulting changes ............................... 51 
Table 7.1:  Comparative analysis between responders and non-responders .................................................. 67 
Table 7.2:  Baseline description of 421 patients ............................................................................................ 69 
Table 7.3:  Health status scores (0-100 scale) in 238 participants of Roland-Morris Disability            
Questionnaire (RMDQ), Bournemouth Questionnaire (BQ), EuroQol-5D (EQ-5D) and 
bothersomeness scale (BS) .......................................................................................................... 71 
Table 7.4:  Construct-specific recovery from low back pain in 238 participants .......................................... 73 
Table 7.5:  Lifestyle changes in 238 participants .......................................................................................... 78 
Table 7.6:  Patient experiences of the process of care in 238 participants .................................................... 79 
Table 7.7:  Mean costs of care (in £) during 3 months in 229 patients .......................................................... 82 
Table 7.8:  Responsiveness of health status measures ................................................................................... 85 
Table 7.9:  Positive percent agreement (PPA) and negative percent agreement (NPA) of construct-             
specific method of determining complete recovery from low back pain ..................................... 87 
Table 7.10: Questionnaire feedback in 238 participants ................................................................................ 88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
List of Figures 
 Page 
Figure 3.1:  Normal distribution in a hypothetical example named Variable_A with superimposed          
distribution curve ..................................................................................................................... 26 
Figure 3.2:  Skewed distribution in hypothetical example named Variable_B with superimposed            
distribution curve ..................................................................................................................... 26 
Figure 6.1:  Data collection process in pilot clinics ..................................................................................... 48 
Figure 7.1:  Data collection process in main study ...................................................................................... 58 
Figure 7.2:  Diagram of flow of data throughout the study ......................................................................... 66 
Figure 7.3:  Frequency (%) perceived level of improvement in 238 participants,  
 i.e. global perceived effect scale .............................................................................................. 72 
Figure 7.4:  Percentage minimal clinically important difference (MCID%) for the Roland-Morris          
Disability Questionnaire (RMDQ), Bournemouth Questionnaire (BQ), EuroQol-5D                    
(EQ-5D) and bothersomeness scale (BS) using four methods: 0.5 Effect Size (ES);                           
1 Standard Error of Measurement (SEM); 1.96 Reliable Change Index (RCI); and                
Receiver Operating Characteristic (ROC). ............................................................................... 75 
Figure 7.5:  Proportion and 95% CI of patients clinically improved for the Roland-Morris Disability  
Questionnaire (RMDQ), Bournemouth Questionnaire (BQ), EuroQol-5D (EQ-5D) and 
bothersomeness scale (BS) using four thresholds: 0.5 Effect Size (ES); 1 Standard                     
Error of Measurement (SEM); 1.96 Reliable Change Index (RCI); and Receiver                  
Operating Characteristic (ROC) ............................................................................................... 76 
Figure 7.6:  Receiver operating characteristic plot depicting the sensitivity and 1-specificity for the                  
0.5 Effect Size (ES), 1 Standard Error of Measurement (SEM), 1.96 Reliable Change                 
Index (RCI) and Receiver Operating Characteristic (ROC) threshold approaches against                 
the external criterion of clinical improvement (i.e. patients categorised as clinically              
improved on the Global Perceived Effect scale) ...................................................................... 77 
Figure 7.7:  Frequency (%) patient experiences of the safety of care in 238 participants,                                        
i.e. adverse events .................................................................................................................... 80 
Figure 7.8:  Other health usage in 238 participants ..................................................................................... 83 
Figure 7.9:  Frequency (%) change in pain medication usage (i.e. pain killers) for back pain during               
three months in 238 participants .............................................................................................. 84 
Figure 7.10:  Bland and Altman plot comparing the number of chiropractic visits as determined by             
patient-report and patient file. ........................................................................................ 86 
 
 
 
 
 
 
 
 
viii 
 
Abbreviations 
AECC Anglo-European College of Chiropractic 
AUC Area under the curve 
BQ Bournemouth Questionnaire 
EQ-5D EuroQol-5D 
ES  Effect Size 
GPE Global Perceived Effect 
HRQL Health-related quality of life  
IMMPACT Initiative on Methods, Measurements, and Pain 
Assessment in Clinical Trials  
MCID Minimal clinically important difference 
MCID% Percent minimal clinically important difference   
MCIDr Raw minimal clinically important difference 
MCS Mean Change Score 
MYMOP Measure Yourself Medical Outcome Profile 
NHS National Health Service 
NICE National Institute of Clinical Excellence 
NPA Negative percent agreement 
ODI Oswestry Disability Index  
OECD Organisation of Economic Co-operation and 
Development 
Picker MSD Picker Musculoskeletal Disorders 
PPA Positive percent agreement 
PSFS Patient Specific Functional Scale 
QALY Quality adjusted life year 
RCI Reliable Change Index 
RMDQ Roland-Morris Disability Questionnaire  
ROC Receiver Operating Characteristic 
SEM Standard Error of Measurement 
SF-36 Short Form-36 
UK BEAM United Kingdom Back Pain Exercise and Manipulation  
ix 
 
Declaration 
Whilst registered as a candidate for the above degree, I have not been registered for 
any other research award. The results and conclusions embodied in this thesis are the 
work of the named candidate and have not been submitted for any other academic 
award. 
 
 
Taco Houweling 
January 2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
Acknowledgements  
I would like to extend my acknowledgements to the following individuals and 
organisations whose support made this research a possibility.  
Acknowledgements are given to the British Chiropractic Association and the Anglo-
European College of Chiropractic (AECC) for their co-operation in generating the 
funding necessary for the conduct of this study. Acknowledgements are also due to 
the patients who participated in this study and the chiropractors who diligently 
collected data for this research. 
I must thank Professor Jennifer Bolton (AECC), whose high expectations, 
unwavering honesty, and never ending patience have made me a better researcher. I 
thank her for the many discussions and for the helpful feedback she gave to me, and 
for the tireless hours she has dedicated to this project and research in general. 
Professor Bolton has been an example of success for me, and I feel privileged that I 
have had the opportunity to work with her over these past years. I am also grateful to 
the rest of my supervisory team, Dr David Newell (AECC) and Professor Graham 
Mills (University of Portsmouth), for their support, guidance and encouragement.  
This accomplishment would not have been possible without the love and support of 
my family. I am grateful to my partner, Sophie Csaszar, for being patient with me 
and keeping me positive while I completed this project, and for her assistance with 
data entry. To my parents, Augustinus and Elisabeth Houweling, who I thank for 
their encouragement and support throughout this journey as well as for teaching me 
the values of dignity and perseverance, which have helped me to succeed in life. To 
my sister, Jiske Houweling, who appreciates the process of doctoral work, and who I 
would like to thank for listening to me in good and bad times. To my brother, Tjerk 
Houweling, who I thank for making me laugh during times of stress.  
Finally, I would like to thank the staff of the Anglo-European College of 
Chiropractic for their support and encouragement. In particular, I wish to thank Dr 
Andrew Vitiello for his helpful tips in conducting research and for listening to me in 
times of need.  
 
xi 
 
Dissemination 
Presentations 
Houweling T, Bolton J and Newell D. Patient-reported quality and related costs of 
care in low back patients undergoing chiropractic treatment. European Chiropractors’ 
Union (2011), Zürich, Switzerland. 
Houweling T. Patient-Reported Outcomes Measures (PROMs): an update and why 
you need to be involved. British Chiropractic Association Conference (2010), 
Kenilworth, UK. 
Houweling T. The Chiropractic Patient-Reported Outcomes Measures Study (C-
PROMS): promotional presentation. European Chiropractors’ Union (2010), London, 
UK.  
Houweling T, Bolton J and Newell D. Outcomes of patients undergoing chiropractic 
care: Phase I (poster presentation). European Chiropractors’ Union (2010), London, 
UK. 
Publications 
Houweling TAW. Reporting improvement from patient-reported outcomes measures. 
Clinical Chiropractic (2009) 13, pp. 15-22.  
 
 
 
 
 
 
xii 
 
  
LITERATURE REVIEW: CHAPTERS 1-3 
 
 
Chapter 1 Patient-reported outcome measures in low back pain 
Chapter 2 Reporting improvement from patient-reported 
outcome measures 
Chapter 3 Assessing cost and patients experiences of care in low 
back pain   
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Preface 
Low back pain has a considerable burden on society. According to a survey 
published in 2000 nearly half the adult population of the United Kingdom reported 
low back pain lasting 24 hours or more over a 12-month period.1 The point and 
lifetime prevalence of low back pain are estimated at 14% and 80% respectively,2-5 
and it is estimated that one in two people who experience low back pain will seek 
health care for their ailment.3 In 2006, musculoskeletal conditions were one of the 
most common reasons for seeking primary care from a general practitioner in the 
United Kingdom, with the low back being the most commonly affected.6 In 1998, the 
cost of health care for all types of low back pain and the cost of lost productivity as a 
result of this condition were estimated at £1,632 and £3,500 million respectively.7 
Since their publication, these values have likely increased and thus the economic 
burden of low back pain in the United Kingdom may be even more substantial 
nowadays. 
Despite the high prevalence of low back pain and the associated costs to society, the 
number of studies investigating observational data on patient outcomes in routine 
health care services, such as chiropractic, is relatively small in comparison to clinical 
trial evidence available on the effectiveness and cost-effectiveness of manual 
therapies for low back pain.8-11 Similarly, there is a need to measure and analyse data 
on patient experiences of the process and safety of care so as to determine the 
adequacy of health care delivery and potential adverse events resulting from the 
service under consideration.12 Such data about patient outcomes and experiences are 
collectively called quality of care indicators and are best measured using data from 
the patients themselves.13  
The use of patient-reported instruments has seen an emergence in health care 
services around the world for the purpose of informing stakeholders, including 
patients, clinicians, insurers and commissioners, about the quality of care.14 For 
example, the Outcomes Framework initiative in the English National Health Service 
(NHS) uses patient-reported instruments to assess the quality of care for conditions 
requiring elective surgery, and long term conditions such as diabetes, asthma and 
chronic obstructive pulmonary disease.15 The need for this information is vital not 
2 
 
only in public services but also in private settings such as chiropractic clinics 
providing care for low back pain and other musculoskeletal complaints. 
In addition to data about the quality of care, collecting information regarding the cost 
of that care is imperative due to rising health care costs and limited budgets.16, 17 The 
United Kingdom is no exception. Data published by the Organisation of Economic 
Co-operation and Development (OECD) show that total health expenditure in the 
United Kingdom rose from £88,490 million in 2003 to £136,439 million in 2009, 
corresponding to 7.8% and 9.8% respectively of the gross domestic product.18 A 
report by the OECD accompanying these figures urges European countries to collect 
more information about the quality of care and cost of treatment in health care 
services so as to assist patients and commissioners in choosing providers, thus 
resulting in more efficient health care delivery.19 
As a result of the importance of data about the quality and cost of care, there is need 
to determine this information in all health care service areas. A study of this type 
assessing the quality and costs of care for low back pain in chiropractic clinics in the 
United Kingdom has not yet been conducted. The basis of this study was to conduct 
such an evaluation from the perspective of those patients undergoing chiropractic 
treatment for low back pain. 
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CHAPTER 1  
Patient-reported outcome measures in low back pain 
1.1 Introduction 
There is an increasing realisation that diagnostic imaging and laboratory test results 
as well as objective functional/physiological outcome measures (e.g. range of 
motion, finger-to-floor and walking distance) should no longer be considered as sole 
or primary outcomes of treatment in low back pain.20 Instead the emphasis has 
shifted to patient self-completed questionnaires evaluating the patient’s experiences 
of the benefit gained on pain, disability and psychological distress as well as other 
important dimensions of health and quality of life.14 Such measures, called patient-
reported outcome measures, are instrumental in determining, based on factors 
relevant to the patient, whether additional care is required or whether the patient 
should be discharged from care and is able to resume a normal working and social 
life.21 Moreover, these measures are vital in assessing treatment effectiveness and 
quality of care from the patient’s perspective.22  
The dimensions of outcome that are most relevant to low back pain patients are 
likely dependent on a number of factors including socio-demographic and clinical 
characteristics as well as other individual characteristics such as the patient’s coping 
strategies.23, 24 This means that, if a comprehensive evaluation of treatment outcomes 
in low back pain patients is to be made, a range of different instruments must be 
used. As such, selecting these measures for inclusion in clinical trials and other 
studies has become an important challenge faced by researchers.25 One possible 
approach to this problem is to include a range of different measures in research 
studies in order not to miss important information.  However, this approach is not 
only time consuming for patients and practitioners, and hence not suitable for clinical 
research, but also hampers meaningful comparisons between studies.26 Consequently, 
there is a need to select outcome measures based on a number of criteria including 
psychometric properties, relevance and clinical utility. The aim of the present chapter 
is to offer a comprehensive review of the different types of patient-reported outcome 
measures in low back pain including those that are used to compare the patients’ 
health status or health-related quality of life at different points in time, i.e. health 
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status measures, and those that evaluate the course of the condition, i.e. low back 
pain recurrence and recovery measures. 
1.2 Health status measures 
1.2.1 Condition-specific measures 
Condition-specific measures are designed to evaluate outcomes in a specific disease 
or population.27 In 2002, a systematic review conducted by Grotle et al.28 identified 
36 validated condition-specific measures for low back pain. An update of this review 
reported that this number had increased to 43 between 2002 and 2009.29 The main 
construct investigated by these measures was activity limitations, with a few items 
reflecting various constructs such as pain and symptoms, sleep disturbances, 
psychological dysfunctions, physical impairments, and social functions.  
The overabundance of condition-specific outcome measures available for low back 
pain reflects the biopsyschosocial nature of this condition.30 This model of health 
posits that the pain experience is not only influenced by physical pathology, but also 
by cognitive-perceptual, psycho-physiological and motoric-environmental factors 
which are different for each individual.31, 32 Owing to the complexity of low back 
pain, and its multi-dimensional nature, capturing outcomes in low back patients 
remains a difficult task. 
In the face of so many outcome measures, and since variability in instruments across 
studies hinders evaluation of treatment effectiveness and quality of care, the 
Initiative on Methods, Measurements, and Pain Assessment in Clinical Trials 
(IMMPACT) recommended that three core health outcome domains should be 
investigated in clinical trials investigating chronic pain conditions such as low back 
pain.33 These are pain, physical functioning and emotional functioning. In spite of 
these recommendations, however, disability remains the outcome of primary 
importance in low back pain research. Indeed, the two most frequently used, 
extensively validated and recommended measures are the Roland-Morris Disability 
Questionnaire (RMDQ) and the Oswestry Disability Index (ODI).25, 28, 34 These are 
similar assessment tools that measure a patients’ perceived level of disability 
resulting from low back pain.34 The RMDQ is composed of 24 dichotomous (i.e. 
yes/no) items that focus on physical disabilities,35 and the ODI consists of 10 verbal 
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rating scales that focus on physical disabilities and pain level.36 Comparative studies 
have shown that although both measures have similar reliability and validity 
properties, the RMDQ is most responsive and appropriate in low back pain patients 
with mild to moderate disability, while the ODI is more responsive in patients with 
severe disability.34 Nevertheless, both measures have functioned satisfactorily in 
settings with differing levels of disability (i.e. physical therapy).37  
Notwithstanding the importance of assessing disability arising from low back pain, in 
order to obtain an accurate representation of the patient’s health status, there remains 
the need to evaluate the multi-dimensional aspect of the condition.30 Although this 
information could be captured using multiple instruments, such data collection 
procedures may be time-consuming and may negatively affect patient and 
practitioner compliance.38 As a result, in effectiveness and health care quality 
studies, it may be more practical to use short, concise measures, which nonetheless 
exhibit the psychometric properties of a valid outcome instrument. Such measures 
can be classified into two types.  
The first is a single question asking about the degree of intrusion of the patient’s 
back pain. An example of this is the bothersomeness scale,39, 40 which enables 
patients to incorporate multiple dimensions of outcome in a single question. The 
second is a multidimensional outcome measure such as Deyo et al.’s core-set25, 26 or 
the Bournemouth Questionnaire (BQ),41, 42 in which a number of dimensions of 
outcome are assessed, each with a single item. The 6-item core-set, in addition to 
health outcomes, includes two questions about work-time loss and satisfaction with 
care.25 The 7-item BQ, on the other hand, is based on the biopsychosocial model of 
health and differs from other measures in that it includes questions about the 
cognitive/behavioural influences in low back pain.41  
While the bothersomeness scale may be useful in text messaging studies in which the 
number of characters used is a restriction, this scale may limit comparison between 
different subjects due to the limited amount of detail it provides.43 Conversely, 
multidimensional measures provide information about several dimensions of 
outcome and may thus facilitate interpretation of health status scores.26 If greater 
precision of measurement than can be achieved with a single item for each dimension 
is required and sufficient resources are available, questionnaires investigating 
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specific dimensions in more depth (e.g. RMDQ and ODI) may be used to supplement 
these multidimensional measures.25  
1.2.2 Health-related quality of life measures 
The increasing interest in evaluating health care quality and efficiency has led to the 
development of a number of generic measures named health-related quality of life 
(HRQL) measures. These measures allow comparison of outcomes across different 
interventions and conditions, and can thus be useful in health care policy decisions.44 
Due to this characteristic, HRQL measures are instrumental in cost effectiveness 
studies, in which the benefit and cost of different interventions can be compared.  
Patients ratings in HRQL measures are used to classify patients into a number of 
health states, which can be converted into a common currency of benefit (i.e. utility 
score), where one is considered ‘full health’ and zero or less is considered ‘death’.45 
The number of health states depicted by an instrument is determined by both the 
number of health dimensions and the number of levels within each dimension.46 The 
utility scores attributed to these health states are typically obtained through surveys 
of the general population and, as such, these scores can assist commissioners in 
making health care policy decisions based on societal preferences.47   
Owing to their broad scope, generic measures may not measure domains as relevant 
to the patient with low back pain as those assessed by condition-specific measures.44 
Indeed, comparative studies between both types of measures have shown that the 
responsiveness and ability to discriminate between improved and non-improved 
patients is inferior in HRQL measures.44 Nevertheless, the instrumental role of these 
measures in health care evaluation studies and their ability to provide a general 
representation of the patient’s health including potential co-morbid features 
constitutes an advantage over condition-specific measures. Therefore, since health-
related quality of life measures may provide a different perspective on health 
outcomes, it may be useful to combine these measures with condition-specific 
instruments in outcomes studies for low back pain.48 In addition, since both 
approaches have different strengths, the IMMPACT commission suggested that the 
use of both condition-specific and HRQL measures should be considered in 
designing chronic pain clinical trials.49  
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A number of validated HRQL measures have been utilised for generic health 
outcomes determination including the EuroQol (EQ-5D),50 the Health Utilities Index 
(HUI),51 the Quality of Well-Being Scale (QWBS)52 and the Short-Form 36 (SF-
36).53 Systematic reviews have shown that the EQ-5D and, to a lesser extent, the SF-
36 are mainly used in health care evaluation studies for non-specific low back pain.9, 
10 The SF-36 is a 36-item questionnaire assessing six dimensions of general health 
(i.e. physical function/role, pain, social functioning, emotional health/role and 
vitality),54 and the EQ-5D is composed of five questions, each assessing a different 
dimension of general health (i.e. mobility, self-care, activity, pain and psychological 
impairment).50 The popularity of the EQ-5D in low back pain research may be 
explained by its conciseness compared to its counterparts, and by a recommendation 
of low back pain experts25, 49 and guidelines55, 56 to include this measure in health 
care evaluation studies. Head-to-head comparisons between the EQ-5D and SF-36 
showed that although both measures have good reliability and validity,50, 54, 57-59 the 
agreement between the utility scores of both measures is low.50 This discrepancy 
may be attributed to differences in scales used, dimensions being assessed and 
methods used for determining utility scores.60 Therefore, although both measures use 
a similar scoring system, only values captured using the same instrument can be 
compared across different conditions and treatments.  
1.2.3 Patient-specific measures 
In keeping with the complexity and multi-dimensional nature of low back pain, a 
recent approach in measuring outcomes in this condition is to evaluate specific 
symptoms, activities or aspects of life identified by patients to be most affected by 
the condition.61 This approach evaluates health status in low back pain patients and 
patients with other conditions using patient-specific outcome measures which, unlike 
fixed-item measures such as generic and condition-specific measures, allow 
individuals to select and rate activities of particular importance.62, 63 Two measures 
have been commonly used in research on low back pain, the Measure Yourself 
Medical Outcome Profile (MYMOP) and the Patient Specific Functional Scale 
(PSFS).62 The MYMOP is a self-generated 4-item measure that covers three domains 
(i.e. symptoms, activity and general well-being),64 and the PSFS investigates the 
patient’s functional status by asking them to select and rate five activities that are 
affected as a result of their condition.65 These measures may address the 
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idiosyncratic nature of low back pain as patients select functional items of greatest 
concern and thus may have greater relevance in terms of the different ways in which 
low back pain affects different individuals.  
Since patient-specific measures focus on items relevant to patients, such measures 
are purportedly more likely to record improvement in outcomes than fixed-item 
measures.66 However, this hypothesis is not supported by evidence in group patient 
data as responsiveness studies comparing condition-specific to fixed-item measures 
show conflicting findings.66-70 The reason for this controversy may be that traditional 
psychometric testing may not be appropriate to instruments with variable item 
content and thus produce inconsistent results.63 Since questionnaire items are not 
standardised, any numeric score may not hold a common meaning and therefore the 
calculation of statistical parameters using such data is questionable. Another 
important limitation in patient-specific measures regarding research involving group 
patient data is that participants require structured guidance to complete these 
measures, thus making data collection time consuming and costly.64 As a result, 
patient-specific measures may not be suitable for quality of care and treatment 
effectiveness research. Nevertheless, due to their relevance to individual patients, 
these measures may be useful for monitoring individual outcomes and informing the 
clinician of an individual patient’s progress.    
1.3 Low back pain recurrence and recovery measures 
A number of cohort studies have demonstrated that low back pain is an episodic or 
recurrent condition,71-75 with incidence rates of recurrence following an episode of 
low back pain ranging from 24% to 33% over 12 months.74 Estimates suggest that 
two thirds of back pain related health care and lost productivity costs can be 
attributed to recurrence of this condition.76 As a result of these high incidence rates 
and costs, in addition to measuring patients’ health or health-related quality of life at 
selected points in time using health status measures, documenting recurrence of low 
back pain in health outcomes assessment is paramount so as to provide additional 
information about the course of disease.  
Although there is a growing interest in evaluating recurrences of low back pain in 
effectiveness and cost-effectiveness studies, no consensus exists in the literature on 
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how to define these.77 Furthermore, if a recurrence means that the patient has firstly 
recovered from the original episode prior to experiencing a new episode of low back 
pain, there is a need to define the concept of recovery (i.e. conclusion of an episode 
before the start of the next). However, there is controversy in the literature regarding 
this topic as well, with a systematic review reporting over 66 different definitions of 
recovery.78 The lack of consistency in definitions used for both recurrence of, and 
recovery from, an episode of low back pain impedes comparison of findings across 
different studies. Therefore, the use of standardised measures for these concepts 
constitutes a priority in low back pain health care research.   
In 2011, in a study using a modified Delphi approach, a panel of researchers defined 
a recurrence of an episode of low back pain as a return of pain in the low back lasting 
at least 24 hours following a period of at least 30 days pain-free.79 This definition of 
a recurrence incorporates the definition by de Vet and co-workers of an episode of 
low back pain,80 in which patients are considered recovered if they have been free of 
low back pain for a period of at least one month.  Despite these recommendations, 
the literature shows differing opinions on the determination of recovery from an 
episode of low back pain. For instance, Hush et al.23 identified in a qualitative study 
on patients’ perceptions about recovery from low back pain that, in addition to 
symptom attenuation such as pain, improved function and achievement of an 
acceptable quality of life were important determinants of recovery. These authors 
concluded that it was not only the patient’s symptoms attenuation that explained 
recovery from low back pain, but the impact of symptoms on the patient’s ability to 
perform daily functional tasks and achieve an acceptable quality of life. Conversely, 
Beaton et al.81 found that the patient’s perception of being recovered from low back 
pain was not only dependent on resolution of the disorder but also on cognitive 
appraisal of, and behavioural adaptation to, the pain experience. As such, construct-
specific measures (i.e. measures evaluating specific dimensions of recovery such as 
pain, function and quality of life) may not reflect the idiosyncrasy of the concept of 
recovery. Measures assessing recovery directly by asking patients whether they 
perceive themselves as recovered may be more relevant as these measures may 
enable patients to incorporate any construct into their rating of recovery.43 The 
response options on such measures may be binary82, or in the form of a Likert 
scale.83, 84 Notwithstanding the importance of direct reports of recovery, construct-
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specific measures may have an advantage over direct reports of recovery in that they 
may facilitate between-subject comparison as the dimensions affected by low back 
pain can be identified.43 Therefore, both direct reports and construct-specific 
measures may provide useful information in the study of low back pain recurrence 
and recovery.  
Various methods of collecting data about recurrence of, and recovery from, an 
episode of low back pain have been utilised. These include questionnaires mailed to 
participants, or telephone interviews conducted, at long time intervals inquiring 
about symptoms and disability over the follow-up period;85-87 more frequent inquiries 
via questionnaires or self-completed diaries;88-93 and daily follow-up via short 
messages automatically sent to participants’ mobile phones.72, 73 Each of these 
methods offers advantages and disadvantages. While data can be collected at 
frequent time intervals by using self-completed diaries and repeated questionnaires, 
such methods require co-operation from study participants and may also be relatively 
expensive.72, 73 On the other hand, using the short message method may be more 
convenient for subjects, but the amount of information that can be assessed using this 
method is often limited. Follow-up at a longer time interval via questionnaire may 
offer an interesting alternative in assessing recurrence of, and recovery from, an 
episode of low back pain; however, the data collected using this method relies on the 
ability of patients to recall information accurately over time. Nonetheless, Stewart et 
al.94 found that recall of key parameters of recurrence and recovery (i.e. activity 
limitation days, and days with pain) showed good correlation with the same data 
recorded on a daily self-completed diary over a 3-month period. This indicates that 
patient-reported outcome measures with an extended recall period may provide valid 
data about low back pain recurrence and recovery.  
1.4 CONCLUSION 
There is an increasing interest in determining health outcomes using patient-reported 
outcome measures so as to assist patients and their clinicians in making decisions 
about treatment as well as commissioners in making informed decisions about health 
care policy. A number of different measures can be used for outcomes evaluation in 
low back pain, and each of them has different strengths and limitations. When 
selecting these measures for use in research conducted in primary care practice, a 
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number of parameters should be taken into consideration including the relevancy of 
the information collected and the ease of use, as well as the course of the condition.  
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CHAPTER 2 
Reporting improvement from patient-reported outcome measures 
2.1 Introduction 
Reporting data from patient-reported outcome measures in a way that is meaningful 
to clinicians, patients and commissioners of healthcare is equally important as the 
selection of these instruments. The use of appropriate reporting procedures has 
important implications for the move towards evidence-based medicine so that data 
from research studies can be translated to clinical practice.95 Moreover, these 
reporting procedures are crucial for the endorsement or rejection of therapies by third 
party payers or government health plans.20, 96 Inappropriate reporting procedures 
could have substantial consequences such as the endorsement of a therapy that in 
reality is of no clinical benefit to the patient, or the rejection of a therapy that is 
highly beneficial.   
In 2001, Chan et al.97 reviewed a sample of randomised controlled trials and noted 
that few authors reported the clinical significance of their results. Moreover, the 
authors of these studies provided little or no justification pertaining to the 
methodology that was utilized to determine the clinical significance of their results. 
In 2007, van Tulder et al.98 reviewed forty-three studies of exercise therapy for 
chronic low back pain. Eighteen studies reported conclusions in favour of exercise 
therapy for chronic low back pain, however, only seven showed a clinically 
important improvement. Hence, the effect of exercise therapy for low back pain may 
have been over-reported. Various authors have stated that traditional statistical 
procedures such as group mean scores and statistical significance of differences 
between scores on outcome measures are of little use to the clinician and patient.99-109 
For instance, in 2004, a randomised controlled trial funded by the Medical Research 
Council (MRC) and the NHS, the United Kingdom Back Pain Exercise and 
Manipulation (UK BEAM) study,110 concluded that best care plus manipulation plus 
exercise showed a moderate benefit at three months compared to best care alone.  
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These conclusions were based upon change scores from the Roland-Morris disability 
questionnaire that showed a mean difference of 1.87 (95% CI 1.15 to 2.60, p < 
0.001) in favour of the best care plus manipulation plus exercise group compared to 
best care alone. Although this net benefit is statistically significant, it is difficult to 
decide whether participants of best care plus exercise plus manipulation gained any 
benefit that was of clinical importance.111 In fact, from the results given in this study, 
it is not possible to decide if any of the interventions under scrutiny led to a clinical 
improvement in any of the patients. 
Presenting change scores for a therapeutic intervention as group means with 
statistical significance represented by p-values has several limitations. Firstly, sample 
variability is not taken into account. It is difficult to determine individual differences 
from a mean change value. Some patients might have achieved scores well above the 
mean, others much lower than the mean.104 Secondly, group mean change values do 
not provide any information concerning meaning of the magnitude of the change. 
Thus, it is difficult for clinicians to determine whether the change in scores 
considerably improved the patient’s condition or whether the change in score was in 
fact too small to be of any benefit to the patient.100 Lastly, there is no relationship 
between statistical significance and clinical improvement.104-106 Furthermore, studies 
with large sample sizes are more likely to yield statistically significant results.112 
Consequently, a statistically significant difference does not necessarily mean that it is 
of clinical importance, and vice versa, clinically significant does not imply that the 
finding is statistically significant. 
Traditional statistical procedures are thus unable to show whether patients consider 
their condition to be clinically improved or not. This information, however, is of 
major importance to researchers, clinicians, third party payers and most importantly 
patients themselves. Two papers published in 2006 by Schünemann et al.112 and 
Brozek et al.101 have advocated the use of dichotomization to simplify the 
understanding of change scores derived from patient-reported outcomes. These 
dichotomization procedures use threshold values to categorize patients as either 
clinically improved or non-clinically improved. Any patient or subject below the 
threshold point is not considered to have undergone a clinically important 
improvement. The proportion of patients benefiting from treatment can then be 
calculated for both single-cohort studies and randomised controlled trials. In 
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randomised controlled trials the net proportion of patients who improved from 
treatment is calculated by subtracting the proportion of subjects who improved in the 
placebo or control group from that in the intervention group.112-114 From this, the 
number needed to treat (NNT) can be calculated.111, 115, 116 The number needed to 
treat, in musculoskeletal research, is the number of subjects needed to treat for one 
subject to benefit from the therapeutic intervention. 
The proportion of patients benefiting from treatment can be determined in two 
different ways. Both methods require the use of specific thresholds of clinical 
improvement. Firstly, the proportion of patients who benefit from treatment can be 
derived directly from global perceived effect scales or global improvement scales. 
Secondly, the proportion of patients improved can be assessed indirectly from 
change scores derived from health status measures using threshold values calculated 
in a number of ways. The aim of the present chapter is to offer a comprehensive 
review of both methods of determining the proportion of patients achieving benefit 
from treatment.  
2.2 Direct method of measuring improvement using Global Perceived Effect 
(GPE) scales 
The GPE scales can be utilized as a method of determining directly how much the 
patient perceives his or her condition to be improved. These scales require the patient 
or subject to state by how much their condition has improved at time points 
throughout and at the end of the intervention. As such, this method is considered to 
be a retrospective outcome measure.117 Conversely, the Bournemouth 
Questionnaire41, 118 and the Roland-Morris Questionnaire,35, 37 for instance, are 
administered pre- and post-treatment and, therefore, these questionnaires can be seen 
as prospective outcomes measures.119 Various GPE scales have been utilized in the 
literature: Four-point scales: worsened - no change - improved - completely 
recovered120, 121; 5-point scales ranging from ‘much better’ to ‘much worse’122-124; 
numerical rating scales ranging from 0 ‘worst possible state’ to 5 ‘no change’ to 10 
‘best possible state’125; and 15-point scales ranging from a ‘very great deal worse’ to 
‘about the same’ to a ‘very great deal better’.126, 127 More recently, however, there 
has been an emergence of 7-point scales. Commonly, two types have been utilized 
(Refer to table 2.1). Firstly, a scale that has ‘very much worse’ and ‘very much 
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better’ at the extremes.128-130 Secondly, a scale showing ‘vastly worsened’ and 
‘completely recovered’ at the extremes.83, 131-133 Some authors have decided not to 
include ‘vastly worsened’ in the scale because there is no opposite of ‘completely 
recovered’.131, 134-136 
 
 
Table 2.1 
 
 
Seven point global perceived change scales. 
 
 Scale 1
128-130 Scale 283, 131-133  
7 very much better completely recovered 7 
6 much better much improved 6 
5 slightly better slightly improved 5 
4 no change no change 4 
3 slightly worse slightly worsened 3 
2 much worse much worsened 2 
1 very much worse vastly worsened 1 
 
 
The determination of reliability includes both the measurement of internal 
consistency (Cronbach’s α) and test-retest reliability. However, presently, due to 
methodological reasons these two parameters have not been established for GPE 
scales. Internal consistency relates individual items of a questionnaire to the total 
score. However, GPE scales are composed of a single item only and, consequently, 
internal consistency cannot be measured. The calculation of test-retest reliability 
would constitute a challenging task as patients would be required to rate global 
improvement twice for a similar condition with a similar period of improvement. 
Moreover, the time interval between test-retest sessions would have to be no longer 
than two weeks.137  
Physical outcomes and health status measures have shown a relationship with GPE 
scales and, thus, there is evidence to support construct validity of the latter. Fritz et 
al.126 compared the Physical Impairment Index, composed of seven physical tests, 
with patients’ perception of change. The subjects defined as ‘unchanged’ on the GPE 
scale showed little variation in Physical Impairment Index scores. Conversely, 
subjects that categorized themselves as ‘improved’ showed a steady reduction in 
impairment scores. Health status measures have shown a similar trend. Patients 
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categorized as ‘unchanged’ showed little variation in health status change scores 
whereas patients categorized as ‘improved’ showed substantial decrease in these 
scores.83, 126, 127, 129-132 Criterion validity cannot be established because there is no 
gold standard for patients’ perception of global improvement.137 The notion of face 
validity is supported by the fact that it is relevant to ask the patient directly how 
much his or her condition has improved. 
Two studies have investigated patients’ ability to recall their initial health state when 
using retrospective outcome measures. Norman et al.117 found that GPE scales were 
correlated with the present state and uncorrelated with the initial state in prospective 
outcome measures (i.e. health status measures). From this it was concluded that 
retrospective outcome measures were affected by recall bias. Middel et al.,138 in 
angina pectoris patients, modified each item of the Minnesota Living with Heart 
Failure Questionnaire (MLHF-Q) into retrospective questions of perceived change. 
No recall bias was found when retrospective and prospective change scores were 
correlated with each other. These controversial results may have been caused by the 
differing concepts measured by GPE scales and prospective outcome measures. 
Global perceived change scales may measure the patient’s overall health status for 
several health dimensions including the effects of treatment, side effects and patient 
expectations.129 
Despite the utilisation of 7-point Likert scales for the assessment of global perceived 
change, it is unknown whether Numerical Rating Scales (NRS) and Visual Analogue 
Scales (VAS) would be more appropriate for its determination. Nevertheless, in pain 
studies, these three rating methods have demonstrated similar responsiveness.139-143 
Moreover, participants have found 7-point Likert scales to be more user-friendly than 
their two counterparts.140, 142-144 Subjects may find a complex 15-point scale difficult 
to interpret and complete without assistance.131 Seven-point scales that have no 
opposite of ‘completely recovered’ are composed of four options for improvement at 
one extreme, two options for deterioration at the other extreme and ‘no change’ in 
the centre. Hence, it could be argued that these scales are non-symmetrical. Scales 
that have ‘very much better’ and ‘very much worse’ at the extremes do not inform 
the clinician whether the patients’ condition has resolved or not. Therefore, scales 
that have ‘completely recovered’ and ‘vastly worsened’ at the extremes are suggested 
(Table 2.1).  
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Generally, on a 7-point likert scale, category six or ‘much better or improved’ has 
arbitrarily been chosen as the threshold for clinically important improvement.83, 128-
130, 132, 135, 136 Therefore, patients that rate themselves as ‘slightly improved or better’ 
are not considered to be significantly improved. Ostelo et al.132 supported their 
decision to include ‘slightly better or improved’ in the clinically non-improved group 
because they found no statistically significant differences between the change scores 
of the ‘slightly improved’ category and the ‘no change’ category. It should be noted 
that there exists a gap between the categories ‘much better or improved’ and ‘slightly 
better or improved’ (refer to Table 2.1). A study by Bolton et al.125 showed that the 
use of an additional category ‘moderately better’ did not increase accuracy of the 
threshold for clinical improvement. Moreover, this gap could be considered to be 
beneficial as it requires patients to decide clearly whether they are clinically 
improved or not. 
2.3 Indirect method of measuring improvement using health status measures 
2.3.1 Determination of threshold of clinical improvement using change scores  
The threshold of clinical improvement has been named in many different ways in the 
literature: Minimal Important Change (MIC),102, 103 Minimal Important Difference 
(MID),107, 109, 134, 145 Minimal Clinically Important Difference (MCID),99, 134, 146 
Minimal Clinically Important Change (MCIC)120, 121, 135, 136, 147 and Minimal 
Detectable Change (MDC).120, 121, 135, 136 
An international panel of experts stated that 30% change from baseline may be 
considered a clinically meaningful  improvement when comparing before and after 
health status scores.106 Although standardized threshold values may be of use for 
individual patients, these values may be inappropriate for the determination of the 
proportion of patients improved. The proportion of patients improved is dependent 
upon the design and population sample of the study.103, 107 Two statistical methods 
have commonly been used to determine the threshold of clinical improvement from 
change scores derived from health status measures. These are distribution- and 
anchor-based methods. Distibution-based methods depend on the distribution of the 
population sample under scrutiny and anchor-based methods are based on an external 
criterion. Traditionally, GPE scales have been used as the external criterion.  
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The following distribution based-methods have been used in the literature. Table 2.2 
outlines the formula and corresponding threshold of clinical improvement for each 
distribution-based method. Cohen’s Effect Size (ES)108, 148, 149 is calculated by 
dividing the group mean change by the group standard deviation at baseline. 
Different threshold values have been used such as an ES of 0.2, 0.33 and 0.5.103, 107, 
108, 146, 150, 151 The Standard Error of Measurement (SEM)145, 152, 153 relates the 
reliability coefficient of the health status measure utilised to the group baseline 
standard deviation. A wide variety of threshold values have been used in the 
literature such as a  1, 2 or 2.58 SEM.103, 123, 145, 150, 154 Some authors have decided to 
use 1.96 SEM, where 1.96 derives from the 95% Confidence Intervals of no 
change.107, 124, 134, 145 Others have used a threshold value of √2 * 1.96 * SEM or 2.77 
SEM because measurement error can occur twice.120, 121, 135, 136, 147 The Reliable 
Change Index (RCI),105 a derivative of the ES and SEM, has also been used. An RCI 
of 1.96 has been considered to be the threshold value for clinical improvement.105, 124, 
125, 134, 155 
 
Table 2.2 
Distribution-based method: formula and 
threshold of clinical improvement. 
Method Formula Threshold  
Effect Size      
(ES)108, 148, 149 
Mean2 - Mean1 X SD 
e.g. X = 0.5 SDb 
Standard Error of 
Measurement 
(SEM)145, 152, 153 
SDb √(1-R) X SEM e.g. X = 1 
Reliable Change  
Index (RCI)105 
Mean2 - Mean1 X √(2SEM2) 
e.g. X = 1.96 √(2SEM2) 
SDb: Standard deviation baseline; R: Reliability Coefficient 
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Several anchor-based methods have been used to derive the threshold of clinical 
improvement. First, the Mean Change Score (MCS)99, 146, 156 approach defines the 
threshold of clinical improvement as the mean change score of patients who selected 
one or a number of categories on the GPE scale. For instance, van der Roer et al.136 
determined the MCS by using the mean change score of all patients who scored 
‘much improved’ on a 6-point GPE scale. Juniper et al.127 calculated the MCS by 
utilizing change scores of patients who rated themselves as ‘± 2: a little better or 
worse’ and ‘± 3: somewhat better or worse’ on a 15-point GPE scale. A second 
anchor-based method assimilates change scores from health status measures to a 
diagnostic test. The GPE scales are used as the gold standard to classify patients as 
improved or not improved. The ability to diagnose patients correctly as improved 
(i.e. sensitivity) and the ability to diagnose patients correctly as not improved (i.e. 
specificity) is calculated for several change scores.146 The change score that 
maximizes sensitivity and specificity is chosen as the threshold of clinical 
improvement. Alternatively, Receiver Operating Characteristic (ROC) curves can be 
used to identifiy the health status score that maximizes sensitivity and specificity.103, 
134-136, 157, 158   
In 2003, Norman et al.159 compared thirty-eight studies that determined thresholds of 
improvement using distribution- and anchor-based methods in patients suffering 
from chronic diseases. The studies examined resulted in thresholds of clinical 
improvement that were consistently close to an ES of 0.5. Similarly, one year later 
Hurst and Bolton155 showed that an ES of 0.5 could accurately discriminate betweeen 
clinically improved and clinically non-improved patients suffering from back or neck 
pain. Norman et al.159 hypothesized that the ES trend amongst studies may be due to 
the limits of human discriminability and, therefore, patients could perceive change 
only beyond an ES of 0.5. 
2.3.2 Considerations when using indirect methods to determine improvement  
The threshold of clinical improvement determined with indirect methods is 
dependent on baseline variables. A number of studies have shown that threshold 
values determined with both distribution- and anchor-based methods were larger for 
patients with higher pain and disability baseline scores than patients with lower 
baseline scores.120, 130, 136 In addition, van der Roer et al.136 found lower threshold 
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values in chronic compared to acute patients. The use of statistics to adjust for 
baseline variables may not necessarily solve the issue as these procedures may not 
reflect change in a realistic manner.99, 146  
Distribution-based methods have the advantage of being sample-dependent.102, 103 
Conversely, anchor-based methods are calculated directly from change scores 
without adjusting for sample variability.102, 134 In other words, the standard deviation 
is not taken into account and, consequently, this method might lead to 
underestimation of the threshold of clinical improvement. Another limitation of the 
anchor-based methods is the utilization of a retrospective outcome measure to 
determine a threshold value on a prospective outcome measure. It is presently 
unknown whether these two outcome measures indeed measure the same concept. 
Moreover, the use of the GPE scale as a gold standard for improvement has been 
questioned by some.117  
Certain distribution-based methods (i.e. the SEM and RCI) are based on the 
coefficient of reliability of the outcome measure used. Although methods that take 
into account the reliability of the instrument may appear beneficial, the 
appropriateness of the coefficient of variation for the determination of the proportion 
of patients improved is questionable. This parameter is often predetermined in other 
studies and, thus, may be different for the population sample under scrutiny. Certain 
authors have attempted to remediate this situation by determining the SEM from 
within-subject variances of patients categorized as clinically non-improved on the 
GPE scale.120, 121, 135, 136 However, the GPE scales have other shortcomings that have 
been stated earlier in this review.  
Norman et al.,113, 114 using simulation studies, examined the effect of different 
indirect threshold values on the net proportion of patients improved. The results of 
the study showed that the choice of threshold value did not influence the net 
proportion of patients improved. Later in 2007 these findings were confirmed by 
Lemieux et al. 160 using data from a randomized controlled trial. Lemieux et al.160 
found no consistent difference in the net proportion of patients improved when 0.2 
SD, 0.5 SD and 1 SEM were used as thresholds for clinical improvement. There may 
be several reasons for these findings. First, the threshold of clinical improvement did 
not take into account individual variations in treatment response. Second, the 
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threshold values used were unable to discriminate between patients clinically 
improved and clinically non-improved. Last, the choice of threshold value for the 
determination of the net proportion of patients improved may in fact not be as 
important as initially believed. Nevertheless, the real cause is yet to be determined.  
Hays et al.161 demonstrated that threshold values determined with various indirect 
methods yielded different proportions of patients improved. Consequently, in single-
cohort studies, the threshold of clinical improvement may have an impact on the 
number of patients improved. For instance, a high threshold value could lead to the 
underestimation of the number of patients improved (i.e. false negatives). 
Conversely, a low threshold value could lead to overestimation of the number of 
patients improved (i.e false positives).    
2.4 Conclusion 
There is a need for data reporting procedures that are relevant to patients, clinicians 
and other stakeholders in the research evidence. Therefore, studies that collect health 
data in the practical clinical setting and others may want to include in their 
methodology the calculation of the proportion of patients improved. It appears that 
both direct methods using GPE scales and indirect methods using changes scores 
derived from health status measures can be used for the determination of the 
proportion of patients improved. Evidence demonstrates that there is convergence 
between the different methods of achieving the proportion of patients improved. To 
date it is unknown whether the use of one method is superior to another and, thus, no 
single method can be recommended. Consequently, it is suggested that patients be 
categorized into clinically improved and clinically non-improved groups using a 
selection of procedures composed of a direct method and indirect methods including 
both distribution- and anchor-based approaches. Moreover, it may be advisable to 
standardise these procedures to allow comparison of studies assessing similar 
conditions or treatment interventions. 
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CHAPTER 3  
Assessing costs and patient experiences of care in low back pain 
3.1 Introduction 
As a result of increasing health care costs and limited budgets, decisions by 
stakeholders regarding the management of low back pain should not only be based 
on health outcomes but also on the cost of an intervention.162 Without such 
information, patients cannot make a fully informed decision about their care and 
commissioners cannot allocate resources based on evidence.163 Therefore, assessing 
the cost of health care services has become of utmost importance. 
In addition to assessing treatment outcomes and costs, it is useful to determine 
patient experiences of the process and safety of care. Research has shown that 
satisfied patients are more likely to adhere to treatment, benefit from their health 
care, and have a higher health-related quality of life.  Furthermore, several studies 
have demonstrated that benign adverse events after manual therapy involving spinal 
manipulation for low back pain are commonly experienced by patients.164-168 These 
patients are typically less satisfied with care and less likely to have clinically 
important improvements in symptoms and disability compared to patients that do not 
experience such events.166 Consequently, the assessment of a patient’s experience of 
care is an important aspect in evaluating the quality of manual therapy services. 
This chapter focuses on issues pertaining to the assessment of parameters that 
complement the evaluation of health outcomes, i.e. costs and patient experiences of 
care.  
3.2 Costs of care 
3.2.1 Measuring costs 
There are two types of costs: direct costs, i.e. the costs of resources directly related 
to, and a consequence of, the health care intervention or service under study, such as 
the cost of consultation and treatment visits, medication, diagnostic procedures and 
other health care; and indirect costs, i.e. the costs of lost productivity as a result of 
low back pain or other conditions being investigated.45 The perspective of the study 
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dictates the costs included in the analysis.169 For example, a study conducted from 
the perspective of the Department of Health does not evaluate the cost of lost 
productivity. Conversely, an analysis conducted from a societal perspective includes 
such costs. An analysis from a societal point of view is typically recommended as 
this constitutes the broadest and most relevant strategy of evaluating costs.17, 170 Two 
types of data are needed in order to calculate the cost of an intervention. Firstly, the 
cost of one unit of each resource (i.e. unit cost), which can be obtained from national 
cost tariffs, and secondly, the amount of resources used to provide that care. 
There are different methods of collecting resource usage data including patient-
reported questionnaires and diaries as well as patient records.171 A drawback of 
obtaining this information from patient records is the difficulty in accessing these 
files.172 Patients may attend a number of different health care services and, therefore, 
patient records may have to be explored in multiple clinics and hospitals. Moreover, 
some information such as time off work and over the counter medication cannot be 
determined using this method.173 While both direct and indirect costs can be assessed 
using patient-reported diaries, the amount of patient co-operation needed for their 
completion is a concern.171  
Patient-reported questionnaires offer an interesting alternative in assessing resource 
usage. This method of assessing costs allows determination of a broad range of 
economic data including lost productivity and out-of-pocket expenses with less effort 
and resources compared to patient records and patient-reported diaries.173 However, 
the accuracy of this type of information relies on the memory of patients and thus 
may be affected by recall error.  
Nevertheless, studies that have assessed the agreement between resource usage data 
collected from patient records and patient-reported questionnaires have shown 
conflicting results.171-177 Some authors reported good agreement and others reported 
considerable differences between the data collected using these two methods. The 
reason for this controversy may be that there is no gold standard for assessing health 
care usage,172 thus comparing different methods of collecting this information may 
be questionable. In addition, the accuracy of patient-reported resource usage may be 
dependent on a number of factors including patient characteristics and number of 
visits. Indeed studies have shown that elderly patients and patients attending health 
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care services frequently were less likely to recall the correct number of visits.174, 175, 
177 These findings suggest that older subjects may be more forgetful and that it may 
be more difficult for patients to recall resource usage with increasing number of 
visits.174 Consequently, since the ability to recall resource usage is setting- and 
population-specific, it may be necessary to report on the accuracy of this information 
alongside cost results in economic studies.  
3.2.2 Analysing costs 
Notwithstanding the difficulties in determining costs of care, the analysis of these 
data can be equally problematic. When information about costs is to be used to 
inform health care policy decisions, it is the average cost of treatment that is 
relevant.178, 179 In economic studies, this figure is presented as the arithmetic mean 
cost per patient and its associated 95% confidence interval, which is a range of 
values for the mean that are considered to be plausible for the population under 
study.180 In other words, the 95% confidence interval of the mean implies that if a 
series of studies were carried out repeatedly on different samples from the same 
population, the mean of these samples would be located within the specified interval 
in 95 percent of cases.  
The traditional or parametric approach to calculating the 95% confidence interval 
assumes, when a histogram of the distribution of the data is plotted with values on 
the horizontal axis and frequencies on the vertical axis (an example is provided in 
Figure 3.1), that data are symmetrically distributed around the mean (i.e. symmetrical 
or normal distribution).180 However, cost data typically show a skewed distribution 
(i.e. non-symmetrical or non-normal distribution),178 usually due to a high proportion 
of patients using few health care resources and a minority of patients consuming a 
large amount of resources (an example is shown in Figure 3.2). Hence, methods of 
determining the 95% confidence interval that assume normality of distribution may 
be inappropriate in economic studies.  
The bootstrap method has been proposed as an alternative technique to determine 
confidence intervals in skewed data.181 This statistical method is a simulation 
technique in which multiple random samples are drawn from the observed data, with 
each sampled item replaced after each random draw, and with each sample providing  
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Figure 3.1: Normal distribution in a hypothetical example named Variable_A with 
superimposed distribution curve. 
Figure 3.2: Skewed distribution in hypothetical example named Variable_B with 
superimposed distribution curve. 
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an estimation of the mean.178 Repeating the process a large number of times provides 
information about the distribution of the mean (i.e. bootstrap distribution),182 thus 
enabling calculation of its confidence interval. Since the original dataset is 
considered the parent population in bootstrap analysis, unlike the hypothetical 
population in parametric statistics, no assumptions are required about the distribution 
of the data.183 Therefore, the use of this method is recommended for confidence 
interval calculation in skewed data such as costs for which parametric assumptions 
cannot be made. 
There are a number of different ways of deriving 95% confidence intervals for the 
mean from its bootstrap distribution. The traditional percentile method uses the 25th 
and 975th largest values of this distribution, i.e. the 2.5th and the 97.5th percentiles, 
respectively, as the limits of the 95% confidence interval.182 This method, however, 
is not adequate in cases where the bootstrap distribution is asymmetrical, which is 
plausible when bootstrap samples are drawn from skewed data.184, 185 In these 
instances, confidence intervals may be too narrow and, thus, the bias-corrected and 
accelerated method of determining the 95% confidence interval is preferred.184 This 
method takes into account characteristics of the bootstrap distribution,185 thus valid 
bootstrap confidence intervals can be calculated for skewed cost data.  
3.2.3 Conducting an economic evaluation 
Once cost data have been determined, it is useful to link this information to the 
consequences of the intervention or service under consideration. It is this link that 
will allow decisions about the cost of a service to be made. Such a procedure is 
termed economic evaluation.186  
Two features characterise an economic evaluation of health care services. First, it 
deals with the input and output, or the cost and outcomes, of a service, and second, 
an economic evaluation involves choices.169 Limited resources, and the consequent 
inability to meet all desired outputs, necessitates that choices be made with regards to 
health care services offered.162, 187 Such choices are made on the basis of many 
criteria. An economic evaluation provides one set of criteria that may be used to 
assist commissioners in allocating a limited health care budget.187  
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In order for a choice to be made, there is a need to conduct a comparative analysis of 
alternative health care services in terms of both the cost and outcomes.186 Therefore, 
the basic tasks of an economic evaluation are to determine and compare the costs and 
consequences of the alternatives being considered. If there is no comparison of 
alternatives (i.e. evaluation of a single service), the evaluation describes a health care 
service and is thus termed a cost-outcome description, which is sometimes referred to 
as a partial economic evaluation.169 Such an evaluation represents an important 
intermediate stage in the understanding of the costs and consequences of a health 
care service. However, a partial economic evaluation cannot assess the efficiency of 
a service (i.e. cost-effectiveness).186  
Linking cost and outcomes in a meaningful way is best done by selecting a measure 
of the benefits of health care services that has a broad applicability, thus allowing for 
greater comparability.188-190 The unit of outcome that is recommended by health 
economists188, 191 and the National Institute of Clinical Excellence (NICE)192 is the 
Quality-Adjusted Life Year (QALY). This measure incorporates both the patient’s 
quality of life, depicted by the utility score attributed to health states from health-
related quality of life measures, and the time spent in that state.191 For example, in an 
evaluation of a health care service for low back pain, the QALY indicates the 
patient’s quality of life over the period of the study. This contrasts from change 
scores which measure the difference in outcome (i.e. a subtraction) between two data 
collection points, thus not taking into consideration the duration of the intervention. 
Instead, the QALY is calculated by multiplying the utility score associated with a 
given health state by the duration of time spent in that state.163 
While the idea of incorporating length of time into the final outcome score has the 
advantage of simplicity,190 this concept may not be as relevant to low back pain 
patients. The use of length of time as an outcome may be informative in the 
evaluation of treatments that increase life expectancy; however, treatments for low 
back pain typically do not affect mortality rates.193 In spite of this limitation, the use 
of QALYs in economic evaluation of low back pain services is suggested as they 
allow the outcomes of interventions applied in different disease areas to be 
compared, thus facilitating resource allocation.186 In addition, since utility scores 
attributed to patient ratings on health-related quality of life measures are typically 
determined using surveys asking the general population to value the importance of 
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each health state, QALYs enable public participation in health care decision 
making.194 
3.3 Patient experiences of care 
3.3.1 Patient experiences of the process of care 
For many years, the patient’s experience of the process of care was assessed using 
global satisfaction scales (i.e. a scale evaluating the level of satisfaction with care in 
general); however, more recently, there has been a move towards the use of scales 
evaluating specific aspects of the process of care.195 The reasons for this move were 
that although research showed that global satisfaction was related to ratings of 
specific aspects of the process of care, specific ratings explained only a small portion 
of the variation in global satisfaction scores, with factors unrelated to the health 
system explaining the majority of this variation.196 In addition, other work conducted 
in this field demonstrated that over half of the patients that were satisfied with care 
indicated problems with specific aspects of the process of care.197 Therefore, since 
global satisfaction scales offer a limited and optimistic picture, detailed questions 
about specific aspects of patients’ experiences are likely to be more informative in 
assessing the quality of the process of care.   
In spite of the number of instruments assessing patient experiences of detailed 
aspects of care, only a single questionnaire has been specifically designed for use in 
patients with musculoskeletal disorders,198-202 i.e. the Picker musculoskeletal 
disorders (MSD) questionnaire.203 This questionnaire may be useful in certain 
settings; however, the length of this instrument (16 items) is a concern in pragmatic 
studies in which patient experiences are collected alongside other data such as patient 
outcomes. In addition, since patient experiences are context-specific and dependent 
upon the population being studied,204, 205 the Picker MSD questionnaire may not be 
relevant to all manual therapy health care services. As a result of the fact that 
standardised questionnaires cannot be used in all service areas, self-developed patient 
experiences items have been used to complement outcomes questions in evaluations 
of health care services for low back pain.206, 207  
In order for patient experiences questions to be relevant to patients, there is a need to 
assess the most important aspects of the process of care. Research in this field has 
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shown that access to care (e.g. facilities, parking, cleanliness), which is so prominent 
in many surveys, is less of a concern in patients’ appraisal of the process of care than 
receiving adequate explanations, spending sufficient time with the practitioner as 
well as being involved in decisions about care.208-210 Having someone show empathy 
and take the time to listen and explain is a priority for patients.211, 212 The failure to 
communicate information about the condition and treatment options is an important 
source of patient discontent.213, 214 These findings indicate that the practitioner’s 
attributes are of primary concern to patients and, therefore, questions evaluating 
patient experiences of the process of care should focus on these.  
The number of categories on scales is another issue of importance in measuring 
patient experiences of the process of care. Garatt et al.215 compared the shape of the 
distribution of 5-point versus 10-point scales and found that the use of 10-point 
scales resulted in non-symmetrical distributions. These findings were due to a 
tendency for patients to select higher satisfaction scores on a 10-point scale, thus 
suggesting that patients may be reluctant to use all categories on this scale. 
Therefore, since 5-point scales performed better than scales with a higher number of 
categories, the use of the former may be more suitable for assessing patient 
experiences. 
Following the determination of patient experiences of the process of care, these data 
should be interpreted in a meaningful way. Five-point scales are typically presented 
with a neutral category in the centre (i.e. ‘neither satisfied nor dissatisfied or don’t 
know’), two positive categories at one extreme (i.e. ‘satisfied or good’ and ‘very 
satisfied or very good’) and two negative categories on the opposite extreme (i.e. 
‘dissatisfied or poor’ and ‘very dissatisfied or very poor’).207, 216 Evidence from a 
qualitative study suggests that patients can differentiate between the two positive 
categories.217 For some, the category ‘satisfied or good’ was described as adequate or 
average, for others it meant that there were aspects of care that could be improved, 
thus optimal care was not achieved. In contrast, the category ‘very satisfied or very 
good’ was described by patients in ways that meant optimal care had been provided. 
Consequently, distinguishing between both positive categories would be a useful 
means to interpret ratings of patient experiences and thus understand where future 
health care could be improved. This may be done by reporting the percentage of 
patients rating ‘very satisfied or good’ against all other categories.217 
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3.3.2 Patient experiences of the safety of care 
Patient experiences of safety or adverse events of care can be collected in two 
different ways: reporting by providers through interviews with patients and by 
patients themselves using patient-reported instruments.218 While data collected by 
clinicians are often preferred because of the level of clinical detail that is provided, 
this method can be time consuming, thus potentially interrupting clinical activities.219 
In addition, clinician-reported methods rely on the clinician’s subjective appraisal of 
the patient’s reaction to treatment and may thus not be entirely accurate.12 Indeed, a 
study comparing clinician and patient reports of adverse events in hospitals found 
wide variations between both reporting strategies, with many events that were not 
documented by clinicians.219 Similar discrepancies were found in a study comparing 
both methods of reporting data in acupuncture patients.218  
The disparities between data about adverse events reported by patients and clinicians 
may be explained by different definitions of such events. Other reasons include 
under-reporting by clinicians, perhaps due to concern about medico legal liability, 
and over-reporting by patients due the use of checklists with tick boxes.12, 218, 219 As a 
result of the limitations of both methods of collecting data, different sources of 
information about adverse events are recommended.  
The methods of measuring adverse events are not the only source of variation in 
results. The definitions used to define such events may also lead to differing findings. 
Although there is currently no consensus about the best way to define adverse events 
following manual therapy for low back pain, previous studies conducted by 
chiropractors, osteopaths and physiotherapists have shown a trend regarding the 
presentation of such events.164, 165, 167, 168, 220, 221 These studies found that adverse 
events were mainly transient and experienced within 24 hours of treatment as well as 
typically characterised by an aggravation of the patient’s complaint or the 
development of new symptoms such as stiffness, soreness and local or radiating 
discomfort. In addition, participants reported in a qualitative study that the severity 
of adverse events was best explained by the impact of symptoms on physical 
functioning.222 According to these participants, physical functioning had priority over 
other factors in evaluating the severity of an adverse event. Hence, questions 
assessing adverse events could be inspired from the findings of these studies.  
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3.4 Conclusion 
Although the assessment of patient outcomes provides crucial information about the 
patient’s progression in terms of improvement and recovery, it does not supply data 
about the cost of treatment, nor does it inform stakeholders about the patient’s 
experience of the delivery and safety of care. Hence, patient experiences and costs of 
care are considered a valuable addition to patient outcomes in performing a 
comprehensive health care evaluation. 
The evaluation of costs enables the attribution of a monetary value to treatment 
outcomes. Therefore, this information is essential in enabling patients to make 
informed decisions about their treatment and assist commissioners in allocating 
resources. However, there are a number of challenges in assessing health care costs, 
including data collection and analysis as well as linking costs to outcomes in a 
meaningful way.  
Patients’ experience of health care, including their opinion about the process and 
safety of care, is useful in assessing the interpersonal dimension of, and potential 
adverse events resulting from, the service under scrutiny. Despite the importance of 
patient experiences in health care, the majority of studies assessing this concept have 
used self-developed questions, mainly due to the fact that no gold standard exists for 
its assessment.  
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CHAPTER 4 
Research plan  
4.1 Background 
As a result of rising health care costs and mounting pressure to improve the delivery 
of health care, there is a need to assess the quality and cost of care in all service 
areas. In the United Kingdom, this information has not been determined in 
chiropractic clinics for the provision of routine services for patients suffering from 
low back pain. This is in contrast to the fact that manual therapy has become an 
increasingly popular therapeutic approach for low back pain, and the number of 
clinical trials conducted in this field has escalated.  
To assess quality and cost of care, the use of a relevant and practical instrument is 
essential. However, the review of the literature has shown that assessing this 
information is not only complex but there is currently no comprehensive or 
standardised patient-reported instrument for low back pain that can simultaneously 
measure costs as well as the two indicators of the quality of care, i.e. patient 
outcomes and experiences.  
4.2 Aim 
The aim of this study was therefore to develop and use an instrument assessing the 
quality and cost of routine chiropractic care in low back pain patients to inform a 
range of stakeholders. Collection of data in busy routine practice necessitated a 
pragmatic approach at the same time as ensuring the instrument was fit for purpose. 
4.3. Objectives 
The objectives of this study were:  
PHASE I - To review the existing knowledge base: 
• To select outcomes relevant to patients, clinicians and healthcare purchasers 
to evaluate low back pain patients undergoing chiropractic treatment, as well 
as methods to measure these. 
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• To select methods of reporting outcomes data in ways that are meaningful to 
stakeholders including patients, clinicians and healthcare purchasers. 
• To select patient experiences relevant to patients, clinicians and healthcare 
purchasers in low back patients undergoing chiropractic treatment, as well as 
methods to measure these. 
• To select methods to measure costs of care relevant to patients, clinicians and 
healthcare purchasers in low back patients undergoing chiropractic treatment. 
PHASE II - To develop an instrument: 
• To measure patient-reported outcomes, experiences and related costs of care 
in low back patients undergoing chiropractic treatment. 
• To capture this information in a comprehensive, relevant and pragmatic 
manner suitable for patients attending a primary care practitioner. 
PHASE III - To undertake a pilot study: 
PHASE IIIa  
• To evaluate the clarity of the documentation. 
• To evaluate the feasability of the data collection process. 
PHASE IIIb  
• To refine the documentation and data collection process based on the results 
of these evaluations. 
PHASE IV - To undertake a main study: 
PHASE IVa  
• To document outcomes, patient experiences and related costs of care in low 
back patients undergoing chiropractic treatment. 
• To evaluate methods of reporting outcomes data in a meaningful manner to 
patients, clinicians and purchasers of healthcare. 
• To evaluate the data collection instrument in terms of: 
a. Accuracy of patient-reported number of visits made to the clinic. 
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b. Responsiveness of health status measures. 
c. Construct-validity of measuring recovery. 
d. Clarity and face validity. 
PHASE IVb  
• To refine the instrument based on the results of these evaluations. 
4.4 Research questions 
The reserach questions of this study were: 
PHASE I - To review existing knowledge base: 
• What outcomes are relevant to low back patients undergoing chiropractic 
treatment and how are these measured? 
• How are outcomes data reported in ways that are meaningful to stakeholders 
including patients, clinicians and healthcare purchasers? 
• What patient experiences are relevant to low back patients undergoing 
chiropractic treatment and how are these measured? 
• How are costs of care that are relevant to patients, clinicians and healthcare 
purchasers measured in low back patients undergoing chiropractic treatment? 
PHASE II - To develop a patient-reported instrument: 
• How are patient-reported outcomes, experiences and costs of care measured 
in low back patients undergoing chiropractic treatment? 
• How is this information captured in a comprehensive, relevant and pragmatic 
manner suitable for patients attending a primary care practitioner? 
PHASE III - To undertake a pilot study: 
PHASE IIIa  
• What is the clarity of the documentation? 
• What is the feasibility of the data collection process? 
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PHASE IIIb  
• What refinements can be made to the documentation and data collection 
process based on the results of these evaluations? 
PHASE IV - To undertake a main study: 
PHASE IVa  
• What are the outcomes, patient experiences and related costs of care in low 
back patients undergoing chiropractic treatment? 
• How can outcomes data be reported in a meaningful manner to patients, 
clinicians and purchasers of healthcare? 
• To evaluate the data collection instrument in terms of: 
a. What is the accuracy of patient-reported number of visits made to 
the clinic? 
b. What is the responsiveness of the health status measures? 
c. What is the construct-validity of measuring recovery? 
d. What is the clarity and face validity of the instrument?  
PHASE IVb  
• What refinements  can be made to the instrument based on the results of 
these evaluations? 
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CHAPTER 5 
Development of data collection instrument 
5.1 Introduction 
Developing a data collection instrument is an important task as it captures the raw 
data that will be used for the analytical part of a research study. Statistical 
manipulation cannot be used after data have been collected to compensate for poor 
content or missing questions. Therefore, all aspects of the condition being assessed 
should be taken into consideration when questionnaire items are devised.137  
Notwithstanding the importance of capturing a maximum of relevant and 
comprehensive information using patient-reported instruments, due to being 
administered in a clinical setting, the length of such measures is always a 
consideration. As such, these questionnaires require particular emphasis on 
practicality and conciseness while at the same time providing an adequate amount of 
information about each aspect of the condition under study.  
The ultimate goal of data collected from patient-reported instruments is to inform 
patients and researchers, as well as to provide support for healthcare commissioning. 
Given the importance of these activities, patient-reported measures should be 
relevant to patients themselves and be supported by published evidence. If validated 
measures are not available to investigate a domain, care should be taken to find other 
relevant sources of scientific evidence to support its measurement.14, 223 
The aim of this chapter is to describe the development of a data collection instrument 
to measure patient outcomes and experiences, as well as costs of care, for patients 
with low back pain in routine chiropractic practice.  
5.2 Methods 
Data collection for the study took place on two occasions; first at baseline before the 
initial consultation and second at three months. Two instruments, ‘Questionnaire 1 at 
initial consultation’ and ‘Questionnaire 2 at three months’, were designed to capture 
the following: 
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• Patient and clinical characteristics at baseline. 
• Patient outcomes at follow-up and in the intervening period of three months.  
• Patient experiences of care during the 3-month period. 
• Costs of care during the 3-month period. 
There were a number of challenges when developing these instruments. Firstly, the 
questionnaires had to be simple and concise to avoid causing any interruption of 
clinical activities. To avoid confusion, skip patterns,224 in which participants are 
referred to a new section of the questionnaire to avoid items not relevant to them, 
were not used. Therefore, each question was answerable by all participants. 
Secondly, since data were not collected during the intervening period from the first 
(baseline) to the second (three months) data collection point it was challenging to 
determine the course of the condition, including the pattern of recovery over this 
time period from a single measure at the end. 
5.3 Results 
Table 5.1 shows a summary of the items included in the baseline and follow-up 
questionnaires, which are given in Appendix 1. In the follow-up questionnaire, 
patients had to recall the progress of their condition over the 3-month period and the 
questionnaire was designed to take this into account. Patients had to recall how they 
felt today (the day they completed the questionnaire), in the past week and in the past 
three months. 
Baseline demographic and clinical characteristics, recorded in the baseline 
questionnaire, were gender, age, employment status, duration of presenting episode 
of low back pain and medication usage.  
Four validated prospective outcome measures were included in the first and second 
questionnaires. First, the Roland-Morris Disability Questionnaire (RMDQ),35 which 
is a disability condition-specific questionnaire for low back pain, second, the 
Bournemouth Questionnaire (BQ),41 which is a comprehensive multidimensional 
condition-specific outcome measure and third, the EuroQol-5D (EQ-5D),50 which is  
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Table 5.1 
Structure of data collection instrument. 
1. Demographic and clinical characteristics at baseline 
• Age 
• Gender 
• Work status 
• Duration of presenting episode of low back pain 
• Medication usage 
2. Patient outcomes  
a. At follow-up (prospective) 
• Roland-Morris Disability Questionnaire (RMDQ) 
• EQ-5D 
• Bothersomeness scale 
• Bournemouth Questionnaire (BQ) 
b. In the intervening period (retrospective) 
• Global Perceived Effect (GPE) scale 
• Recovery  
3. Patient experiences during the 3-month period 
a. Process of care 
• Satisfaction with care 
• Perceived helpfulness of care 
b. Safety of care during  
• Adverse events  
4. Cost of care during the 3-month period 
a. Direct costs 
• Chiropractic visits 
• Diagnostic procedures 
• Change in medication usage 
• Other healthcare usage 
• Disability/incapacity benefits 
b. Indirect costs 
• Work time loss 
5. Additional data collected at follow-up 
• Lifestyle changes 
• Questionnaire feedback 
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a generic non disease-specific instrument used to value health-related quality of life, 
and lastly, the bothersomeness scale,39 which is a single question asking about the 
degree of intrusion of the patient’s back pain. The second questionnaire also included 
two retrospective outcomes for measurement of the intervening period between the 
two data collection points. These were Global Perceived Effect83 and recovery. 
Patients were considered to be recovered if they are free of low back pain and are 
able to perform their usual physical and social activities without interference from 
their back pain for a whole month preceding the second data collection point.23, 78 
Measures of patient-reported experiences were included in the follow-up 
questionnaire. These questions measured aspects of the process and safety of care. 
Patient experiences with the process of care were: global satisfaction with care and 
perceived helpfulness of care. Safety of care was measured by assessing whether 
patients had experienced any adverse events and their severity during the 3-month 
period. In addition, a number of questionnaire feedback items and items about 
potential lifestyle changes that patients made during the 3-month period were 
included at the end of the follow-up questionnaire.  
Costs over the 3-month period (follow-up questionnaire) were measured from a 
healthcare and societal perspective. Direct costs were chiropractic visits, diagnostic 
procedures used, change in medication usage, as well as other healthcare usage and 
disability/incapacity benefits. Patients were asked to report on the number of 
treatments received over the 3-month period. Indirect cost to society was taken into 
consideration as work time loss because of back pain during the 3-month period.  
5.4 Discussion 
All scales assessing clinical and demographic characteristics except for the duration 
of the presenting episode of low back pain (i.e. chronicity) were self-developed 
based on items derived from a number of sources.85-87, 225-233 The scale assessing the 
chronicity of low back pain was adopted from the work by Dunn et al.234 In this 
qualitative study, the clarity of participants’ responses appeared higher using a 
question asking patients to recall their last pain-free month compared to a more 
traditional question asking patients to recall the time of onset of their low back pain. 
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All the included health status outcome measures and the GPE scale have been tested 
for validity, reliability, and responsiveness and shown to be robust. 34, 35, 39, 41, 50, 59, 235 
The RMDQ and EQ-5D, assessing condition-specific disability and generic HRQL 
respectively, were included in the instrument as they are frequently used in low back 
pain research, and recommended by low back experts and guidelines.9, 10, 25, 28, 34, 49, 55, 56 
In addition, the BQ and bothersomeness scale were included in the instrument so as 
to provide data about the multidimensional aspect of the condition, including 
physical, psychological, cognitive/behavioral and social dimensions of back pain.  
A 7-point GPE scale was used with ‘completely recovered’ at one extreme to 
determine, in addition to patient’s perceived improvement, whether the patient’s 
condition had resolved (i.e. conclusion of an episode of low back pain). The 7-point 
GPE scale has been widely used in the literature,83, 128, 132, 133, 138, 236 and has been 
shown to be as responsive as the more cumbersome 14-point scales.236 
 Questions about specifc aspects of recovery from low back pain (i.e. construct-
specific method of determing recovery) were also included in the instrument. In 
previous research, such questions have been based on the definition by de Vet et al.78 
in which recovery is dependent on pain-free periods. In the present study, in addition 
to pain, physical function and quality of life were investigated due to participants 
reporting in a recent qualitative study that these dimensions were important 
determinants of the concept of recovery from low back pain.23 The construct validity 
of this self-developed scale was determined in the main study by comparing patients 
categorised as recoverd using the construct-specific questions and patients 
categorised as ‘completely recoverd’ on the GPE scale (i.e. direct report of recovery). 
Patient experiences of the process of care were determined using two 5-point scales 
assessing global satisfaction with care and perceived helpfulness of care. Such 
measures have been used extensively in the literature.208 The scale assessing adverse 
events, i.e. patient experiences of the safety of care, was self-developed based on 
existing research about the most common presentation and severity of such events in 
low back pain patients receiving chiropractic care and other forms of manual 
therapy.164, 165, 167, 168, 220-222 
The validity of patient experiences scales is rarely reported in the literature. Since no 
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gold standard is available for patient-reported measures, validity is usually 
determined by measuring the degree of closeness of the measure under study to a 
measure of the same construct (i.e. construct validity).137 However, measures of a 
similar construct are generally not available for patient experiences, thus construct 
validity cannot be determined for scales assessing these.  
The scales used to assess all cost variables except change in medication usage were 
adopted from a randomized controlled trial of acupuncture and usual care conducted 
for the NHS.207 The determination of medication usage necessitated a scale that was 
specifically tailored to the study. Since pain medication for low back pain typically 
includes over-the-counter medication, it was difficult to determine the exact type or 
quantity of medication patients consumed during the study. Instead, patients were 
asked to report on the change in use of medication since the beginning of the study.  
Evaluating the validity of cost information is controversial since all methods of 
collecting these data suffer from drawbacks. For instance, practitioners may 
inadvertently omit data from patient records and patients may be unable to recall 
their health care usage. Despite this limitation, the validity of data about number of 
visits, which is typically the most important source of error in measuring costs, was 
assessed in a sample of patients from the main study by comparing patient-reported 
number of visits made to the clinic and the same information reported in patient 
records. 
The relevance of an instrument to stakeholders is dependent on the validity of its 
content. Content validity is a theoretical concept that refers to the extent to which the 
content of an instrument appears to comprehensively examine the full scope of the 
domain it is intended to measure.237 The data collection instrument included 
variables assessing all aspects of the quality of care as stated in the document ‘High 
Quality of Care for All’13 published by the Department of Health. Moreover, the 
instrument assessed all aspects of the cost of care as stated in the costing report for 
low back pain published by NICE,238 which accompanies the guidance for the early 
management of persistent non-specific low back pain.239 To provide information 
about the broader impact of low back pain on society, costs resulting from lost 
productivity were calculated. As such, the instrument tapped all relevant aspect of 
the quality and cost of care. 
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The clarity of an instrument is depicted by the notion of face validity. This concept 
refers to the participants’ subjective assessment of the presentation and relevance of 
the patient-reported instrument.137 This was determined by including in the follow-up 
questionnaire three participant feedback questions about the clarity, length and 
relevance of the questionnaires they completed. 
5.5 Conclusion 
A wide range of data was needed for meeting the objectives of this study and, 
therefore, a comprehensive yet pragmatic instrument was required for data 
collection. Due to the fact that no standardised measure was available for all 
constructs under scrutiny, validated measures were included in the instrument when 
possible, and self-developed scales based on existing evidence were used in all other 
cases. As such, the final instrument provided information about all aspects of the 
quality and cost of care in a succinct manner and could thus be used for data 
collection in the participating clinics.  
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CHAPTER 6   
Pilot study 
6.1 Introduction 
Collecting data in a pragmatic setting is an uncertain exercise. As a result, following 
the development of the data collection instrument, in studies using patient-reported 
data, a pilot study is typically conducted on a small number of patients or 
participants.240 A pilot study is a small scale rehearsal of the intended or main 
research enabling investigators to test the logistics of the data collection process. Any 
issues arising during a pilot study can be corrected prior or early in the main study’s 
data collection period.223 
A pilot study can be external or internal. An external pilot study is planned and 
carried out separately from the main study whereas an internal pilot study is 
conducted alongside the main study.240 The advantage of an external pilot study lies 
in the ability to refine the main study prior to its commencement. Pilot studies should 
have a well-defined set of aims and objectives to ensure methodological rigour and 
scientific validity.  
6.2 Aims and objectives 
The aims of this pilot study were to test and evaluate the methods of data collection 
including the clarity of the study documentation and feasibility of the data collection 
process. 
The objectives of the pilot study were: 
PHASE IIIa  
• To evaluate the clarity of the documentation (Appendix 1): 
o Baseline and follow-up questionnaire. 
o Cover letter accompanying data collection pack –                     
for the attention of chiropractors and clinic staff.  
o Cover letter accompanying follow-up questionnaire –  
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for the attention of participants. 
o User guide regarding data collection process. 
o Number of patient visits form and accompanying cover letter –          
for the attention of chiropractors and clinic staff. 
• To evaluate the feasibility of the data collection process: 
o Patient recruitment by chiropractors and/or clinic staff. 
o Administration of questionnaires by chiropractors and/or clinics 
staff. 
o Data storage procedures. 
PHASE IIIb  
• To refine the documentation and data collection process based on the results 
of these evaluations. 
6.3 Methods 
6.3.1 Selection of chiropractors 
A convenience sample of four chiropractors who were affiliated with the AECC and 
listed as members of the British Chiropractic Association for the year 2010 was used 
for the pilot study.  This type of sample was adopted to ease the communication as 
practitioner feedback was an important aspect of this pilot study. All four 
chiropractors agreed to participate in the research.  
6.3.2 Procedures of pilot study 
The pilot study was conducted in clinics between May and June 2010. Data 
collection took place on two occasions, at baseline (baseline questionnaire) and at 
three months (follow-up questionnaire). The four participating chiropractors were 
mailed a study pack containing a cover letter, a user guide, 10 questionnaires and 10 
pre-paid envelopes. Approximately five days after this mailing, the pilot practitioners 
and/or clinic managers were contacted by phone and/or electronic mail to enquire 
whether the data collection pack had arrived and whether they had any questions 
regarding the conduct of data collection and related procedures. A written log of 
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communications with any of the pilot practitioner and/or clinics managers and 
reflective notes were assembled and continually added to regarding any queries made 
or problems encountered throughout the study. Following completion of the data 
collection period, the pilot practitioners were acknowledged via phone and/or email 
for their involvement. In addition, they were asked: i) whether the instructions (cover 
letter and user guide) were clear and understandable; ii) whether patients had any 
issues with the baseline questionnaire including the information and informed 
consent sections; iii) whether there were any issues with the data collection process 
in general; and iv) how much time on average was needed for patients to read and 
complete the questionnaire.  
Chiropractors and/or their staff were asked to recruit 10 consecutive new low back 
patients fulfilling the following inclusion criteria: 
• Low back pain with or without leg pain as main complaint. 
• Aged 18 years or older. 
• No treatment for low back pain from a healthcare professional except from 
their GP in the past three months.  
• Literate in English. 
• Women who were not pregnant. 
The data collection process is shown in Figure 6.1. Eligible patients were asked to 
arrive at the clinic 10 to 15 minutes before their initial consultation to allow 
sufficient time to read about the study and complete the baseline questionnaire. 
Patients were asked by clinic staff to read the information at the start of the 
questionnaire and decide whether or not they wished to participate in the study. If 
patients decided to take part in the study, they were asked to sign the informed 
consent section of the questionnaire and complete all questions in the document. 
Once completed, the questionnaire was immediately returned to the AECC in a 
single pre-paid envelope. If patients decided that they did not want to take part in the 
study, the chiropractor or clinic staff recorded their gender and birth date at the back 
of the questionnaire and returned the questionnaire uncompleted.  
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Figure 6.1: Data collection process in pilot clinics. 
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Approximately five working days prior to the follow-up data collection point at three 
months, patients receiving care were mailed the follow-up questionnaire along with a 
cover letter and a pre-paid envelope. Participants were given the option to complete 
the questionnaire online by following a web link provided on the cover page of the 
paper questionnaire. Non-responders were sent a first reminder via phone and a 
second reminder via text message and/or electronic mail two and four weeks after the 
second data collection point respectively. A final reminder was conducted via 
telephone five weeks after the follow-up data collection point. Following completion 
of reminder procedures, participating chiropractors and/or clinic staff were sent the 
number of patient visits form requesting the number of visits participants made to the 
clinic between baseline and follow-up data collection points. 
6.3.3 Procedures of data analysis  
Analysis of written notes 
A qualitative approach based on thematic analysis241, 242 was used taking into 
consideration the verbal comments received from the pilot practitioners and the 
reflective notes taken as the study proceeded. Through systematic analysis of the 
written notes, main themes emerged.  
Analysis of patient data 
Baseline demographics were reported using descriptive statistics. Data from the 
baseline and follow-up questionnaires were scrutinised and the frequency of 
irregularities or inconsistencies in these recorded. Based on these recordings, those 
questionnaire items which required action were identified. 
6.4 Results 
Since it was difficult to contact practitioners on the telephone, the majority of 
feedback was received via electronic mail. Thirty-eight questionnaires were received 
from the pilot clinics, with only one of the practitioners failing to collect data on ten 
consecutive patients. This appeared to be largely due to the fact that this practitioner 
had recently started practising on his own and thus was seeing a limited number of 
new patients. Thirty-two patients consented to participate in the study, with 17 being 
male. The mean age of these patients was 43 (SD = 15.9) years. Twenty-one of the 
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patients consenting to participate responded to the follow-up questionnaire and two 
of these patients submitted their response online. Analysis of the written notes and 
patient data revealed two main themes: 1) issues pertaining to the data collection 
process and resulting changes, and 2) issues pertaining to the clarity of the 
documentation and resulting changes.  
6.4.1 Issues pertaining to the data collection process and resulting changes 
The results are presented in Table 6.1. All practitioners reported that conducting the 
study did not significantly disrupt their normal practice patterns and, in most clinics, 
completion of the baseline questionnaire took less time than initially anticipated. A 
number of changes were made to improve patient recruitment including adapting the 
data collection process for multi-practitioner clinics, and modifying the procedures 
regarding participants non-amenable to care and those participants not consenting to 
participate in the study. The reminder process was also addressed. Since telephone 
reminders did not increase the number of patients responding at follow-up, these 
reminders were not conducted in the main study. 
6.4.2 Issues pertaining to the clarity of the documentation and resulting changes  
The results are presented in Table 6.2. No issues regarding clarity were identified by 
practitioners. Patient data revealed that asking about the duration between recovery 
of low back pain and completion of the follow-up questionnaire was confusing for 
patients and, thus, this item was amended in the follow-up questionnaire.  In 
addition, a number of minor changes were made to the follow-up questionnaire and 
the accompanying cover letter, as well as to the number of visits form, so as to 
improve the understandability of these documents.  
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Table 6.1 
Issues pertaining to the data collection process and resulting changes. 
Issue (pilot study)   Change (main study) 
Patient recruitment practitioner specific  Patient recruitment made clinic specific 
The four participating chiropractors were 
working in multi-practitioner clinics. These 
practitioners commented that involving the 
clinic as whole as opposed to individual 
clinicians would maximise the number of 
new low back pain patients recruited in the 
study. 
 The instructions were modified in the user 
guide. Making the study clinic specific 
allowed for any new low back pain patients 
attending multi-practitioner clinics to be 
recruited in the study. 
Baseline questionnaire returned 
uncompleted for non-consenting participants  
No record was kept of non-consenting  
participants  
If patients did not consent to participate in  
the pilot study, the baseline questionnaire  
was returned uncompleted with patient's  
gender and birth date recorded by clinic staff 
on the back cover of this questionnaire. A 
substantial number (6) of baseline 
questionnaires were returned uncompleted  
for these patients.    
  The user guide and baseline questionnaire 
were modified. If patients did not consent 
to participate in the study, the baseline 
questionnaire was returned to clinic staff 
and no further action was taken.  
No record of patients non-amenable to care  Information recorded at the back of the baseline questionnaire 
One practitioner commented on this issue. 
Since there was no record of patients non-
amenable to care, the follow-up 
questionnaire may have been posted to 
patients who did not receive care. 
  The user guide and baseline questionnaire 
were modified. After the initial consultation 
(with or without treatment), clinic staff 
recorded on the back cover of the baseline 
questionnaire whether the patient was 
receiving / would receive care at the clinic.  
Baseline questionnaire completion time:  
10-15 minutes  
Baseline questionnaire completion time: 
5-10 minutes 
All but one practitioner reported that patients 
completed the baseline questionnaire on 
average between 5 to 10 minutes. 
  The instructions in the user guide were 
modified. 
Third reminder conducted over telephone  
for non-responders at follow-up  No third reminder was conducted 
None of the participants responded to the 
telephone reminders. 
  Two reminders were conducted: first, via 
post, and, second, via electronic mail/text 
message. 
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Table 6.2 
Issues pertaining to the clarity of the documentation and resulting changes. 
Issue (pilot study)   Change (main study) 
Duration between recovery from low back 
pain and completion of the follow-up 
questionnaire 
 Item removed from follow-up questionnaire 
Patients were asked whether they were 
recovered (i.e. free of pain, able to carry out 
usual activities and achieved an acceptable 
quality of life for a whole month) at the time 
of completion of the questionnaire and, if so, 
for how long, over a whole month, they had 
been in this state. However, patient data 
revealed inconsistencies in the answers to 
this item: 
 Patients were asked, using the same  
definitions, whether they were recovered  
anytime during the previous 3 months and 
whether they were still recovered at the 
time of completion of the questionnaire (i.e. 
'today'). 
• In 3 cases, the patient was defined as 
‘recovered’ in one or more dimension(s) (i.e. 
pain, usual activities and/or quality of life) but 
did not complete the duration box.  
   
• In 3 cases, the patient was defined as 
‘recovered’ in one or more dimension(s) but 
a duration of less than four weeks was 
reported (i.e. not recovered). 
   
Cover letter for the attention of participants  Cover letter amended 
It may have been unclear that participants  
had to return the follow-up questionnaire  
even if they had completed their treatment. 
One participant stated during a reminder 
conducted over the telephone: 
 
This matter was clearly explained in the  
cover letter accompanying the  
follow-up questionnaire. 
• '... but I am not going to the chiropractor 
anymore so why would I have to complete 
the questionnaire?’     
Follow-up questionnaire instructions  Follow-up questionnaire instructions amended  
The additional time required by participants 
responding to reminders was not reflected  
in these instructions (reflective notes).   
Follow-up questionnaire instructions were 
reworded so as to take into consideration  
this additional period of time. 
Number of treatments made to clinic  Number of visits made to clinic 
The difference between a treatment  
session and an initial consultation may be  
unclear to patients (reflective notes). 
  ‘Number of treatments' reworded to 
'number of visits' in the follow-up 
questionnaire and in the number of visits 
form. 
Overall satisfaction scale  Satisfaction scale replaced with more  detailed scale 
This scale did not provide information  
about specific aspects of the delivery  
of care (reflective notes). 
  This scale provided information about the 
time and explanations given by the 
chiropractor as well as the patient's 
involvement in decisions about care. 
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6.5 Conclusion 
This pilot study provided an opportunity to evaluate all aspects of data collection 
within the actual setting of a chiropractic practice, and as such was instrumental in 
facilitating and informing the main study. The data obtained in this pilot study led to 
changes to both the data collection process and documentation, of which the main 
changes included rewording the questions requesting information on recovery from 
low back pain, and improving the reminder and patient recruitment processes.  
Due to the small sample size, it is unknown whether the patients and clinics included 
in this study provided sufficient heterogeneity to account for all the issues that could 
arise in the subsequent main study. However, as none of the participants in this pilot 
study, neither patients nor practitioners, were included in the main study, increasing 
the pilot sample size would have meant a reduction in available participants for the 
main study. A further limitation of this pilot study is that although comments were 
received from practitioners, the patients were not questioned regarding the clarity of 
the documentation. It may therefore have been useful to conduct face-to-face 
interviews with patients following the data collection process. 
All data from the pilot study were received by June 2010, and following analysis and 
consequential revisions, the main study was implemented in August 2010. 
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CHAPTER 7  
Main study 
7.1 Introduction 
The aims of the main study were to use the data collection instrument and procedures 
developed in the pilot study to assess the quality and costs of care in low back 
patients undergoing chiropractic treatment. In addition, observations were made to 
ensure the instrument was fit for purpose.  
7.2 Methods 
7.2.1 Study design 
The study was designed as prospective single cohort multi-centre study in which low 
back pain patients receiving chiropractic treatment were followed over a period of 
three months from the date of their initial consultation. 
7.2.2 Patient sample 
Sampling method 
Quality of care research resembles survey investigations closely in that findings in a 
portion of the population (i.e. sample) are generalized to the population under 
consideration (i.e. sampling frame),243 which in the present case was new episode 
low back pain patients undergoing chiropractic treatment. In survey research, the 
population is normally too large or unknown and, therefore, a portion of the sampling 
frame is selected for inclusion in the research study using sampling methods.244 Such 
methods aim to reduce bias in the selection of subjects, which may decrease the 
generalisability of results to the population under investigation.245  
Probability sampling is often considered as the method of choice when obtaining a 
sample.246 In probability sampling, potential participants are randomly or 
systematically selected from the sampling frame so as to ensure each patient has the 
same chance of being included in the study. 244, 245 This method was not possible in 
this study as it was not feasible to construct a sampling frame or, in other words, a 
list of all people in the United Kingdom planning to receive chiropractic treatment 
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for a new episode of low back pain. Moreover, low back pain patients should be 
treated immediately in accordance with clinical guidelines239, 247 and thus these 
patients had to be recruited in the study without delay. In the present study, a 
particular form of non-probability sampling was used called consecutive sampling. In 
consecutive sampling, a convenience (i.e. easy to access) sample of patients or 
subjects is selected in a consecutive manner.246 Consecutive sampling is considered 
to be the most appropriate non-probability sampling method since this procedure 
reduces the chance of participants being selected arbitrarily by practitioners or clinic 
staff.245 Chiropractic clinics were asked to recruit 10 patients into the study which 
was considered a feasible sample in that this number would not be overly onerous to 
the clinic.  
Sample size 
In order to determine the number of participants that should be included in a study, 
some form of effect size, such as the magnitude of the difference or effect between 
patient groups, is typically required. No effect size as such was measured to evaluate 
the quality and related cost of care in this study and, therefore, traditional sample size 
statistics based on effect size and statistical power were not relevant.248 Survey 
sample size statistics may appear to be more relevant in this situation but these 
procedures are based on the assumption that the entire population under 
consideration is known (i.e. sampling frame).243 Without prior knowledge of the size 
of the sampling frame, the best alternative was to take as large a sample as possible 
within the resource constraints of the study. Incorrect inferences from the data 
collected are less likely to be made when samples are larger rather than small. 
Furthermore, the larger the sample studied, the more likely the sample findings will 
be representative of the sampling frame and population.249  
Although, sample size estimation could not be performed for meeting most of the 
study objectives, it was necessary to perform this calculation for one of the research 
questions. This was to determine the number of patient files to be screened for the 
evaluation of patients’ accuracy of recall of number of visits. The accuracy of recall 
was determined by measuring the difference between the mean number of visits 
made to the clinic as reported by patients and the mean of the same information 
reported in patient files. The effect size corresponds to the magnitude of the 
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difference between two means and, thus, an estimation of sample size could be 
performed.250 Sample size is calculated taking into account a number of factors. First, 
the alpha level (α) or level of statistical significance which guards against the null-
hypothesis being incorrectly rejected (i.e. type I error), second, the beta level (β) 
which guards against the null-hypothesis being incorrectly accepted (i.e. type II 
error) and, third, the statistical power (P), which is defined as P = 1-β.248, 249 The 
alpha level and statistical power are conventionally set at 0.05 or 5% and 0.80 or 
80% respectively.248 Using the software GPower 3.1, a moderate effect size (0.30)251 
yielded a sample size of 84 subjects. As a result, patient files were screened in 17 
clinics assuming a conservative patient response rate at follow-up of 50% (i.e. five 
files per clinic), which gave a total of 85 subjects. 
7.2.3 Recruitment and sample of chiropractors 
The study was promoted to chiropractors listed as members of the British 
Chiropractic Association from the beginning of the study (February 2009) to the start 
of data collection (August 2010). Practitioners were invited to participate in the study 
through presentations held at conferences and articles published in periodicals as 
well as emails sent to them via relevant associations. As an inducement to participate 
in the study, each participating practitioner/clinic manager was entered in a prize 
draw, which was conducted at the end of data collection. The companies and 
institutions that donated these items did not place any conditions on these 
contributions in terms of research design, conduct and publication.  
The main study was conducted in clinics between August 2010 and July 2011. Those 
clinics that responded to the invitation to participate were mailed a study pack 
containing a cover letter, a user guide, 10 baseline questionnaires (Appendix 2) and 
10 pre-paid envelopes. The participating clinics were allocated to three groups that 
were mailed the study pack on different dates so that not all clinics were recruited at 
the same time. 
Two weeks following dispatch of their study pack, participating chiropractors and/or 
clinic staff were contacted to confirm receipt of the documentation and to determine 
whether they had any queries regarding the data collection process.  
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7.2.4 Data collection procedures  
Chiropractors and/or their staff were asked to recruit 10 consecutive new low back 
patients who fulfilled the inclusion criteria. A diagram of the data collection process, 
revised following the pilot study, is presented in Figure 7.1. Eligible patients were 
asked to arrive at the clinic 5 to 10 minutes before their initial consultation to allow 
sufficient time to inform themselves about the study and complete the baseline 
questionnaire. After reading the information at the start of the questionnaire, patients 
decided whether or not they wished to participate in the study. If patients decided to 
take part, they were asked to sign the informed consent section of the questionnaire 
and then respond to questions. Following the initial consultation (with or without 
treatment), the chiropractor or clinic staff recorded at the end of the questionnaire 
whether the patient was receiving/would receive chiropractic care, and returned the 
document in a single pre-paid envelope. If patients decided that they did not want to 
take part in the study, they were asked to return the questionnaire to clinic staff and 
no further action was taken.   
Approximately five working days prior to the second data collection point at three 
months, participants were mailed the follow-up questionnaire (Appendix 2) along 
with a cover letter and a pre-paid envelope. If participants found it more convenient 
to submit the questionnaire online, they could do so by following a web link 
provided on the cover page of the paper questionnaire. Non-responders were sent a 
first reminder via phone and a second reminder via text message and/or electronic 
mail, two and four weeks after the second data collection point respectively.  
Following completion of reminder procedures, 17 clinics were randomly selected 
from the participating clinics database using computer generated numbers, and these 
clinics were sent the number of patient visits form requesting the number of visits 
participants made to the clinic between baseline and follow-up data collection points 
(Appendix 2). 
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Figure 7.1: Data collection process in pilot clinics. 
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7.2.5 The chiropractic intervention 
No restrictions or guidelines were given to chiropractors with regards to treatment 
and patients were managed as they normally would be in routine care. A number of 
therapeutic procedures are typically used by chiropractors in the United Kingdom 
including manipulation or adjustment, advice about therapeutic exercise and 
activities of daily living (e.g. postural and ergonomic advice), as well as psychosocial 
counseling.252, 253 Although guidelines have been published recommending manual 
therapy (i.e. manipulative therapy, acupuncture and exercise) for the treatment of 
non-specific low back pain,239, 247 there is currently no firm evidence that favours one 
treatment approach over another. Hence, this study was entirely pragmatic in terms 
of the nature of the intervention and the number of treatment sessions for each 
patient.  
7.2.6 Ethics 
After having been informed about the study, all patients wishing to participate were 
required to give written consent as part of the baseline questionnaire. Participants 
were informed that they could withdraw from the study at any time without prejudice 
and that the information they provided would remain anonymous. The study was 
granted approval by the AECC Research Ethics Sub-Committee in October 2009 
(Appendix 3). 
7.2.7 Quality check for data entry errors 
Data were cleaned and investigated for data entry errors. A random selection, 
determined using computer generated numbers, of 177 questionnaires (approximately 
25% of all questionnaires) was checked manually, in which no data entry errors were 
found. However, it was discovered, in a small number of patients, that data from 
aspects of the construct-specific recovery from low back pain questions had been 
entered in wrong columns, thus theses incorrect values were corrected.  
7.2.8 Data analysis 
Statistical analysis for this study was undertaken using SPSS version 20.0 (IBM, 
Inc., New York, USA). Histograms of the frequency distribution of the continuous 
variables are presented in Appendix 4A, 4B and 4C. These variables were 
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approximately normally distributed except for cost data in which the distribution was 
highly skewed.  
Missing data were reported for all analyses, and as these data were less than 5% for 
all variables except lifestyle changes (ranging from 5% to 11%) and EQ-5D change 
scores (7%), a complete case analysis was performed. The use of this approach is 
substantiated by the work of Scheffer,254 in which simulations using differing levels 
of missing data showed that a percentage of missing data less than 5% had no 
significant impact on the calculation of means and standard deviations irrespective of 
the pattern of missingness (i.e. missing or not missing at random).  
In addition to descriptive analyses using mean and standard deviation for continuous 
variables as well as number and percent for categorical and ordinal variables, more 
detailed analyses were performed in order to answer the research questions of the 
study. 
Documentation of health outcomes, patient experiences and costs of care as well as 
evaluation of outcome reporting methods 
The scales of the RMDQ, BQ, EQ-5D and bothersomeness scale were transformed to 
cover an interval ranging from 0-100, thus enabling comparison between measures in 
spite of their different scoring intervals. Baseline and follow-up health status scores 
were compared using dependent t-tests. The raw change score for each health status 
measure was obtained by subtracting the follow-up score from the baseline score 
except for the EQ-5D for which the baseline score was subtracted from the follow-up 
score. The percentage change score was also determined for the individual BQ scales 
and the formula for this calculation was: (raw change score/baseline score)*100.129  
The EQ-5D scores at baseline and follow-up were transformed into utilities using a 
representative British sample.255 In addition, quality adjusted life years (QALYs) 
participants had experienced over the 3-month study period were estimated by 
calculating areas under the health utility curves,163 with straight-line interpolation 
between utilities at baseline and follow-up (an example of this calculation is given in 
Appendix 5).  
60 
 
The raw and percentage minimal clinically important difference (MCIDr and 
MCID% respectively),  which represent the cut-off of clinical improvement, were 
determined using three distribution-based methods, i.e. 0.5 ES,159 1 SEM,145 and 1.96 
RCI,105  as well as one anchor-based method, i.e. ROC.256 These four methods were 
selected as they have been the most frequently used and recommended in the field of 
outcomes research for low back pain.107, 109, 146 The formulas used for the 
distribution-based methods were: half a standard deviation at baseline for the 0.5 ES 
method, the standard deviation at baseline multiplied by √(1 – reliability coefficient) 
for the 1 SEM method, and 1.96  multiplied by √(2SEM2) for the 1.96 RCI method. 
In the ROC method, the GPE scale was used as the external criterion to determine 
the ability of the measure to diagnose patients correctly as clinically improved (i.e. 
sensitivity) and the ability to diagnose patients correctly as clinically non-improved 
(i.e. specificity). The participants who selected categories ‘very much improved’ or 
‘completely recoverd’ on the GPE scale were considered clinically improved, and the 
change score on the outcome measure that maximised sensitivity and specificy 
indicated the MCID.  
Using indirect methods of measuring improvement (i.e. using the cut-offs on RMDQ, 
BQ, EQ-5D and bothersomness scale), patients were classified as clinically improved 
or clinically non-improved and the proportion of patients  clinically improved was 
determined. Confidence intervals for these proportions were obtained using the 
Unmodified Wald method described by Newcombe.257 This procedure was also used 
to calculate confidence intervals for the percentage of patients rating the process of 
care as ‘very helpful’ or ‘very good’. 
To determine the diagnostic accuracy of each cut-off method, the sensitivity, 
specificity and Cohen’s Kappa coefficient were determined for each threshold 
approach. Sensitivity and specificity were calculated using 2x2 tables (an example of 
this calculation is given in Appendix 6), and ROC plots were constructed to explore 
the sensitivity and 1-specficity of each cut-off approach using an external criterion of 
improvement. The criterion used in this study was the proportion of patients 
clinically improved using the direct method of measuring improvement (i.e. patients 
categorized as clinically improved on the GPE scale). 
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Cohen’s Kappa coefficient (i.e. non-weighted Kappa) was used as an indicator of 
overall agreement between both methods of determining improvement and represents 
percentage agreement between methods corrected for chance.258 The values of Kappa 
can range from -1 to +1 (i.e. perfect agreement), although, in practice, values below 0 
(i.e. agreement no better than chance) rarely occur. The Kappa coefficient was 
evaluated using the categorisation by Fleiss: ≥ 0.75, strong agreement; 0.4–0.75, 
moderate agreement; and ≤ 0.4, poor agreement.259  
Costs of care were calculated by multiplying unit costs by health care usage. Unit 
costs were determined from relevant national databases and values were adjusted for 
inflation when required (Appendix 7). Ninety-five percent confidence intervals for 
mean costs were calculated using bias-corrected and accelerated non-parametric 
bootstrapping with 1000 replications.179   
To examine for potential biases from loss to follow-up, socio-demographic and 
clinical characteristics, as well as baseline health status scores, for participants who 
completed and did not complete the follow-up questionnaire were compared using 
the independent t-test for continuous variables and the Chi2 test for categorical 
variables. 
Evaluation of data collection instrument 
Evaluation of the responsiveness of health status measures included the assessment 
of both internal and external responsiveness. Internal responsiveness reflects the 
ability of a measure to change over a pre-specified period, and external 
responsiveness denotes the extent to which change in a measure over a pre-specified 
period relates to corresponding change in a reference criterion.260 Internal 
responsiveness is typically determined using one of two methods: i) Cohen’s effect 
size (i.e. change in the measure divided by the standard deviation of baseline scores) 
and the standardized response mean (i.e. change in the measure divided by the 
standard deviation of change scores).261  
In the present study, Cohen’s effect size was selected as it has been the most 
frequently used to assess internal responsiveness in low back pain research and has 
been recommended by experts in this field.29, 261 Indeed, Norman and colleagues 
recommend the use of this measure as anchoring observed change against variability 
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at baseline may be less vulnerable to extreme values than its alternative. In addition, 
Cohen’s effect size facilitates interpretation since effect sizes can be compared to 
standards of size such as Cohen’s small (0.2), medium (0.5) and large (0.8) 
thresholds.137   
Internal responsiveness methods share the limitation that they do not relate change in 
the measure to an external measure of clinical change (i.e. external responsiveness), 
thus the clinical importance of the observed change cannot be determined.260 To 
remedy this problem some investigators have calculated an effect size statistic only 
for patients who rate their health as clinically improved.261 The major weakness of 
this approach is that it does not involve a comparison of change in the measure 
between patients who are clinically improved and clinically non-improved.260  
In the present study, external responsiveness of the health status measures was 
determined using the area under the curve (AUC) of ROC analysis.262 The ROC 
curves were plotted as sensitivity against 1-specificity for different cut-off points in 
change scores. The area under the curve is an indicator of the probability of correctly 
identifying the clinically improved patients from the non-clinically improved 
patients. An AUC of 0.5 indicates chance discrimination, whereas a minimal value of 
at least 0.7, arbitrarily, is considered to be acceptable and 1.0 perfect discrimination.  
The criterion validity (accuracy) of patient-reported number of visits made to the 
clinic was assessed using the non-parametric approach to comparing methods by 
Bland and Altman,263 which involved plotting the differences between patient-
reported visits and visits as based on patient files (patient-report – patient file) versus 
mean values of the two methods. The number of visits obtained using both methods 
were compared using Wilcoxon signed-rank test, and the significance of the 
relationship between the differences versus the mean was assessed using Spearman 
correlation coefficient. In addition, the limits within which the majority of 
differences fell were determined using visual inspection of the graph (accurate 
reporters were considered as those values between -1 and +1).  
Evaluation of the construct validity of measuring complete recovery from low back 
pain using construct-specific questions was investigated by assessing the agreement 
between patients categorised as completely recovered using the GPE scale and the 
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construct-specific questions (i.e. acceptable quality of life, no disability and no pain 
for a whole month). Cohen’s Kappa coefficient (i.e. non-weighted Kappa) was used 
as an indicator of overall agreement. In addition, positive percent agreement (PPA) 
and negative percent agreement (NPA) were calculated to provide information about 
the types and sources of potential disagreement.264 Positive percent agreement 
depicts the percentage of patients correctly categorised as completely recovered (i.e. 
as per GPE scale) using the construct-specific method, and NPA indicates the 
percentage of patients correctly categorised as not completely recovered using the 
same method. The calculation of PPA and NPA is analogous to that of sensitivity and 
specificity (outlined in Appendix 6) respectively, with the only difference being that 
an imperfect reference standard is used for the determination of PPA and NPA. 
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7.3 Results 
7.3.1 Response rate 
Seventy-one clinics agreed to participate in the study, with a total of 123 
chiropractors working in these practices. Of these clinics, three single-practitioner 
clinics resigned from the study after receiving the data collection pack. The reasons 
given for this were: i) the study was too complex; ii) the receptionists did not feel 
comfortable conducting the study; and iii) the practitioner left the clinic for 
unforeseen circumstances. 
Given that clinics were each asked to return 10 patient-reported baseline 
questionnaires, the maximum possible number of participants for the remaining 
clinics was 680. These clinics returned complete sets of baseline data from 428 
patients. The main reason for not returning all 10 baseline questionnaires was a lack 
of new patients fulfilling the inclusion criteria within a reasonable time span for the 
study.  
A diagram of the flow of data throughout the study is shown in Figure 7.2. From the 
428 returned baseline questionnaires, seven forms were discarded due to non-
compliance with the inclusion criteria or excessive missing data, thus 421 patients 
formed the baseline sample of the study. The number of patients who completed the 
follow-up questionnaire was 238 (57% of the baseline sample), and of these, 214 
(90%) returned the questionnaire by post and 24 (10%) submitted the questionnaire 
online. 
Baseline data of the responder and non-responder cohorts (i.e. patients who 
completed the baseline questionnaire and did not complete the follow-up 
questionnaire) are shown in Table 7.1. Significant differences (p < 0.05) between 
responders and non-responders were found for age and gender. The patients who 
responded were older (mean = 47.3 years, SD = 13.13 years) than non-responders 
(mean = 40.4 years, SD = 14.45 years), and women were more likely to respond than 
men, with 136 (56%) of the responders being female. No significant differences 
between responders and non-responders were found for all other clinical and socio-
demographic variables (i.e. work status, pain history and medication usage) and for 
all baseline health status scores.  
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Figure 7.2: Diagram of flow of data throughout the study. 
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Table 7.1: Comparative analysis between responders and non-responders. Significant variables are 
marked with an asterisk (*).  
Variable   
 Responders  
(n = 238) 
Non-responders  
(n = 183) 
*Age Mean (SD, range) number of years  
Missing 
 47.3 (14.45, 19-88) 
2 
40.4 (13.13, 18-78) 
2 
*Gender Male 
Female 
Missing 
 104 (44) 
134 (56) 
0 
102 (56) 
81 (44) 
0 
Work status In paid (including self) employment  
At home and not looking for work 
Unemployed because of back pain 
Unemployed because of other reasons 
Retired 
Student 
Missing 
 183 (77) 
8 (3) 
1 (< 1) 
7 (3) 
35 (15) 
4 (2) 
0 
152 (83) 
6 (3) 
2 (1) 
5 (3) 
14 (8) 
4 (2) 
0 
Pain history < 3 months 
3-6 months 
7-12 months 
1-2 years 
3-5 years 
6-10 years 
> 10 years 
Missing 
 
84 (35) 
37 (16) 
29 (12) 
29 (12) 
23 (10) 
14 (6) 
21 (9) 
1 (< 1) 
76 (42) 
18 (10) 
21 (12) 
19 (10) 
15 (8) 
14 (8) 
19 (10) 
1 (< 1) 
Medication 
usage 
Never 
Rarely 
Sometimes 
Every day 
Missing 
 
50 (21) 
53 (22) 
83 (35) 
52 (22) 
0 
33 (18) 
32 (18) 
76 (42) 
40 (22) 
2 (< 1) 
Values are frequency (%) unless stated otherwise. N = number of observations. Statistical significance 
(p < 0.05) determined using Chi2 test for categorical and independent t-test for continuous variables. 
67 
 
 Table 7.1 (continued): Comparative analysis between responders and non-responders. Significant 
variables are marked with an asterisk (*). 
Variable   
 Responders  
(n = 238) 
Non-responders  
(n = 183) 
RMDQ Mean (SD) score 
Missing 
 
7.4 (5.13) 
0 
8.0 (5.46) 
0 
BQ Mean (SD) score 
Missing 
 
29.4 (15.41) 
5 
30.8 (14.62) 
2 
EQ-5D Mean (SD) score 
Missing 
 
0.59 (0.27) 
10 
0.60 (0.25) 
6 
Bothersomeness 
scale 
Mean (SD) score 
Missing 
 
3.5 (0.96) 
0 
3.5 (0.95) 
0 
RMDQ = Roland-Morris Disability Questionnaire. BQ = Bournemouth Questionnaire.  
EQ-5D = EuroQol-5D. 
 
 
 
 
7.3.2 Sample characteristics 
The socio-demographic and clinical characteristics of the baseline sample are 
presented in Table 7.2. Of the 421 patients, gender was equally distributed (206 male 
participants or 49% of sample) and the mean age was 44.3 years (SD = 14.30, range 
= 18-88) years. The majority of patients were in paid employment (335, 80%) and 
only a small proportion of participants (3, 1%) were unemployed because of back 
pain. The remaining patients were either not looking for work, unemployed for 
reasons other than back pain, retired or studying. The chronicity of low back pain 
ranged from less than 3 months to more than 10 years, with 169 (38%) participants 
suffering from an acute/subacute low back pain episode for less than 3 months. The 
majority of patients (251, 60%) were using pain medication for their back pain either 
‘sometimes’ or ‘everyday’, while the remaining participants used these drugs either 
‘rarely’ or ‘never’. 
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Table 7.2: Baseline description of 421 patients. 
Variable    
Age Mean (SD, range) years 
Missing 
 
44.3 (14.30, 18-88) 
4 (1) 
Gender Male 
Female 
Missing 
 206 (49) 
215 (51) 
0 
Work status In paid (including self) employment  
At home and not looking for work 
Unemployed because of back pain 
Unemployed because of other reasons 
Retired 
Student 
Missing 
 335 (80) 
14 (3) 
3 (1) 
12 (3) 
49 (12) 
8 (2) 
0 
Pain history < 3 months 
3-6 months 
7-12 months 
1-2 years 
3-5 years 
6-10 years 
> 10 years 
Missing 
 169 (38) 
55 (13) 
50 (12) 
48 (12) 
38 (9) 
28 (7) 
40 (10) 
2 ( < 1) 
Medication usage Never 
Rarely 
Sometimes 
Every day 
Missing 
 83 (20) 
85 (20) 
159 (38) 
92 (22) 
2 (< 1) 
Values are number (%) unless stated otherwise.  
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7.3.3 Health outcomes 
Health status scores are presented in Table 7.3. All health status measures including 
the RMDQ, the total BQ and BQ subscales, the EQ-5D and the bothersomeness scale 
showed significant raw change scores (p < 0.001) between baseline and follow-up 
data collection points, and using the calculation given in Appendix 5, the mean 
QALYs over the 3-month period was 0.174 (95% CI = 0.168 to 0.180).  
Despite raw change scores being statistically significant, there were important 
differences between measures with regards to percentage change scores. The 
percentage change scores for the RMDQ and total BQ were similar (62%) whereas 
these values were lower for the EQ-5D and bothersomeness scale (34% and 38% 
respectively).  
The mean RMDQ and total BQ scores were, respectively, moderate at baseline 
(mean = 30.8, SD = 21.37; mean = 38.1, SD = 19.99) and low at follow-up (mean = 
11.6, SD = 16.21; mean = 14.6, SD = 15.33). However, the mean bothersomeness 
score was high at baseline (mean = 69.2, SD = 19.26) and moderate at follow-up 
(mean = 42.8, SD = 18.62), and the mean EQ-5D utility score (i.e. higher utility 
score indicates better health) was moderate at baseline (mean = 59.5, SD = 27.14) 
and high at follow-up (mean = 79.8, SD = 20.22). 
The scores of the individual BQ domains generally tended towards the centre of the 
scales at baseline and towards the low end of the scales at follow-up. The percentage 
change scores of the BQ subscales ranged from 57% to 68%. At baseline, pain levels 
were moderate to severe (mean = 57.7, SD = 24.56), depression levels were low 
(mean = 26.9, SD =28.76), and all other BQ domains were moderately affected 
(mean scores ranging from 36.8, SD = 29.15, to 45.3, SD = 27.34). At the 3-month 
follow-up, the mean scores on the BQ subscales ranged from 10.4 (SD = 18.44) to 
24.3 (SD = 22.70).  
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Table 7.3: Health status scores (0-100 scale) in 238 participants of Roland-Morris Disability Questionnaire (RMDQ), Bournemouth 
Questionnaire (BQ), EuroQol-5D (EQ-5D) and bothersomeness scale (BS). 
 Baseline  Follow-up Missing  
*Raw change        
(95% CI) 
Percentage change 
(%) 
RMDQ 30.8 (21.37) 11.6 (16.21) 0 19.2 (16.31 to 22.00) 62 
BQ 
Pain 
Disability in activities of daily living 
Disability in social activities 
Anxiety 
Depression 
Fear avoidance beliefs 
Locus of control 
Total 
 
57.7 (24.56) 
45.3 (27.34) 
40.4 (31.20) 
36.8 (29.15) 
26.9 (28.76) 
44.4 (30.30) 
42.0 (27.11) 
38.1 (19.99) 
 
 
24.3 (22.70) 
16.5 (20.75) 
12.9 (20.15) 
13.9 (20.48) 
10.4 (18.44) 
19.1 (24.31) 
17.9 (21.23) 
14.6 (15.33) 
 
3 
2 
4 
1 
2 
1 
3 
8 
 
33.5 (29.73 to 37.25) 
28.8 (24.85 to 32.78) 
27.5 (23.15 to 31.89) 
22.9 (19.06 to 26.68) 
16.5 (12.84 to 20.21) 
25.3 (20.97 to 29.58) 
24.1 (19.79 to 28.38) 
23.5 (20.62 to 26.47) 
 
 
58 
64 
68 
62 
61 
57 
57 
62 
EQ-5D (utility) 59.5 (27.14) 79.8 (20.22) 18 20.3 (16.43 to 24.23) 34 
BS 69.2 (19.26) 42.8 (18.62) 1 26.5 (23.32 to 29.66) 38 
Values are in mean (SD) unless stated otherwise. Ranges of original scales: RMDQ = 0-24; total BQ = 0-77; Individual BQ scales = 0-10;  
EQ-5D = 0-1; BS = 1-5. * Significant difference (p < 0.001) between baseline and follow-up score using dependent t-test.  
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On the GPE scale (values given in Figure 7.3), of the 238 patients at follow-up, 45 
(19%, 95% CI = 14.0% to 23.9%) were categorised as ‘completely recovered’ and 
168 (71%, 95% CI = 64.8% to 76.3%) were considered clinically improved (i.e. 
category ‘very much improved’ and ‘completely recovered’). Construct-specific 
recovery from low back is shown in Table 7.4. Eighty-one (34%) of the patients at 
follow-up were pain free for a whole month at any time during the study, and 66 
(81%) of these patients were still in this pain-free period at follow-up. One hundred 
and thirty-seven (58%) and 170 (71%) of the patients at follow-up were able to carry 
out usual activities and achieved an acceptable quality of life, respectively, without 
interference from back pain for a whole month at any time during the study, and 115 
(84%) and 154 (91%) of these patients respectively were still in these interference-
free periods at follow-up. Complete recovery from low back pain, determined by 
recovery on all three dimensions (i.e. acceptable quality of life, no disability and no 
pain), at any time during the study, was achieved by 73 (31%) of the patients at 
follow-up, and 61 (84%) of these patients were still completely recovered at follow-
up. This indicates that 12 (5%) of the patients at follow-up had a recurrence of their 
presenting episode of low back pain within the 3-month period of the study.   
 
Figure 7.3: Frequency (%) perceived level of improvement in 238 participants,  
i.e. global perceived effect scale. 
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Table 7.4: Construct-specific recovery from low back pain in 238 participants. 
At anytime during the study  
i.e. since completing the baseline questionnaire 
At follow-up 
i.e. on the day of completion of the follow-up questionnaire 
Free of back pain for a whole month Yes  
No  
Missing 
 
81 (34) 
156 (66) 
1 (< 1) 
Still in pain-free period Yes  
No  
Missing 
 
66 (81) 
15 (19) 
0 
Able to carry out usual activities without 
interference from back pain for a whole month 
Yes  
No  
Missing 
 
137 (58) 
100 (42) 
1 (< 1) 
Still in interference-free 
period 
Yes  
No  
Missing 
 
115 (84) 
21 (15) 
1 (< 1) 
Achieved an acceptable quality of life without 
interference from back pain for a whole month 
Yes  
No  
Missing 
 
170 (71) 
67 (28) 
1 (< 1) 
Still in interference-free 
period 
Yes  
No  
Missing 
 
154 (91) 
15 (9) 
1 (< 1) 
Complete recovery i.e. ‘yes’ to the three previous 
questions about pain, usual activities and quality 
of life 
Yes  
No  
Missing 
 
73 (31) 
164 (69) 
1 (< 1) 
Still completely recovered Yes  
No  
Missing 
 
61 (84) 
12 (16) 
0 
Values are frequency (%). 
If yes 
If yes 
If yes 
If yes 
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The MCIDr and MCID% values (i.e. cut-offs) for each health status measure are 
presented in Figure 7.4. Sensitivity and specificity values for a range of cut-off points 
for each measure using ROC analysis can be found in Appendix 8. There was large 
variability in both the MCIDr and MCID% values within the instruments and across 
measures, calculated by the distribution-based methods (i.e. 1.96 RCI, 0.5 ES and 1 
SEM) and anchor-based method (i.e. ROC). In general, however, a similar pattern of 
results was obtained for the MCID% values for all measures except the EQ-5D. The 
MCID% values of the RMDQ, BQ and bothersomeness scale determined using the 1 
SEM, 0.5 ES, 1.96 RCI, and ROC respectively showed the same increasing order: 
15%, 35%, 43% and 61% for the RMDQ; 12%, 26%, 32% and 36% for the BQ; and 
6%, 14%, 17% and 43% for the bothersomeness scale. The EQ-5D demonstrated a 
different pattern from its counterparts, with 1.96 RCI yielding the highest percentage 
MCID% (29%), 1 SEM yielding the lowest MCID% (10%) and 0.5 ES and ROC 
each yielding a similar MCID% (24%).  
The proportions of patients improved for each measure, calculated by the indirect 
method of determining improvement (i.e. using the ROC, 1.96 RCI, 0.5 ES and 1 
SEM cut-offs) are shown in Figure 7.5. There was large variation in the proportion of 
patients improved by the same method across measures and across different methods 
within measures. Generally, however, the proportions of patients clinically improved 
showed an inverse relationship compared to the corresponding MCID% cut-off 
values (i.e. the lower the MCID%, the higher the proportion of patients improved and 
vice-versa) for all measures except for the bothersomeness scale. These proportions, 
using the ROC, 1.96 RCI, 0.5 ES and 1 SEM cut-offs, respectively, were: 42%, 49%, 
57% and 65% for the RMDQ; and 61%, 65%, 70% and 78% for the BQ. With 
respect to the EQ-5D, the proportion of patients clinically improved was highest 
using the 1 SEM cut-off (56%), lowest using the 1.96 RCI cut-off (42%), and similar 
using the 0.5 ES and ROC cut-offs (43%). Although different methods of 
determining the MCID yielded differing cut-offs for the bothersomeness scale, the 
proportion of patients clinically improved was similar using the 0.5 ES, 1 SEM and 
1.96 RCI cut-offs (74%), and was nearly half this value (40%) using the ROC cut-
off.
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 Figure 7.4: Percentage minimal clinically important difference (MCID%) for the Roland-Morris Disability Questionnaire (RMDQ), Bournemouth Questionnaire (BQ), EuroQol-5D 
(EQ-5D) and bothersomeness scale (BS) using four methods: 0.5 Effect Size (ES); 1 Standard Error of Measurement (SEM); 1.96 Reliable Change Index (RCI); and Receiver 
Operating Characteristic (ROC). Note: MCIDr = Raw minimal clinically important difference. 
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Figure 7.5: Proportion and 95% CI of patients clinically improved for the Roland-Morris Disability Questionnaire (RMDQ), Bournemouth Questionnaire (BQ), EuroQol-5D (EQ-
5D) and bothersomeness scale (BS) using four thresholds: 0.5 Effect Size (ES); 1 Standard Error of Measurement (SEM); 1.96 Reliable Change Index (RCI); and Receiver 
Operating Characteristic (ROC).
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In order to assess the diagnostic accuracy of the different thresholds of clinical 
improvement, each of them was plotted on a ROC graph against the criterion of 
clinical improvement, i.e. patients who selected the categories either ‘much 
improved’ or ‘completely recovered’ on the GPE scale (Figure 7.6). The agreement 
between patients categorised as clinically improved using the GPE scale and the cut-
offs was generally poor (Cohen’s Kappa coefficient ranging from 0.28 to 0.36). The 
general trend was for cut-offs to have moderate sensitivity and specificity, with the 
0.5 ES, 1 SEM and 1.96 RCI cut-offs tending to be more sensitive (0.57–0.90) than 
specific (0.49–0.85), and the ROC cut-offs tending to be more specific (0.63–0.91) 
than sensitive (0.52–0.73). 
 
Figure 7.6: Receiver operating characteristic plot depicting the sensitivity and 1-specificity for the 0.5 
Effect Size (ES), 1 Standard Error of Measurement (SEM), 1.96 Reliable Change Index (RCI) and 
Receiver Operating Characteristic (ROC) threshold approaches against the external criterion of clinical 
improvement (i.e. patients categorised as clinically improved on the Global Perceived Effect scale). 
Note: k = Cohen’s Kappa statistic; RMDQ = Roland-Morris Disability Questionnaire; BQ = 
Bournemouth Questionnaire; EQ-5D = EuroQol-5D; BS = Bothersomeness scale.  
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Lifestyle changes are shown in Table 7.5. An increase in awareness of early warning 
signs of back pain, specific exercises for back pain, care when lifting and awareness 
of posture was most frequently reported, with these variables being rated as 
‘increased’ by 136 to 181 (57% to 76%) of the patients at follow-up. Fewer patients 
reported an increase in rest and general physical activity/exercise, with 60 and 85 
(25% and 36%) of the patients at follow-up rating these variables as ‘increased’ 
respectively. 
 
Values are frequency (%). 
 
 
Table 7.5: Lifestyle changes in 238 participants. 
Variable    
Awareness of early warning signs 
of back pain 
Increased 
No change 
Decreased 
Missing 
 
136 (57) 
76 (32) 
2 (1) 
24 (10) 
Rest Increased 
No change 
Decreased 
Missing 
 60 (25) 
145 (61) 
6 (3) 
27 (11) 
Specific exercises for back pain Increased 
No change 
Decreased 
Missing 
 157 (66) 
65 (27) 
2 (1) 
14 (6) 
General physical activity/exercise Increased 
No change 
Decreased 
Missing 
 85 (36) 
112 (47) 
16 (7) 
25 (11) 
Care when lifting Increased 
No change 
Decreased 
Missing 
 160 (67) 
61 (26) 
1 ( < 1) 
16 (7) 
Awareness of posture Increased 
No change 
Decreased 
Missing 
 181 (76) 
45 (19) 
0 
12 (5) 
78 
 
7.3.4 Patient experiences of care 
Patient experiences of the process of care are shown in Table 7.6. Of the patients at 
follow-up, 129 (54%) rated the chiropractic care for their low back pain as ‘very 
helpful’ and a minority of these patients (12, 5%) rated this care as ‘unhelpful’ or 
‘very unhelpful’. The practitioners’ attributes (i.e. time and explanations given by 
chiropractor as well involvement in decisions about care) were most frequently 
perceived as very good, with these variables being rated as ‘very good’ in 157 to 168 
(66% to 71%) cases. Only rarely (6 cases, 3%) were practitioners’ attributes rated as 
‘unhelpful’. 
Patient experiences of the safety of care are given in Figure 7.7. Of the patients at 
follow-up, 125 (52%) experienced adverse events to care (i.e. worsening of their 
back pain, stiffness, soreness and/or general discomfort immediately or shortly after 
the chiropractic treatment visits). A minority of these patients (13, 5%) reported that 
they were unable to carry on with their usual activities and/or work as a result of 
these events. 
 
Table 7.6: Patient experiences of the process of care in 238 participants. 
Perceived helpfulness of care Very helpful 
Helpful 
Don’t know 
Unhelpful 
Very unhelpful 
Missing 
 
129 (54) 
67 (28) 
30 (13) 
9 (4) 
3 (1) 
0 
Percentage (95% CI) of patients who rated perceived helpfulness  
of care as ‘very helpful’  
 
54 (47.9 to 60.5) 
Rating of chiropractor giving the 
patient enough time  
Very good 
Good 
Don’t know 
Unhelpful 
Very unhelpful 
Missing 
 159 (67) 
61 (26) 
12 (5) 
6 (3) 
0 
0 
Percentage (95% CI) of patients who rated the chiropractor as ‘very 
good’ at giving enough time 
 67 (60.9 to 72.8) 
Values are frequency (%) unless stated otherwise. 
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Table 7.6 (continued): Patient experiences of the process of care in 238 participants. 
Rating of chiropractor giving the 
patient an explanation for their 
back pain 
Very good 
Good 
Don’t know 
Unhelpful 
Very unhelpful 
Missing 
 168 (71) 
57 (24) 
7 (3) 
6 (3) 
0 
0 
Percentage (95% CI) of patients who rated the chiropractor as ‘very 
good’ at giving an explanation about their back pain 
 71 (64.8 to 76.3) 
Rating of chiropractor involving 
the patient in decisions about 
care  
Very good 
Good 
Don’t know 
Unhelpful 
Very unhelpful 
Missing 
 157 (66) 
61 (26) 
14 (6) 
6 (3) 
0 
0 
Percentage (95% CI) of patients who rated the chiropractor as ‘very 
good’ at involving them in decisions about care 
 66 (60.0 to 71.9) 
Values are frequency (%) unless stated otherwise. 
 
 
Figure 7.7: Frequency (%) patient experiences of the safety of care in 238 participants,  
i.e. adverse events. 
No 
106 (45) 
Unsure 
7 (3) 
Yes but carry on 
with activities 
112 (47) 
Yes and not 
carry on with 
activities 
13 (5) 
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7.3.5 Health care costs and usage 
Costs of care 
Costs during the 3-month study period are shown in Table 7.7. The mean total cost of 
care was £481.83 (95% CI = 333.17 to 639.42) per patient. Indirect costs (i.e. time 
off work) were the most important contributor to total costs (59.6%), and costs of 
chiropractic visits the second most important contributor, which accounted for nearly 
one-third of total costs (32.8%). Other health care usage including practitioner visits, 
medical procedures and diagnostic imaging were responsible for a small proportion 
of total costs ranging from 0.4% to 1.6%.  
Health care usage  
The mean chiropractic consultation rate for back pain was 5.9 per patient (SD = 4.03, 
range = 1-25 visits) for the 3-month study period. Two-thirds (33%) of the patients 
visited their chiropractor over six times during this period and accounted for 59% of 
all visits (n = 1352 visits).  
Other health care use is shown in Figure 7.8. General practitioners were seen for 
back pain by 44 (18%) of the patients at follow-up, and the number of patients 
attending the hospital accident and emergency department, physiotherapist and 
medical specialist for back pain ranged from 9 to 15 (4% to 6%). Diagnostic 
radiology and MRI/CT scans of the back were received by 22 (9%) and 11 (5%) 
patients respectively. An injection into the spine was performed on one occasion 
only, and no back surgery or overnight stay in hospital was required by any patient in 
the study.  
One hundred eighty-seven (79%) of the patients at follow-up were in paid 
employment and 27 (14%) of these were on sick leave for back pain for 26 (SD = 
31.6, range 1-95) days on average during the study period, with high utilisers (≥ 5 
days) accounting for 97% of all days of sick leave (n = 704 days) taken by patients 
for back pain within the 3-month period of the study. Disability/incapacity benefits 
for back pain were only applied for on a single occasion. 
Change in pain medication for back pain during the study period is given in Figure 
7.9. One hundred and forty-four (61%) of the patients at follow-up reported never or 
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hardly ever using pain medication for back pain during the study period, and 60 
(25%) of the same patients  reported their use of this medication had reduced since 
completing the first questionnaire.  
 
 
Table 7.7 Mean costs of care (in £) during 3 months in 229 patients.  
 
Mean (95% CI) 
% of total 
costs 
Direct costs 194.47 (174.65 to 215.19) 40.4 
Chiropractic consultations 157.99 (145.02 to 171.91) 32.8 
General practitioner consultations 6.60 (4.87 to 8.33) 1.4 
Outpatient hospital visits to A & E department 1.93 (0.86 to 3.21) 0.4 
Outpatient hospital visits to a physiotherapist 4.72 (1.97 to 7.47) 1.0 
Outpatient hospital visits to medical specialist 7.76 (3.88 to 11.65) 1.6 
Overnight stay in hospital 0 0 
Radiographs (X-ray) 5.85 (3.44 to 8.56) 1.2 
MRI/CT scans 7.07 (3.54 to11.32) 1.5 
Injections into spine 2.54 (0.00 to 5.08) 0.5 
Low back surgery 0 0 
Indirect costs (i.e. time off work) 287.36 (152.95 to 429.05) 59.6 
Total costs 481.83 (333.17 to 639.42) 100 
Ninety-five percent confidence intervals (95% CI) are drawn from bootstrap analysis. Nine of the 238 
participants at follow-up (4%) had incomplete cost data and were not included in the cost calculation.  
A & E = accident and Emergency. MRI/CT = Magnetic Resonance Imaging/Computed Tomography. 
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Figure 7.8: Other health usage in 238 participants.  
Note: A & E = accident and emergency; MRI/CT = magnetic resonance imaging and computed tomography. 
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Figure 7.9: Frequency (%) change in pain medication usage (i.e. pain killers) for back pain during three 
months in 238 participants. 
 
7.3.6 Evaluation of data collection instrument 
Responsiveness of health status measures 
The responsiveness of the health status measures contained in the data collection 
instrument is shown in Table 7.8. The effect sizes, depicting internal responsiveness 
or sensitivity to change, in increasing order, were 0.77, 0.87, 1.20 and 1.38 for the 
EQ-5D, RMDQ, BQ and bothersomeness scale respectively. The effect sizes of the 
BQ and bothersomeness scale were significantly different (non-overlapping 
confidence intervals) compared to those of the RMDQ and EQ-5D. With regards to 
external responsiveness, the AUC of ROC for all measures ranged from 0.73 to 0.78 
and the differences between these values were non-significant when considering the 
confidence intervals, thus indicating that all measures had similar levels of ability to 
discriminate between clinically improved and clinically non-improved patients.   
 
 
Never, or hardly 
ever 
144 (61) 
Reduced 
60 (25) 
Same 
22 (9) 
Increased 
12 (5) 
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Table 7.8: Responsiveness of health status measures. 
 Internal responsiveness External responsiveness 
ES (95% CI) *AUC of ROC (95% CI) 
RMDQ 0.87 (0.74 to 1.00) 0.75 (0.68 to 0.82) 
BQ 1.20 (1.05 to 1.35) 0.77 (0.70 to 0.84) 
EQ-5D 0.77 (0.62 to 0.92) 0.73 (0.66 to 0.81) 
Bothersomeness scale 1.38 (1.22 to 1.55) 0.78 (0.72 to 0.84) 
ES = Cohen’s effect size. AUC of ROC = Area under the curve of Receiver Operating  
Characteristic. RMDQ = Roland-Morris Disability Questionnaire. BQ = Bournemouth  
Questionnaire. EQ-5D = EuroQol-5D. * Significant at p < 0.001. 
 
Criterion validity of patient-reported number of visits made to the clinic 
Criterion validity (accuracy) of patient-reported number of visits made to the clinic 
was evaluated by comparing the number of visits reported by patients to those 
reported in patients’ files from 17 participating clinics. All 17 clinics returned the 
number of patient visits form, thus 89 participants (37% of patients at follow-up) 
were included in the validation sample used to determine the accuracy of patient-
reported number of visits. No significant differences (p < 0.05) were found between 
the validation sample and the complete cohort in the distribution of clinical and 
demographic variables as well as baseline health status scores (Appendix 9). The 
power of the validation study was calculated to be adequate (P = 0.83; the 
recommended level being 0.80 or higher).   
The mean number of visits reported in the follow-up questionnaire and in patient 
files was 4.6 (SD = 2.91) and 5.3 (SD = 3.26) respectively. Under-reporting was seen 
in 39 patients (44%) and over-reporting in only 13 patients (15%), with a mean of 0.6 
(bootstrap 95% CI = 0.27 to 1.02) of additional visits reported in patient files 
(Wilcoxon signed-rank test, p < 0.001). In terms of economic significance, a 
difference of approximately 1 visit per patient would result either in an increase or 
decrease of the total costs in this study by 5%.  
A Bland and Altman plot of the differences between methods (patient file – patient-
report) versus mean values of the two methods is shown in Figure 7.10. The 
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differences between methods ranged between -5 and 8 visits (i.e. a negative value 
indicates patient over-reporting of visits), and 93% of the values were located 
between -3 and 3 visits, indicating that the level of agreement was inadequate. The 
plot also illustrates the fact that patients tended to under-report visits as the majority 
of the points were located above zero. In addition, the graph shows an increase in the 
variability with an increasing number of visits, with a significant upward bias 
indicating a trend towards under-reporting with increasing number of chiropractic 
visits in the previous three months (Spearman correlation coefficient = 0.295, p < 
0.01).  
 
 
 
Figure 7.10: Bland and Altman plot comparing the number of chiropractic visits as determined by 
patient-report and patient file. The solid lines indicate the limits within which 93% of the 
differences lie, the wider dashed line represents the regression line, and the dotted line is drawn 
at zero (exact agreement). The size of each bubble is proportional to the number of patients with 
the corresponding x and y values. 
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Construct validity of measuring complete recovery from low back pain using 
construct-specific questions 
Construct validity of measuring complete recovery from low back pain using 
construct-specific questions (i.e. acceptable quality of life, no disability and no pain 
for a whole month) was assessed by comparing patients categorized as completely 
recovered using these questions with those who selected the category ‘completely 
recovered’ on the GPE scale. Cohen’s Kappa coefficient was 0.70 (p < 0.001), 
indicating good overall agreement between the two methods of measuring complete 
recovery from low back pain. A 2x2 contingency table was constructed (Table 7.9) 
for both methods of determining complete recovery so as to provide more detail 
about misclassified cases. This table showed that the majority of patients completely 
recovered from low back pain (i.e. as per GPE) were correctly classified as such by 
the construct-specific method of determining complete recovery (positive percent 
agreement = 88.9%), and that an approximately similar proportion of patients not 
completely recovered from low back pain were correctly classified as such by this 
method (negative percent agreement = 89.5%).  
Table 7.9: Positive percent agreement (PPA) and negative percent agreement (NPA) of construct-
specific method of determining complete recovery from low back pain.  
  
Global Perceived Effect  
i.e. patients categorised as ‘completely 
recovered’ 
  Recovered Not recovered Total 
Construct-specific method  
i.e. positive response to three 
questions about pain, usual 
activities and quality of life 
Recovered 40 20 60 
Not recovered 5 170 175 
Total 45 190 235 
 
PPA (relative to Global Perceived Effect) =  88.9% (40/45) 
NPA (relative to Global Perceived Effect) = 89.5% (170/190) 
Three of the 238 participants at follow-up (1%) were not included in the agreement calculation due to 
incomplete data.  
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Questionnaire feedback  
Questionnaire feedback results are given in Table 7.10. Nearly all of the patients at 
follow-up agreed or strongly agreed that the questions were clear and easy to answer 
(229, 96%) and that completion of the questions was not too disruptive or time 
consuming (233, 98%). The majority of the patients at follow-up agreed or strongly 
agreed that the questions were relevant to them and their back pain (202, 85%). 
 
 
Table 7.10: Questionnaire feedback in 238 participants. 
Variable    
Overall, the questions were clear 
and easy to answer 
Strongly agree 
Agree 
Don’t know 
Disagree 
Strongly disagree 
Missing 
 
109 (46) 
120 (50) 
3 (1) 
5 (2) 
0 
1 (< 1) 
Overall, the questions were 
relevant to me and my back pain 
Strongly agree 
Agree 
Don’t know 
Disagree 
Strongly disagree 
Missing 
 76 (32) 
126 (53) 
12 (5) 
23 (10) 
1 (< 1) 
0 
Overall, completion of the 
questionnaires was not too 
disruptive or time consuming 
Strongly agree 
Agree 
Don’t know 
Disagree 
Strongly disagree 
Missing 
 114 (48) 
119 (50) 
2 (1) 
3 (1) 
0 
0 
Values are frequency (%). 
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7.4 Discussion 
The present study intended to systematically document the quality and costs of care 
reported by low back patients three months after starting chiropractic care. It is 
unique in that it is the first attempt at combining information about health outcomes, 
patient experiences and costs of care in a single study conducted in routine everyday 
chiropractic practice in the United Kingdom. In addition, a secondary aim of the 
main study was to conduct an evaluation of the data collection instrument in terms of 
its suitability for purpose and ability to collect accurate and valid data. This 
evaluation was necessary as certain aspects of the instrument had not been used 
previously, and its performance in real-life clinical practice had to be determined 
before the main study could proceed.  
The response rate at follow-up was reasonable and in line with that obtained in other 
observational studies conducted with chiropractic patients using postal follow-up 
(ranging from 54% to 63%).230, 265-267 Quality of care research by the British National 
Health Service, using a similar design to the present study, showed comparably 
higher response rates (ranging from 64% to 90%) in patients undergoing surgical 
procedures.268 This discrepancy may be explained by surgical procedures having a 
greater impact on people’s lives and requiring longer follow-up than chiropractic 
care, thus perhaps encouraging a larger number of patients to respond to a follow-up 
questionnaire.  
The typical low back pain patient attending a chiropractic clinic, according to 
published observational studies, is middle-aged, male and female in equal 
proportions and suffers from acute or sub-acute symptoms (< 3 months).72, 73, 226, 230, 
231, 266, 267, 269 The characteristics of the patients participating in the present study 
reflected these findings except for the duration of the presenting episode of low back 
pain. Indeed, the proportion of patients suffering from chronic low back pain (> 3 
months) was markedly higher than that reported in other multi-centre studies 
conducted in Norway, Denmark and Switzerland (ranging from 20% to 36%).72, 73, 
230, 269 These controversial findings may be explained by the fact that chiropractic 
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care generally constitutes an out-of-pocket expense for patients in the United 
Kingdom, thus visiting a chiropractor for low back pain may have been a last resort 
option for many patients.  
In general, patients who enrolled in the present study improved markedly on the BQ 
and RMDQ in the first three months of care and had low levels of pain and disability 
at the end of the 3-month study period. These findings are in line with two recent 
papers including a systematic review and a meta-analysis of the course of low back 
pain in patients treated by general practitioners, chiropractors, physiotherapist and 
specialists.270, 271 According to these studies, acute/sub-acute and persistent low back 
pain patients typically show rapid improvements in pain and disability within the 
first few weeks of treatment.  
Of particular interest was that on the BQ, in addition to pain and disability, psycho-
social and cognitive-behavioural dimensions of the low back pain experience were 
also affected. Despite patients being considerably distressed at the initial 
consultation, fear avoidance beliefs on work and pain as well as anxiety were 
negligible at follow-up, indicating that cognitive appraisal of, and behavioural 
adaptation to, the pain experience had likely taken place during the study period. 
These findings are in opposition to research conducted by Langworthy and Breen in 
which it was concluded that chiropractic patients were not particularly distressed at 
the time of initial presentation.265 Since the study by these authors was conducted in 
a single chiropractic clinic, its findings may not be generalisable to patients across a 
range of chiropractic clinics.  
In contrast to pain and disability, there was little improvement over the study period 
in how much the pain bothered the patient, measured using a 5-point bothersomeness 
scale, and in patient health-related quality of life, measured using the EQ-5D. With 
respect to bothersomeness, these findings are not unique as similar low levels of 
improvement were found using a five-point bothersomeness scale in a previous study 
conducted on chiropractic patients with low back pain.265 Dunn and Croft39 have 
shown that the bothersomeness scale can be used to classify low back pain patients in 
primary care practice and that it is a valid measure of severity, being associated with 
measures of pain, disability and psychological health. While the bothersomeness 
scale has the potential to be a concise research instrument for low back pain, the 
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usefulness of this measure as an outcome measure in clinical practice and the 
significance of its scores have yet to be determined.   
With regards to health-related quality of life, the rather small improvement noted 
over the study period on the EQ-5D compared to that on the RMDQ and BQ was 
likely the result of differences in scoring methods between measures. The scores 
produced by patients for the EQ-5D are transformed into utilities by means of tariffs 
or weights which have been estimated using preferences from a sample of the general 
population, while untransformed patient values are used for its counterparts.191 
Research comparing health-related quality of life measures, such as the EQ-5D, and 
condition-specific measures, such as the RMDQ and BQ, has shown that the 
difference in perspective between these measures can lead to dissimilar results.44, 272 
To put the EQ-5D results into perspective, when health-related quality of life in the 
present 3-month study was transformed into QALYs, it corresponded approximately 
to one-fourth of the average QALYs per patient (0.659) in the manipulation group of 
the United Kingdom back pain exercise and manipulation randomised trial, which 
was conducted over a one year period.273 Although comparisons between values of 
different studies should be made carefully, including health-related quality of life, it 
appears that participants fared equally well in a real-life clinical practice environment 
and in the environment of a clinical trial.   
Two attempts were made at determining the clinical importance of the improvement 
in health outcomes in this patient sample. The first was the direct method of 
measuring improvement using patient perceived level of improvement on the GPE, 
and the second was the indirect method of measuring improvement using cut-off 
points in change scores, which enabled patients to be categorised as either clinically 
improved or clinically non-improved, on the RMDQ, BQ, EQ-5D and 
bothersomeness scale. Although the proportion of patients clinically improved 
determined using the first method was high, a wide range of proportions were 
obtained for the second method due to the variability in the cut-offs of clinical 
improvement within instruments and across measures, calculated by the distribution-
based methods (i.e. 1.96 RCI, 0.5 ES and 1 SEM) and anchor-based method (i.e. 
ROC).  
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There appears to be controversy comparing cut-offs of clinical improvement in low 
back pain patients determined using different approaches, with some reports citing 
large variability in these values and others stating similarities.145, 159, 160, 256, 274, 275 
These opposing findings may be due to the fact that the threshold of clinical 
importance is population and context specific.103, 107 For instance, Norman et al.,159 
who concluded that, in most cases, the cut-off of clinical improvement appeared to 
be approximately half a standard deviation, conducted their research with patients 
suffering from chronic conditions. Conversely, in the present study, the particularity 
of the sample including acute, sub-acute and persistent low back pain patients may 
have had an impact on the variability of the threshold of clinical improvement when 
determined using different approaches. 
In addition to the variability in the estimates produced of the proportion of patients 
improved, low agreement was found when the patients categorised as improved 
using the cut-offs were compared to those considered clinically improved on the 
GPE scale (i.e. category ‘much improved’ and ‘completely recovered’). These 
findings were similar to those of Beaton et al.274 (low to moderate agreement) and 
may be the result of inherent differences between methods. Indeed, when the 
proportion of patients improved is determined using the GPE scale, it is based on 
individual patient reports of improvement, whereas when this proportion is 
determined using health status cut-off points, it is based on group change scores, 
hence not taking into account individual patient variability.276 In spite of this 
limitation, the use of cut-offs of clinical improvement is recommended as such 
thresholds are useful tools in making health status change scores more readily 
interpretable. 
In terms of diagnostic accuracy of the cut-offs, when using the GPE as an external 
criterion of clinical improvement, the ROC method generally yielded the most 
specific estimates of the proportion of patients clinically improved.  In selecting a 
cut-off method with high specificity, the probability of false-positive values is 
reduced, and the certainty that patients have clinically improved if the change score 
exceeds the cut-off is increased.276 In chiropractic practice, typically a wait-and-see 
policy prior to referral for surgery does not harm, thus rendering conservative cut-
offs desirable, such as those determined using the ROC method. In addition, when 
contrasted to distribution-based methods (i.e. 0.5 ES, 1 SEM and 1.96 RCI), the ROC 
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method offers the advantage of being clinically relevant to patients because an 
external criterion based on patient opinion is used.102, 103, 107, 275-277 Given these 
factors, if a single cut-off method had to be recommended for use in patients 
undergoing routine treatment for low back pain, the ROC method would be favoured. 
In addition to suggesting the best available method for determining how many 
patients have clinically improved, it may useful to select a single health status 
measure for use in routine outcome research so as to streamline results between 
studies as well as to ensure the relevance of findings to patients, clinicians and 
commissioners. If a single low back pain health status measure were to be 
recommended based on the results of this study, a sensible option would be the BQ. 
When contrasted to the RMDQ, EQ-5D and bothersomeness scale, the BQ is the only 
measure that offers comprehensive information about a number of dimensions 
relevant to the low back pain experience including sensory, functional, affective and 
cognitive/behavioural dimensions.41  
In terms of responsiveness, the results of this study also favoured the BQ. Although 
the health status measures included in the present study had similar discriminative 
performance between patients that were clinically improved and those that were not, 
there were important differences between measures with regards to their capacity to 
detect change in health status over time (i.e. sensitivity to change). Indeed, the BQ 
was significantly more sensitive to change than the RMDQ and EQ-5D, and these 
findings were in accordance with previous reports on the responsiveness of the BQ, 
RMDQ and EQ-5D.29, 41, 44, 50, 59 Despite its low responsiveness, the EQ-5D remains 
an important addition in studies assessing health care costs since it enables the 
calculation of QALYs.162 With regards to the bothersomeness scale, its sensitivity to 
change was comparable to the BQ; however, the scale width of the bothersomeness 
scale was insufficient as three out of four health status cut-offs were less than one 
bothersomeness scale point, hence any improvement would be considered clinically 
important on this measure.  
The calculation of the proportion of patients clinically improved is only one aspect of 
the picture. This figure provides no information about patients whose episode of low 
back has resolved, or in other words the proportion of patients recovered from low 
back pain. In the present study, the proportion of patients considered recovered at 
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three months (i.e. acceptable quality of life, no disability and no pain for a whole 
month) was markedly inferior to the proportion of patients clinically improved. One 
explanation for this paradox may be mostly the chronic patients that participated in 
the present study for whom the study period may have been too short to fully recover 
from their condition.  
A second reason for the discrepancy between the proportion of patients categorised 
as clinically improved and recovered may be the stringent criteria used to define 
recovery from low back pain. Typically, in previous studies, patients were 
considered as recovered if they had been free of low back pain for a whole month 
preceding follow-up data collection points, which is a defintion based on the work by 
de Vet and colleagues.80 Henschke et al.81, 85, 87, 228, 229 took this defintion further by 
considering patients as recovered if, in addition to being pain-free for a whole month, 
they had no disability for a similar period. In the present study, the decision to add a 
third domain (i.e. quality of life) to those of pain and disability was based on the 
findings of a qualitative study conducted by Hush et al.23 in which patients 
considered quality of life an important entity of low back pain recovery.  
The construct validity of the definition of recovery from low back pain was evaluated 
by comparing patients that had no pain, no disability and an acceptable quality of life 
for a whole month preceding the second data collection point to those who scored 
‘completed recovered’ on the GPE scale. Although high agreement was found 
between both methods of determining the proportion of patients recovered, a 
minority of patients were either misclassified as recovered or not recovered using the 
definition of recovery. The idiosyncrasy of the concept of recovery from low back 
pain may be at the origin of these findings.81 For some patients, the mere absence of 
pain and disability as well as the achievement of acceptable quality of life may be 
insufficient to consider themselves recovered, and for others, these critieria may be 
irrelevant as they may have adjusted to living with the disorder or redefined the 
meaning of recovery by accommodating the pain as part of their lives. Taking into 
account the individualistic nature of the concept of recovery as well as the similarites 
between recovery as determined by the definitons and the GPE, if a decision needed 
to be made regarding the mesurement of this concept in clinical practice, the more 
concise GPE method would be recommended.  
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Despite the stringent criteria used to define recovery, the proportion of patients 
recovered from low low back pain in the present study was close to the pooled 
estimate (33%) of the same information after the first three months of primary care 
reported in a recent systematic review of 11 studies.278 However, when patients 
considered recovered at any time during the study were compared against those still 
recovered at follow-up (i.e. recurrence of low back pain), dispartities were found 
between the present study and the literature. Indeed, while a fairly low rate of 
recurrence after the presenting episode of low back pain was found in the present 
study, moderate to high rates of recurrence were reported in published studies 
(ranging from 33% to 69% ).71, 74 This discrepancy may be explained by the 
relatively short duration of the present study which may have been insufficent for 
some patients to achieve a state of no pain, no disability and an acceptable quality of 
life for a whole month (i.e. recovery) followed by the onset of a new episode of low 
back pain (i.e. recurrence).  
The final aspect of the outcome evaluation of the present study involved the 
determination of lifestyle changes that patients made during the study period. The 
answers to these questions showed that although specific activities for back pain, 
such as tailored exercise, postural alteration and awareness of back pain signs were 
increased, activities to promote general health, such as general exercise and rest, 
remained unchanged. These findings are to be expected as the goal of chiropractic 
treatment, in principle, is to manage the patient’s complaint and not to improve their 
general wellness. However, the rate of missing data for these questions was relatively 
high compared to other variables, indicating that patients may have felt that these 
questions were unclear or irrelevant to their condition.  
In addition to determining how well the patients were doing (i.e. health outcomes), it 
was important to investigate the patients’ experience of the care provided. Although 
health outcomes are considered the most important indicator of the quality of care, 
patient experiences can offer information about the process and safety of care, which 
in turn may influence outcomes and hence the quality of care.12 With regards to the 
process of chiropractic care, published studies have shown that this treatment option 
is generally welcomed by patients for low back pain, with the proportion of patients 
who consider chiropractic care for this condition as ‘very helpful’ ranging from 53% 
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to 66%.279-281 The values of the present study pertaining to perceived helpfulness of 
care fell within these ranges.  
Previous studies comparing perceived helpfulness of chiropractic care, general 
practitioner care and other therapies for the treatment of low back pain showed that 
chiropractic care was generally associated with the same, or a greater, level of 
perceived benefit as other forms of treatment for this condition.279-282 Although this 
may appear as an important discovery, some authors have criticised generic scales, 
such as the one used to assess perceived helpfulness of care, for being unspecific 
and, therefore, patient ratings may be biased by factors irrelevant to the process of 
care.195-197, 208, 283, 284 This concern was taken into account by evaluating, in addition 
to perceived helpfulness of care, specific aspects of the process of care. The aspects 
evaluated pertained to the practitioner’s ability to communicate information and 
advice to patients as well as to interact with them, which are considered by patients 
as the most important determinants of a positive experience of care.211-214, 285, 286  
These practitioner attributes, including time and explanations given by the 
chiropractor as well as the patient's involvement in decisions about care, were rated 
as ‘very good’ by the majority of patients in the present study. The same aspects of 
the process of care, in the GP Patient Survey 2011-2012, were rated as ‘very good’ 
by a comparatively lower proportion of participants drawn from a random sample of 
patients attending general practitioner clinics in the United Kingdom (values ranging 
from 47% to 52%).216 However, these differences between studies should be 
interpreted carefully as they were small in magnitude and the patients seen by 
chiropractors and general practitioners are typically not the same. Moreover, the 
response rate of the GP patient survey 2011-2012 was fairly low (38%). 
The safety of chiropractic care and manipulative therapy in general, which is the 
main treatment procedure used by chiropractors, has been the topic of much debate, 
with some scientists arguing that these therapies may be unsafe.287 However, the 
findings of the present study pertaining to patient experiences of adverse events, 
which were defined as worsening of back pain, stiffness, soreness and/or general 
discomfort immediately or shortly after the chiropractic treatment visits, showed that 
these assumptions may be unfounded. Indeed, the findings of the present study were 
in accordance with previous research showing that adverse reactions in patients 
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receiving chiropractic care are common, but are typically benign and have little to no 
influence on activities of daily living.164, 165, 167, 220  
The uniqueness of the findings on adverse events in the present study lies in the fact 
that these data were collected from patients as opposed to practitioners from whom 
this information has typically been gathered in the past. Some authors have argued 
that studies relying on practitioners to report data on adverse reactions resulting from 
treatment may suffer from underreporting, perhaps due to practitioners fearing 
criticism.218, 219 Since the findings on adverse events of the present study were in line 
with previous research conducted using practitioner-reported data, it appears that 
underreporting by practitioners may not be a concern when assessing data on adverse 
events in chiropractic clinics.  
In order to enable the attribution of a monetary value to the health outcomes 
achieved, the costs of the services provided during the 3-month study period were 
monitored. Nearly the entirety of treatment costs (i.e. direct costs) referred to 
chiropractic visits since other health care and diagnostic imaging were only used on 
few occasions. These findings are in accordance with the costing report 
accompanying the guidelines for the management of low back pain by the National 
Institute of Clinical Excellence.238 This report concluded that few additional services 
would be required by the English National Health Service if low back pain patients 
were treated by manual therapists such as chiropractors.   
One comparable study was found on the cost of low back pain in routine clinical 
practice, which was conducted in German general practitioner clinics by Becker et 
al.288 In contrary to the present study, only a small proportion of treatment costs were 
attributed to primary practitioner visits (i.e. general practitioner), and the main 
contributor to these costs were visits to specialists and manual therapists as well as 
medication and diagnostic procedure usage. These disparities between studies in 
terms of other health care usage may be due to differences in study settings and 
patients. Indeed, there is evidence to support the fact that different types of patients 
are seen by general practitioners and chiropractors, with chiropractic patients tending 
to have fewer chronic conditions than general practitioner patients.279  
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With regards to the costs of lost productivity resulting from time away from work 
(i.e. indirect costs), the present study was in accordance with previous reports on the 
cost of health care for low back pain, showing that indirect costs are typically the 
most important contributor to total costs.170 However, the findings of the present 
study differed to those of an observational study conducted in general practitioner 
clinics in that only a minority of patients took time off work for low back pain 
compared to nearly one-third of patients (32.5%) going on leave for this matter in the 
general practitioner study.288 In the present study, the reasons for the importance of 
the contribution of indirect costs to total costs in spite of the low rate of leave may be 
twofold. First, indirect costs may have been unfairly weighted against total costs due 
the low cost of chiropractic treatment, and second, the few patients that took time off 
work may have taken prolonged sick leave for low back pain. There was evidence to 
support the latter as nearly all patients on sick leave due to low back pain took over 5 
days off work for their condition.  
Due to the fact that the accuracy of cost data on treatment visits in chiropractic 
clinics had not been evaluated previously, it was imperative to conduct such an 
analysis in the present study.171, 172, 174-177 When the accuracy of the cost data on 
chiropractic visits was evaluated by comparing patient-reported number of visits 
made to the clinic and the same information reported in patients’ files, low 
agreement was found between the two methods of determining these data. However, 
even if patient-reported data of chiropractic visits were more accurate, the use of this 
information is not likely to bias the results on costs unless there were systematic 
differences between patient-reported visits and visits as based on patient files.173  
In the present study, there was evidence that this was happening, with patients 
tending to under-report the number of visits, particularly for higher numbers, by on 
average approximately one visit when compared to the number of visits reported in 
patient files. Whilst this difference between the two methods of data collection was 
statistically significant, it was not of economic significance as the change in total 
costs when varying the number of visits by ± 1 was minor. In addition, even if 
patient files and self-report were in exact agreement, it is uncertain whether the 
patient file represents the more reliable source of data on number of visits. Indeed, 
these data may have been omitted from files by mistake or recorded in such a form 
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that they were not easily accessible to the clinic staff responsible for returning the 
number of patient visits made to the clinic during the study period. 
The present study had several limitations, with the principal limitation being that the 
data documented may not necessarily be the result of the treatment administered 
since the study design lacked a control group for comparison. Instead these data 
could be partly or entirely attributed to non-specific treatment effects including 
measurement error and the natural course of condition. However, the focus of the 
present study was in evaluating the quality and cost of care per se, irrespective of the 
effects, either specific or non-specific, of that care. 
Bias in relation to patient selection and patient-report must be considered, such as 
chiropractors or clinic staff recruiting patients who are more likely to improve or 
who provide polite positive answers. To avoid arbitrary selection of patients by 
practitioners or clinic staff, consecutive sampling was indicated and the importance 
of recruiting patients consecutively was emphasized in the user guide mailed to 
participating chiropractors prior to the commencement of the study. To counteract 
patients from inflating responses, patients were not considered clinically improved 
unless they selected the category ‘much improved’ or ‘completely recovered’ on the 
GPE scale, and those who selected ‘slightly improved’ on this scale were not 
considered clinically improved.  
Other limitations pertaining to patient responses are the possibility of recall bias and 
misattribution due to patients being unable to distinguish between low back pain-
related procedures and others. Although the 3-month study period may have been too 
short for some patients to show improvement or recovery from low back pain, a 
period of more than three months may have increased recall bias, with some patients 
remembering costs and outcomes less well if they occurred early on in the 
monitoring period. Moreover, there was evidence of a difference in the patient 
characteristics of responders and non-responders at follow-up, which may have 
affected the generalisibility of the findings of this study.  
Similarly, the practitioners that volunteered for inclusion into the study may have 
been a source of bias as 120 of the 1314 chiropractors (9%) that were members of the 
British Chiropractic Association at the time of data collection participated in the 
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study.289 A selection bias may be present because practitioners willing to participate 
in research may be more focused on evidence-based care than non-participating 
chiropractors. In addition, due to patients being recruited from multiple practices, 
there was the possibility that patient data were clustered within practitioners. Such 
clustering effects would increase the width of the confidence intervals but would not 
affect the point estimates.218 In a trade-off to maximize practitioner participation and 
compliance, the design of the present study precluded reported events from being 
linked to individual practitioners, hence clustering effects could not be evaluated.  
Bias may not only arise from patients and practitioners, it may also originate from 
the measures selected for inclusion in the data collection instrument as each measure 
used may potentially lead to different results. In clinical trials, such bias is often 
reduced by investigating outcomes and other data by a large number of research 
tools. In order to maximize participation rates and the clinical relevance of results, 
the use of lengthy questionnaires that could interfere with the usual activities taking 
place in clinics and the daily schedule of participants was avoided. The results 
pertaining to the face validity of the data collection instrument confirmed that these 
goals were met because nearly all patients felt that completion of the questions was 
not too disruptive or time consuming, and that questions were relevant, clear and 
easy to answer. 
The strengths of this study were the large study sample and the good quality of the 
data, with few questionnaires with faulty answers that had to be discarded and only 
few missing data. Additional strengths include the evaluation of costs of care and the 
use of strict definitions of low back pain recurrence and recovery. Positive aspects of 
the study design were that events in a real-life clinical situation were documented 
and that a wide variety of practitioners and patients were included in the study, thus 
making the results clinically relevant for those participating, and generalisable to 
others. Secondary gains of the study were that it allowed practitioners to participate 
in research without having to spend an excessive amount of time with the project, 
hence making them aware of the rigours associated with data collection and 
encouraging an interest in the study results, and in research in general.  
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CHAPTER 8  
Conclusions and recommendations 
The present study documented, likely for the first time, simultaneously the quality 
and costs of care in low back patients undergoing chiropractic treatment. The main 
findings of the study were that patients who presented with low back pain of varying 
duration improved markedly within the first three months of starting care, and 
expressed high levels of satisfaction with chiropractic treatment and with the 
encounter with their clinician. Chiropractic care was shown to be relatively safe, with 
common yet benign side-effects that had no significant effects on activities of daily 
living. Moreover, the costs of the health care provided during the study period were 
relatively low and few other health care professionals or procedures were used in 
conjunction with chiropractic care.  
In order to provide additional information about the course of disease, data on low 
back pain recovery and recurrences were also assessed. These data revealed an 
important point which was that although the majority of patients showed marked 
improvements in health outcomes within the first three months of starting care, the 
rate of recovery from low back pain (i.e. full resolution of episode of low back pain) 
was considerably low during this period. In addition, recurrences of low back pain 
(i.e. onset of a new episode of low back pain following recovery from a previous 
episode) occurred in a number of patients who had recovered from the presenting 
episode of low back pain. These findings are consistent with those of previous 
research about the course of low back pain in primary care, showing that low back 
pain is a complex condition that has an untidy pattern of symptoms with incomplete 
recovery and potential recurrences in a relatively short space of time. 
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As part of this study, the data collection instrument was evaluated for its suitability 
for purpose and ability to collect relevant data from which a number of 
recommendations ensued. These recommendations pertained to the use of outcome 
measures for conducting observational research in clinical practice as well as the 
methods used to report patient improvement from these measures. 
The findings of this study support chiropractic care as a treatment option for low 
back pain. If chiropractic care is provided as part of the National Health Service in 
the future for patients suffering from low back pain, it may be suggested that the 
workload on general practitioners could be eased, hence improving the quality of 
care and potentially reducing treatment costs. This might not only result from a 
redistribution of low back pain patients to other health care facilities but also from 
the provision of more specialised care.  
Future research on the quality and costs of care in low back pain patients and others 
undergoing chiropractic care should consist of a large-scale questionnaire-based 
study using a similar design to the present one and taking into account the 
recommendations regarding data collection and reporting made in this study. Such 
research could be conducted in chiropractic clinics in the United Kingdom on a 
continuous basis, allowing for systematic collection and analysis of data. In order for 
this to progress the leadership of the chiropractic profession must recruit personnel 
whose role it is to build a national information database on the quality and cost of 
care and, perhaps, make data collection by chiropractors and their staff a compulsory 
aspect of membership. Research on the quality and costs of care should not only be 
conducted by the chiropractic profession but should also be expanded to related 
primary health care professionals, such as general practitioners and physiotherapists. 
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Appendix 1: Pilot study documentation. 
 
 
• User guide regarding data collection process 
• Baseline and follow-up questionnaire 
• Cover letter accompanying data collection pack –                     
for the attention of chiropractors and clinic staff  
• Cover letter accompanying follow-up questionnaire –  
for the attention of participants 
• Number of patient visits form and accompanying cover letter –           
for the attention of chiropractors and clinic staff 
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C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
USER GUIDE 
1. What is this study about? 
The purpose of the Chiropractic Patient Reported Outcome Measures Study (C-PROMS) is to develop 
two short questionnaires to collect routine information concerning outcomes and cost in chiropractic 
practices across the United Kingdom. This information is required to assess and improve the quality of 
chiropractic care and to inform patients, clinicians and third-party payers. 
2. How is the study being done? 
You or your staff will collect data (Questionnaire 1) from 10 consecutive eligible new patients, who 
consent to participate in the study, presenting to your clinic for the first time with low back pain. 
Thereafter, patients will be sent a second questionnaire (Questionnaire 2) at three months by post. This 
second questionnaire will be sent directly from the Anglo-European College of Chiropractic, so there is 
no work involved for you or your staff. If your clinic is equipped with a computer booking system, you or 
your staff may be sent a form requesting the total number of treatments each of these patients received 
within this three month period. All your contact details will be kept confidential for the purposes of this 
study. 
3. How long will the study last? 
Starting from April 2010, patient recruitment will last until 
February 2011.   
4. Setting up the study 
Before data collection can start, the following should have 
happened:  
• You should have received copies of Questionnaire 1 and 
a pre-paid return envelope for each copy.  
• You should have read this User Guide and if you have 
staff (e.g. receptionist, practice manager) ensure all of 
them understand how to collect and submit data (they all 
should have read this User Guide). 
NOW YOU ARE READY TO START DATA 
COLLECTION. 
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5. Patient eligibility criteria for participation in the study 
To be eligible for participation in the study, patients must fulfil ALL of the following: 
 Patients must HAVE LOW BACK PAIN WITH OR WITHOUT LEG PAIN as their main complaint 
 Patients must be 18 years of age or older 
 Patients must NOT HAVE received treatment for their low back pain from a healthcare 
professional EXCEPT FROM THEIR GP in the PAST 3 MONTHS  
 Patients must NOT be pregnant 
 Patients must be literate in English 
6. Patient recruitment 
6.1. On the phone 
You will recruit 10 CONSECUTIVE NEW PATIENTS presenting with low back pain. When these new 
patients make an appointment at the clinic they should be told: 
• “the clinic is currently taking part in a study about low back pain” 
• “you will be given more information about the study when you arrive for your appointment so you can 
decide whether you want to take part or not” 
• “there will be no change to your chiropractic treatment whether you want to take part or not” 
• “we would like you to arrive 10-15 minutes early for your appointment to allow time for you to read 
the information about the study and complete the forms” 
6.2. At the clinic 
Please consider the following questions: 
• Is the patient eligible (refer to eligibility criteria) to enter the study? 
If they are not eligible, take no further action. 
 
If they are eligible, then proceed to the next stage. 
  
• If eligible, then please give them the questionnaire booklet (Questionnaire 1) and ask them to read 
the information at the start (page 1) and decide if they wish to complete the questionnaire. The 
questionnaire has been designed for patients to read and complete by themselves; you do not have 
to help the patient with the questionnaire. The patient now reads the information at the start of the 
Questionnaire (page 1). 
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• If after reading the information the patient informs you that they DO NOT want to take part, 
please complete the questions on the back cover of the questionnaire (see diagram below):   
 
 
 
 
 
 
 
 
 
 
 
 
 The booklet should then be put into one of the pre-paid envelopes provided and returned to 
the Principal Investigator at the AECC as soon as possible. You do NOT have to wait until all 
the data are collected (10 patients) to return each questionnaire.  
N.B. Even though the patient does not want to take part, this still counts as one of your 
10 consecutive eligible patients. 
• If a patient decides they DO want to take part in the study, please ask them to proceed and 
complete the questionnaire.  The patient must complete the questionnaire in the practice 
before any treatment and return it to you straight away. Then, please: 
 Check that the patient’s name and address have been completed on page 2 of the 
questionnaire. 
 Place the completed questionnaire into one of the pre-paid envelopes supplied and return it to 
the Principal Investigator at the AECC (one questionnaire in a single envelope) as soon as 
possible. 
7. Want to know more? 
Dr Taco Houweling (Principal Investigator): Tel: 01202 436234 / 079 31444501;  
 Email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor):  Tel: 01202 436200; Email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor):  Tel: 01202 436200; Email: dnewell@aecc.ac.uk Anglo-
European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
This is on the back cover of 
the questionnaire booklet 
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THANK YOU FOR YOUR TIME AND HELP WITH THIS STUDY. 
Patient makes appointment and 
is informed about the study. 
Patient is told to arrive 10-15 minutes early. 
Patient arrives at clinic. 
Refer to eligibility criteria. 
Is patient eligible for the study? 
RECRUIT 10 PATIENTS 
Patient is given questionnaire 
and reads information on page 1. 
Does patient want to take part in 
the study? 
Patient completes questionnaire. 
Questionnaire is returned to AECC in one of 
the pre-paid envelopes straight away. 
YES 
YES 
Complete questions on back 
cover of questionnaire. 
Questionnaire is returned to AECC in one 
of the pre-paid envelopes straight away. 
Take no further action. NO 
NO 
Summary of 
information flow 
within C-PROMS 
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REMEMBER: Please do not return more than one questionnaire in a single envelope 
 
 
PATIENT-REPORTED OUTCOME MEASURES 
 
 
Code number: 
     
 
 
 
QUESTIONNAIRE 1 
AT INITIAL CONSULTATION 
 
 
 
 
 
 
 
 
 
 
 
 
CHIROPRACTIC 
 
 
 C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
INFORMATION AND YOUR CONSENT 
What is the Chiropractic Patient-Reported Outcome Measures Study (C-PROMS)? 
The purpose of this research study is to collect information in chiropractic clinics regarding your 
experiences of care and the costs of treatment. The information that patients provide is an important 
part of the way in which decisions are made regarding the delivery of healthcare services in the UK. 
How is the study being done?  
You will be asked to complete two questionnaires; each one will take about 10-15 minutes of your 
time. The first questionnaire you will be asked to complete today. The second questionnaire you will 
receive in the post in about 3 months time, which you will be asked to complete and then return in an 
enclosed stamped addressed envelope. In addition, we may ask your chiropractor the total number of 
treatments you have received over this 3 month period. 
Who is undertaking this study? 
Dr Taco Houweling is the Principal Investigator, and is conducting this study as part of a PhD funded 
by the Anglo-European College of Chiropractic and the British Chiropractic Association.  
Why should I take part? 
This study will help improve patient care in the future, from which you may benefit. 
Do I have to take part? 
Your participation is voluntary and you are free to withdraw at any time without giving any reason. 
Your chiropractic care is NOT affected either by your decision to participate or not, or by any decision 
to withdraw once you have started. 
What will happen to the information I give? 
All the information is strictly confidential and will NOT be divulged to your chiropractor. It will be used 
anonymously and only for the research study. Published reports will not refer to any individuals; your 
name and address is only required to enable us to send you the questionnaire at the 3 month follow-
up. If we need to send you a reminder, we will do so by post, phone and/or email. 
What now? 
If you agree to take part please sign below and complete the questionnaire now. Otherwise, please 
hand back the questionnaire to the person who gave it to you. 
I have read and understood the information given above and agree to take part in the study: 
Signature:  Name (please print):  Date: 
     
Want to know more? 
Dr Taco Houweling (Principal Investigator): Tel: 07931444501; email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor): Tel: 01202 436200; email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor): Tel: 01202 436200; email: dnewell@aecc.ac.uk  
Anglo-European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
THANK YOU FOR YOUR CO-OPERATION AND TIME. 
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 PATIENT DETAILS 
 
Today’s date: D D 
 M M  2 0 Y Y          
 
Title: 
                   
 
 
First name: 
                   
 
 
Surname: 
                   
 
 
Address: 
                   
 
 
                   
 
 
Town/City: 
                   
 
 
County: 
                   
 
 
Postcode: 
                   
 
 
Phone: 
     
- 
             
 
 
Mobile: 
     
- 
             
 
 
E-mail: 
                   
 
 
 
Please write your name and contact details in CAPITAL LETTERS BELOW so that we may 
contact you by post for the questionnaire at 3 months or by post/email/phone if 
reminders are necessary. 
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A1. Are you? (tick ONE) A2. How old are you? (in YEARS) 
  
 
Male   
 
   
  
 
Female    
                  
A3. Please describe your CURRENT WORK (PAID EMPLOYMENT) STATUS? (tick ONE) 
  
 
In paid employment  
  
 
At home and not looking for work 
  
 
Unemployed because of back pain 
  
 
Unemployed because of other reasons 
  
 
Retired 
  
 
Student 
 
A4. How long is it since you had a WHOLE MONTH WITHOUT any back pain? (tick ONE) 
 
  Less than 3 months 
  
 
3-6 months 
  
 
7-12 months 
  
 
1-2 years 
  
 
3-5 years 
  
 
6-10 years 
  
 
More than 10 years 
   
A5. Are you taking any MEDICATION (PAIN KILLERS) for your back pain? (tick ONE) 
Every day Sometimes Rarely Never 
 
 
 
 
 
 
 
 
 
A. The following questions are about you and your low back pain. 
Please answer ALL the questions below. Before answering each question, read 
through all the options and then tick the box or boxes that best describe(s) you.  
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B1.   I stay at home most of the time because of my back.   
B2.  
 
I change position frequently to try and get my back comfortable.    
B3.  
 
I walk more slowly than usual because of my back. 
B4.  
 
Because of my back I am not doing any of the jobs that I usually do around the house. 
B5.  
 
Because of my back, I use a handrail to get upstairs. 
B6.  
 
Because of my back, I lie down to rest more often. 
B7.  
 
Because of my back, I have to hold on to something to get out of an easy chair. 
B8.  
 
Because of my back, I try to get other people to do things for me. 
B9.   I get dressed more slowly than usual because of my back. 
B10.  
 
I only stand for short periods of time because of my back. 
B11.  
 
Because of my back, I try not to bend or kneel down. 
B12.  
 
I find it difficult to get out of a chair because of my back. 
B13.  
 
My back is painful almost all the time. 
B14.  
 
I find it difficult to turn over in bed because of my back. 
B15.  
 
My appetite is not very good because of my back pain. 
B16.  
 
I have trouble putting on my socks (or stockings) because of the pain in my back. 
B17.  
 
I only walk short distances because of my back. 
B18.  
 
I sleep less well because of my back. 
B19.   Because of my back pain, I get dressed with help from someone else. 
B20.  
 
I sit down for most of the day because of my back. 
B21.  
 
I avoid heavy jobs around the house because of my back. 
B22.  
 
Because of my back pain, I am more irritable and bad tempered with people than usual. 
B23.  
 
Because of my back, I go upstairs more slowly than usual. 
B24.  
 
I stay in bed most of the time because of my back 
 
 
B. When your back hurts, you may find it difficult to do some of the things you normally do.  
This list contains sentences that people have used to describe themselves when they have back 
pain.  When you read them, you may find that some stand out because they describe you TODAY. 
When you read a sentence that describes you TODAY, put a tick against it.  
 If the sentence does not describe you, then leave the space blank and go on to the next one.   
Remember, only tick the sentence if you are sure it describes you TODAY. 
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C1. Mobility  
 I have NO problems walking about  
 
 I have SOME problems in walking about  
 
 I am CONFINED TO BED  
 
 
   
C2. Self-Care  
 I have NO problems with self-care  
 
 I have SOME problems washing or dressing myself  
 
 I am UNABLE to wash or dress myself  
 
 
   
C3. Usual Activities  
(e.g. work, study, housework, family or leisure activities) 
 
 I have NO problems with performing my usual activities  
 
 I have SOME problems with performing my usual activities  
 
 I am UNABLE to perform my usual activities  
 
 
  
C4. Pain/Discomfort  
 I have NO pain or discomfort  
 
 I have MODERATE pain or discomfort  
 
 I have EXTREME pain or discomfort  
 
 
  
C5. Anxiety/Depression  
 I am NOT anxious or depressed  
 
 I am MODERATELY anxious or depressed  
 
 I am EXTREMELY anxious or depressed  
 
 
 
D1. In the past week, how BOTHERSOME has your back pain been? (tick ONE) 
 
Not at all Slightly Moderately Very much Extremely 
   
 
 
 
 
 
 
 
C. By placing A TICK IN ONE BOX IN EACH GROUP BELOW, please indicate which statements  
best describe your own HEALTH STATE TODAY. 
D.  The following question is about your low back pain and how it has been  
IN THE PAST WEEK. 
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E1. Over the past few days, on average, how would you rate your low back pain on a scale where ‘0’ is 
‘no pain’ and ‘10’ is ‘worst pain possible’? 
             0 1 2 3 4 5 6 7 8 9 10 
No pain                         
           
E2. Over the past few days, on average, how has your low back pain interfered with your daily activities 
(housework, washing, dressing, lifting, walking, driving, climbing stairs, getting in/out of bed/chair, 
sleeping) on a scale where ‘0’ is ‘no interference’ and ‘10’ is ‘completely unable to carry on with normal 
daily activities’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                         
           
E3. Over the past few days, on average, how much has your low back pain interfered with your normal 
social routine including recreational, social and family activities, on a scale where ‘0’ is ‘no interference’ 
and ‘10’ is ‘completely unable to participate in any social and recreational activity’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                        
           
E4. Over the past few days, on average, how anxious (uptight, tense, irritable, difficulty in relaxing/ 
concentrating) have you been feeling, on a scale where ‘0’ is ‘not at all anxious’ and ‘10’ is ‘extremely 
anxious’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all anxious                        
           
E5. Over the past few days, how depressed (down-in-the–dumps, sad, in low spirits, pessimistic, 
lethargic) have you been feeling, on a scale where ‘0’ is ‘not at all depressed’ and ‘10’ is ‘extremely 
depressed’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all depressed                        
           
E6. Over the past few days, how do you think your work (both inside the home and/or employed work) 
have affected your low back pain, on a scale where ‘0’ is ‘make it no worse’ and ‘10’ is ‘make it very much 
worse’? 
             0 1 2 3 4 5 6 7 8 9 10 
Make it now worse                        
           
E7. Over the past few days, on average, how much have you been able to control (help/reduce) and cope 
with your low back pain on your own, on a scale where ‘0’ is ‘I can control it completely’ and ‘10’ is  
‘I have no control whatsoever’? 
            
I have complete  
control over my pain 
0 1 2 3 4 5 6 7 8 9 10 
                      
 
THANK YOU FOR YOUR TIME IN COMPLETING THIS FORM. 
PLEASE RETURN THIS QUESTIONNAIRE TO THE PERSON WHO GAVE IT TO YOU. 
E. Please TICK ONE BOX FOR EACH OF THE FOLLOWING QUESTIONS about your low back pain         
and how it has affected you OVER THE PAST FEW DAYS. 
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FOR CLINIC STAFF USE ONLY 
If the patient did NOT consent to take part in the study, 
please complete the following about the patient: 
Today’s date: D D  M M  2 0 Y Y          
 
Sex: Male   Female             
 
Date of birth: D D  M M  1 9 Y Y          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFORMATION FOR CLINIC STAFF 
After the patient has returned the questionnaire to you, please:  
 
 Place the questionnaire into one of the pre-paid envelopes  
supplied and return it to the AECC as soon as possible.  
PLEASE REMEMBER – only one questionnaire in a single 
envelope 
 
 
 
 
 CHIROPRACTIC 
PATIENT-REPORTED OUTCOME MEASURES 
 
 
Code number: 
     
 
 
 
QUESTIONNAIRE 2 
AT THREE MONTHS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
INFORMATION 
About three months ago, at the chiropractic clinic, you completed a questionnaire about your low 
back pain. As a follow up, we now ask you to complete this questionnaire and return it using the pre-
paid envelope provided. Please state today’s date and your name below. Your name is only required 
so we can match this questionnaire to the one you completed three months ago. None of the 
information you give here will be divulged to your chiropractor; it will only be used (anonymously) for 
the purpose of the research study. 
Today’s date: D D 
 M M  2 0 Y Y          
 
Your name: 
                   
 
Questionnaire Instructions 
The questions on the following pages are about your back pain and how it has been since you 
completed the first questionnaire. The form starts by asking you to consider how your back pain is 
TODAY and then how it has been over the PAST WEEK, PAST MONTH AND PAST 3 MONTHS. Please think back 
and try to remember how your back pain has changed during this period of time. 
 
 
 
 
3 
m
on
th
s a
go
   
1 
m
on
th
 a
go
 
 
1 
w
ee
k 
ag
o 
 
? 
 
 
 
Questionnaire 1  Questionnaire 2 
TODAY 
Want to know more? 
Dr Taco Houweling (Principal Investigator): Tel: 01202 436234 / 079 31444501;  
 Email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor):  Tel: 01202 436200; Email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor):  Tel: 01202 436200; Email: dnewell@aecc.ac.uk  
Anglo-European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
THANK YOU FOR YOUR CO-OPERATION AND TIME. 
How am I today? How have I 
been over the past week, past 
month and past 3 months? 
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A1.   I stay at home most of the time because of my back.   
A2.  
 
I change position frequently to try and get my back comfortable.    
A3.  
 
I walk more slowly than usual because of my back. 
A4.  
 
Because of my back I am not doing any of the jobs that I usually do around the house. 
A5.  
 
Because of my back, I use a handrail to get upstairs. 
A6.  
 
Because of my back, I lie down to rest more often. 
A7.  
 
Because of my back, I have to hold on to something to get out of an easy chair. 
A8.  
 
Because of my back, I try to get other people to do things for me. 
A9.   I get dressed more slowly than usual because of my back. 
A10.  
 
I only stand for short periods of time because of my back. 
A11.  
 
Because of my back, I try not to bend or kneel down. 
A12.  
 
I find it difficult to get out of a chair because of my back. 
A13.  
 
My back is painful almost all the time. 
A14.  
 
I find it difficult to turn over in bed because of my back. 
A15.  
 
My appetite is not very good because of my back pain. 
A16.  
 
I have trouble putting on my socks (or stockings) because of the pain in my back. 
A17.  
 
I only walk short distances because of my back. 
A18.  
 
I sleep less well because of my back. 
A19.   Because of my back pain, I get dressed with help from someone else. 
A20.  
 
I sit down for most of the day because of my back. 
A21.  
 
I avoid heavy jobs around the house because of my back. 
A22.  
 
Because of my back pain, I am more irritable and bad tempered with people than usual. 
A23.  
 
Because of my back, I go upstairs more slowly than usual. 
A24.  
 
I stay in bed most of the time because of my back 
 
 
A. When your back hurts, you may find it difficult to do some of the things you normally 
do.  
This list contains sentences that people have used to describe themselves when they have back 
pain.  When you read them, you may find that some stand out because they describe you TODAY. 
When you read a sentence that describes you TODAY, put a tick against it.  
 If the sentence does not describe you, then leave the space blank and go on to the next one.   
Remember, only tick the sentence if you are sure it describes you TODAY. 
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B1. Mobility  
 I have NO problems walking about  
 
 I have SOME problems in walking about  
 
 I am CONFINED TO BED  
 
 
   
B2. Self-Care  
 I have NO problems with self-care  
 
 I have SOME problems washing or dressing myself  
 
 I am UNABLE to wash or dress myself  
 
 
   
B3. Usual Activities  
(e.g. work, study, housework, family or leisure activities) 
 
 I have NO problems with performing my usual activities  
 
 I have SOME problems with performing my usual activities  
 
 I am UNABLE to perform my usual activities  
 
 
  
B4. Pain/Discomfort  
 I have NO pain or discomfort  
 
 I have MODERATE pain or discomfort  
 
 I have EXTREME pain or discomfort  
 
 
  
B5. Anxiety/Depression  
 I am NOT anxious or depressed  
 
 I am MODERATELY anxious or depressed  
 
 I am EXTREMELY anxious or depressed  
 
 
 
C1. In the past week, how BOTHERSOME has your back pain been? (tick ONE) 
 
Not at all Slightly Moderately Very much Extremely 
   
 
 
 
 
 
 
 
B. By placing A TICK IN ONE BOX IN EACH GROUP BELOW, please indicate which statements  
best describe your own HEALTH STATE TODAY. 
C.  The following question is about your low back pain and how it has been  
IN THE PAST WEEK. 
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D1. Over the past few days, on average, how would you rate your low back pain on a scale where ‘0’ is 
‘no pain’ and ‘10’ is ‘worst pain possible’? 
             0 1 2 3 4 5 6 7 8 9 10 
No pain                         
           
D2. Over the past few days, on average, how has your low back pain interfered with your daily activities 
(housework, washing, dressing, lifting, walking, driving, climbing stairs, getting in/out of bed/chair, 
sleeping) on a scale where ‘0’ is ‘no interference’ and ‘10’ is ‘completely unable to carry on with normal 
daily activities’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                         
           
D3. Over the past few days, on average, how much has your low back pain interfered with your normal 
social routine including recreational, social and family activities, on a scale where ‘0’ is ‘no interference’ 
and ‘10’ is ‘completely unable to participate in any social and recreational activity’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                        
           
D4. Over the past few days, on average, how anxious (uptight, tense, irritable, difficulty in relaxing/ 
concentrating) have you been feeling, on a scale where ‘0’ is ‘not at all anxious’ and ‘10’ is ‘extremely 
anxious’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all anxious                        
           
D5. Over the past few days, how depressed (down-in-the–dumps, sad, in low spirits, pessimistic, 
lethargic) have you been feeling, on a scale where ‘0’ is ‘not at all depressed’ and ‘10’ is ‘extremely 
depressed’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all depressed                        
           
D6. Over the past few days, how do you think your work (both inside the home and/or employed work) 
have affected your low back pain, on a scale where ‘0’ is ‘make it no worse’ and ‘10’ is ‘make it very much 
worse’? 
             0 1 2 3 4 5 6 7 8 9 10 
Make it now worse                        
           
D7. Over the past few days, on average, how much have you been able to control (help/reduce) and cope 
with your low back pain on your own, on a scale where ‘0’ is ‘I can control it completely’ and ‘10’ is  
‘I have no control whatsoever’? 
            
I have complete  
control over my pain 
0 1 2 3 4 5 6 7 8 9 10 
                      
 
 
D. Please TICK ONE BOX FOR EACH OF THE FOLLOWING QUESTIONS about your low back pain  
and how it has affected you OVER THE PAST FEW DAYS. 
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E1. Have you been FREE OF YOUR BACK PAIN for the past month? (tick ONE) 
 
 
 
No  
 
 
 
 
 
Yes 
 If yes, how long ago did this pain-free  
period first start? (in WEEKS) 
  
 
  
E2. For the past month, have you been able to carry on (or resume) YOUR USUAL WORK/ 
ACTIVITIES/TASKS (e.g. work, washing and dressing, housework, walking, sitting, exercise) 
without any interference from back pain? (tick ONE) 
 
 
 
No 
 
 
 
 
 
Yes 
 If yes, how long ago did your back pain  
first cause no interference? (in WEEKS) 
  
 
  
E3. For the past month, have you had AN ACCEPTABLE QUALITY OF LIFE (e.g. socialising with 
family and friends, sleeping well, feeling well, energetic and confident) without any interference 
from back pain? (tick ONE) 
 
 
 
No 
 
 
 
 
 
Yes 
 If yes, how long ago did your back pain  
first cause no interference? (in WEEKS) 
   
 
 
 
 
F1. In the past 3 months, have you needed to take any TIME OFF WORK (PAID EMPLOYMENT)  
for your back pain? (tick ONE) 
 
 
 
No 
 
 
 
Yes 
 If yes, please state for how long you 
were/have been off work? (in DAYS) 
   
 
 
 
I am not in paid employment 
(e.g. at home and not looking for work, retired, student, unemployed) 
 
 
 
E. The following questions are about your low back pain and how it has affected you  
IN THE PAST MONTH. 
F. The following questions are about your low back pain and how it has been  
IN THE PAST 3 MONTHS (SINCE YOU COMPLETED THE FIRST QUESTIONNAIRE). 
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F2. In the past 3 months, how has your use  
of MEDICATION (PAIN KILLERS) for your  
back pain changed? (tick ONE) 
F5. In the past 3 months, did you attend  
ANY of the following for your back pain?  
(tick AS MANY AS APPLY) 
 
  
I have NEVER, or HARDLY EVER,  
used any pain killers 
 
  GP  
 
 
 
I have REDUCED my use of pain killers 
 
 
 
Outpatient hospital visit to  
Accident and Emergency department  
 
 
 
I am taking about the SAME amount  
of pain killers 
 
 
 
Outpatient hospital visit to a 
physiotherapist 
 
 
 
I have INCREASED my use  
of pain killers 
 
 
 
Outpatient hospital visit to a  
medical specialist (e.g. pain clinic, 
orthopaedic surgery, rheumatology) 
    
 
 
Overnight stay in hospital 
F3. In the past 3 months, did you receive  
ANY of the following for your back pain? 
(tick AS MANY AS APPLY) 
   
F6.  How would you describe your  
back pain NOW compared to how you  
were 3 months ago when you completed  
the first questionnaire? (tick ONE) 
 
  X-Ray 
  
 
MRI/CT scan 
  
 
Injections into spine (e.g. epidural)    Very much improved  
  
 
Low back surgery   
 
Much improved 
     
 
Slightly improved 
   
 
No change F4. In the past 3 months, have you applied 
for/received DISABILITY/INCAPACITY BENEFITS 
for your back pain? (tick ONE) 
  
 
Slightly worsened 
 
  Yes 
  
 
Much worsened 
  
 
No   
 
Very much worsened 
 
F7. Please indicate whether you have made any CHANGES in the following in order to  
TAKE CARE OF YOUR BACK in the past 3 months? (tick ONE BOX PER LINE) 
  Increased No change Decreased 
Awareness of early warning signs of back pain       
Rest  
 
 
 
 
 
Specific exercises for your back  
 
 
 
 
 
General physical activity/exercise  
 
 
 
 
 
Care when lifting  
 
 
 
 
 
Awareness of posture  
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Please go to F5. 
 
 
 G. The following questions are about chiropractic treatment for your low back pain  
IN THE PAST 3 MONTHS (SINCE YOU COMPLETED THE FIRST QUESTIONNAIRE). 
 
G1. In the past 3 months, HOW MANY chiropractic treatment sessions have you received for 
your back pain? (please write in NUMBER OF SESSIONS) 
 
 
   
 
    
G2. When was your LAST chiropractic treatment session? (tick ONE) 
1 month ago or less Between 1 and 2 months ago More than 2 months ago 
 
 
 
 
 
 
 
G3. Did you experience any worsening of your back pain, stiffness, soreness and/or general 
discomfort IMMEDIATELY OR SHORTLY AFTER any of these chiropractic treatment sessions?  
(tick ONE) 
   No 
  
 
Unsure 
   Yes, but I could carry on with my usual activities and/or work 
  
 
Yes and I could NOT carry on with my usual activities and/or work 
 
G4. Overall, how SATISFIED are you with the chiropractic care you received for your back pain? 
(tick ONE) 
Very satisfied Satisfied Undecided Dissatisfied Very dissatisfied 
 
 
 
 
 
 
 
 
 
 
     
G5. Overall, how do you feel the chiropractic care helped your back pain? (tick ONE) 
Very helpful Helpful Undecided Unhelpful Very Unhelpful 
 
 
 
 
 
 
 
 
 
 
 
 
THANK YOU FOR YOUR TIME IN COMPLETING THIS FORM. 
PLEASE RETURN THIS QUESTIONNAIRE IN THE PRE-PAID ENVELOPE. 
 
H. Finally, we would like some FEEDBACK regarding the QUESTIONNAIRES you have completed 
for this study (tick ONE BOX FOR EACH STATEMENT). 
 Strongly 
agree Agree Unsure Disagree 
Strongly 
disagree 
H1. Overall, the questions were clear  
and easy to answer           
H2. Overall, the questions were relevant  
to me and my back pain           
H3. Overall, completion of the questionnaires  
was NOT too disruptive or time consuming           
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 22 November 2010 
 
 
 
Dear ..., 
RE: Chiropractic Patient-Reported Outcome Measures Study (C-PROMS) 
Thank you for agreeing to participate in the above study. 
Please find enclosed the following documents: 
 1 User guide 
 10 Pre-treatment questionnaires (Questionnaire 1) 
 10 Pre-paid return envelopes 
 
The first thing you should do is carefully read about the study and how it is conducted 
in the User Guide. This should take you no more than 5-10 minutes. The study has 
been designed to cause minimal disruption to your practice. The data collection 
process is straightforward, but it is important that you understand the procedures we 
ask you to follow. If you have any questions, please feel free to contact us, either by 
phone or email, using the contact details given on page 3 of the User Guide. Moreover, 
if you require additional questionnaires or pre-paid envelopes please do not hesitate to 
contact the Principal Investigator. 
 
Once you are familiar with the procedures of the study, you are ready to start. You can 
start at any time that is convenient to you, but once you do start you must 
consecutively recruit 10 patients who meet the eligibility criteria. It is important that 
you follow the instructions detailed in the User Guide so that all the data you collect 
are valid and complete. The credibility of this study is dependent on your efforts and 
diligence in this process, and for this we are very grateful.  
 
All participating chiropractors will automatically be entered into a prize draw unless 
we hear from you to the contrary. The results of the draw will be announced near the 
end of the study. 
 
Thank you for your time. 
 
Yours sincerely, 
 
 
Taco Houweling, DC, MRes (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton, PhD, MA (Ed.), FCC (Hon) 
 
David Newell, MSc, PhD 
 
 
 
 
 
 
 
 
 
  
21 September 2010 
 
 
 
Dear Sir/Madam, 
RE: Chiropractic Patient-Reported Outcome Measures Study (C-PROMS) 
Thank you for agreeing to participate in the above study. 
Please find enclosed the following documents: 
 Questionnaire 
 Pre-paid return envelope 
 
About three months ago you completed a questionnaire about your low back pain at 
the chiropractic clinic. We now ask you to complete a final follow-up questionnaire for 
this study. The information you provide in this questionnaire will help us improve 
patient care, from which you may benefit. 
  
The first thing you should do is read the information and instructions on page 2 of the 
enclosed questionnaire. Once you have done so, you are ready to complete the 
questionnaire, which should take you no more than 5-10 minutes of your time. Please 
do so and return it as soon as possible in the pre-paid envelope provided. For your 
convenience, this questionnaire can also be completed and submitted online at 
http://www.aecc.ac.uk/research/c-proms.aspx using the code number on the front 
cover of the enclosed questionnaire. 
 
Thank you for your co-operation and time. 
 
Yours faithfully, 
 
 
 
Taco Houweling (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton (Study Supervisor) 
 
David Newell (Study Supervisor) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Patient name 
 
Study period 
ends: 
 Total number of visits 
during study period 
(includes initial 
consultation visit) 
1. asdf  adsf 
  
  
2. asdf  asdf 
  
  
3. asdf  asdf 
  
  
4. asdf  asdf 
  
  
5. asdf  asdf 
  
  
   
 
 
   
 
 
   
  
   
  
   
  
 
 
 
 
Please state below the TOTAL NUMBER OF TREATMENTS each patient received 
during the study period from the FIRST DAY THEY ATTENDED THE CLINIC 
(initial consultation) to the END OF THE STUDY PERIOD (INCLUSIVE).   
 
 
 1 July 2011 
 
 
 
Dear …, 
 
RE: Chiropractic Patient-Reported Outcome Measure Study (C-PROMS);  
 Number of visits to the clinic 
 
A few months ago, you participated in this study by administering questionnaires to 
a number of NEW low back pain patients presenting to your clinic; thank you for 
doing so. We now need to ask you the total number of treatments these new patients 
received during the study period. This information can be gathered from your 
computer booking software. 
 
Please fill in the enclosed form and return it in the pre-paid envelope 
provided as soon as possible. These data will be kept completely confidential. 
Please find enclosed a copy of the signed informed consent forms of the participating 
patients to allow you to release this information. 
 
Thank you very much for your time and co-operation. 
 
Kind Regards,  
 
 
 
 
Taco Houweling (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton (Study Supervisor) 
 
David Newell (Study Supervisor) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Appendix 2: Main study documentation. 
 
 
• User guide regarding data collection process 
• Baseline and follow-up questionnaire 
• Cover letter accompanying data collection pack –                     
for the attention of chiropractors and clinic staff  
• Cover letter accompanying follow-up questionnaire –  
for the attention of participants 
• Number of patient visits form and accompanying cover letter –           
for the attention of chiropractors and clinic staff 
150 
 
 C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
USER GUIDE 
1. What is this study about? 
The purpose of the Chiropractic Patient Reported Outcome Measures Study (C-PROMS) is to develop 
two short questionnaires to collect routine information concerning outcomes and costs in chiropractic 
practices across the United Kingdom. This information is required to assess and improve the quality of 
chiropractic care and to inform patients, clinicians and third-party payers. 
2. How is the study being done? 
You or your staff will collect data (Questionnaire 1) from 10 consecutive eligible new patients 
presenting to your clinic for the first time with low back pain. These patients can be seen by any 
chiropractor working in your clinic. Thereafter, patients will be sent a second questionnaire 
(Questionnaire 2) at three months by post from the AECC, so there is no work involved for your clinic. If 
your clinic is equipped with a computer booking system, you or your staff may be sent a form requesting 
the total number of visits each of these patients made to the clinic within this three month period. For 
administrative purposes, if you work in multiple clinics, this study should be conducted in one clinic 
only. All your contact details will be kept confidential for the purposes of this study. 
3. When does the study start? 
The study starts in August 2010. 
4. Setting up the study 
Before data collection can start, the following should have 
happened:  
• You should have received copies of Questionnaire 1 and 
a pre-paid return envelope for each copy.  
• You should have read this User Guide and if you have 
staff (e.g. receptionist, practice manager) ensure all of 
them understand how to collect and submit data (they all 
should have read this User Guide). 
NOW YOU ARE READY TO START DATA 
COLLECTION. 
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 5. Patient eligibility criteria for participation in the study 
To be eligible for participation in the study, patients must fulfil ALL of the following: 
 Patients must HAVE LOW BACK PAIN WITH OR WITHOUT LEG PAIN as their main complaint 
 Patients must be 18 years of age or older 
 Patients must NOT HAVE received treatment for their low back pain from a healthcare 
professional EXCEPT FROM THEIR GP in the PAST 3 MONTHS  
 Patients must NOT be pregnant 
 Patients must be literate in English 
6. Patient recruitment 
a. On the phone 
You will recruit 10 CONSECUTIVE NEW PATIENTS presenting with low back pain. When these new 
patients make an appointment at the clinic they should be told: 
• “the clinic is currently taking part in a study about low back pain” 
• “you will be given more information about the study when you arrive for your appointment so you can 
decide whether you want to take part or not” 
• “there will be no change to your chiropractic treatment whether you want to take part or not” 
• “we would like you to arrive 5-10 minutes early for your appointment to allow time for you to read the 
information about the study and complete the forms” 
b. At the clinic 
Please consider the following questions: 
• Is the patient eligible (refer to eligibility criteria) to enter the study? 
If they are not eligible, take no further action. 
 
If they are eligible, then proceed to the next stage. 
  
• If eligible, then please give them the questionnaire booklet (Questionnaire 1) and ask them to read 
the information at the start (page 1) and decide if they wish to complete the questionnaire. The 
questionnaire has been designed for patients to read and complete by themselves; you do not have 
to help the patient with the questionnaire. The patient now reads the information at the start of the 
Questionnaire (page 1). 
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 • If after reading the information the patient informs you that they DO NOT want to take part, 
please ask the patient to return the questionnaire to you and take no further action.   
• If a patient decides they DO want to take part in the study, please ask them to proceed and 
complete the questionnaire. The patient must complete the questionnaire in the practice 
before any treatment and return it to you straight away. Then, please: 
 Check that the patient has signed the informed consent on page 1 and the patient’s contact 
details have been completed on page 2 of the questionnaire. 
 After the initial consultation (with or without treatment), complete the box on the back cover of 
the questionnaire (see diagram below). This can be done by clinic staff when the patient 
returns to the front desk for payment and/or further appointment booking. 
 
 Place the completed questionnaire into one of the pre-paid envelopes supplied and return it to 
the Principal Investigator at the AECC (one questionnaire in a single envelope) as soon as 
possible. You do NOT have to wait until all the data are collected (10 patients) to return each 
questionnaire.  
7. Want to know more? 
Mr Taco Houweling (Principal Investigator): Tel: 01202 436234 / 079 31444501;  
 Email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor):  Tel: 01202 436200; Email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor):  Tel: 01202 436200; Email: dnewell@aecc.ac.uk  
Anglo-European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
  
This is on the back cover of 
the questionnaire booklet 
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Ask patient to return 
questionnaire to you. 
Take no further action. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgments: C-PROMS is funded by the British Chiropractic Association (BCA) and the Anglo-
European College of Chiropractic (AECC). The study has been submitted and approved by the Ethics 
Sub-Committee of the AECC.  
 
THANK YOU FOR YOUR TIME AND HELP WITH THIS STUDY. 
 
Patient makes appointment and 
is informed about the study. 
Patient is told to arrive 5-10 minutes early. 
Patient arrives at clinic. 
Refer to eligibility criteria. 
Is patient eligible for the study? 
 
RECRUIT 10 PATIENTS 
Patient is given questionnaire and 
reads information on page 1. 
Does patient want to take part in the 
study? 
Patient completes questionnaire. 
After initial consultation, complete 
question on back cover of questionnaire. 
Questionnaire is returned to AECC in one of the pre-paid 
envelopes straight away. 
YES 
YES 
Take no further action. NO 
NO 
Summary of 
information flow 
within C-PROMS 
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REMEMBER: Please do not return more than one questionnaire in a single envelope 
 
 
 PATIENT-REPORTED OUTCOME MEASURES 
 
 
Code number: 
     
 
 
 
QUESTIONNAIRE 1 
AT INITIAL CONSULTATION 
 
 
 
 
 
 
 
 
 
 
 
 
CHIROPRACTIC 
 
 
 C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
INFORMATION AND YOUR CONSENT 
What is the Chiropractic Patient-Reported Outcome Measures Study (C-PROMS)? 
The purpose of this research study is to collect information in chiropractic clinics regarding your 
experiences of care and the costs of treatment. The information that patients provide is an important 
part of the way in which decisions are made regarding the delivery of healthcare services in the UK. 
How is the study being done?  
You will be asked to complete two questionnaires; each one will take about 5-10 minutes of your 
time. The first questionnaire you will be asked to complete today. The second questionnaire you will 
receive in the post in about 3 months time, which you will be asked to complete and then return in an 
enclosed stamped addressed envelope. In addition, we may ask your chiropractor the total number of 
visits you have made to the clinic over this 3-month period. 
Who is undertaking this study? 
Mr Taco Houweling is the Principal Investigator, and is conducting this study as part of a PhD funded 
by the Anglo-European College of Chiropractic and the British Chiropractic Association.  
Why should I take part? 
This study will help improve patient care in the future, from which you may benefit. 
Do I have to take part? 
Your participation is voluntary and you are free to withdraw at any time without giving any reason. 
Your chiropractic care is NOT affected either by your decision to participate or not, or by any decision 
to withdraw once you have started. 
What will happen to the information I give? 
All the information is strictly confidential and will NOT be divulged to your chiropractor. It will be used 
anonymously and only for the research study. Published reports will not refer to any individuals; your 
name and address are only required to enable us to send you the questionnaire at the 3-month 
follow-up. If we need to send you a reminder, we will do so by post, phone and/or email. 
What now? 
If you agree to take part please sign below and complete the questionnaire now. Otherwise, please 
hand back the questionnaire to the person who gave it to you. 
I have read and understood the information given above and agree to take part in the study: 
Signature:  Name (please print):  Date: 
     
Want to know more? 
Mr Taco Houweling (Principal Investigator): Tel: 07931444501; email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor): Tel: 01202 436200; email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor): Tel: 01202 436200; email: dnewell@aecc.ac.uk  
Anglo-European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
THANK YOU FOR YOUR CO-OPERATION AND TIME. 
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 PATIENT DETAILS 
 
Today’s date: D D 
 M M  2 0 Y Y          
 
Title: 
                   
 
 
First name: 
                   
 
 
Surname: 
                   
 
 
Address: 
                   
 
 
                   
 
 
Town/City: 
                   
 
 
County: 
                   
 
 
Postcode: 
                   
 
 
Phone: 
     
- 
             
 
 
Mobile: 
     
- 
             
 
 
E-mail: 
                   
 
 
 
Please write your name and contact details in CAPITAL LETTERS BELOW so that we may 
contact you by post for the questionnaire at 3 months or by post/email/phone if 
reminders are necessary. 
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A1. Are you? (tick ONE) A2. How old are you? (in YEARS) 
  
 
Male   
 
   
  
 
Female    
                  
A3. Please describe your CURRENT WORK (PAID EMPLOYMENT) STATUS? (tick ONE) 
  
 
In paid (including self) employment  
  
 
At home and not looking for work 
  
 
Unemployed because of back pain 
  
 
Unemployed because of other reasons 
  
 
Retired 
  
 
Student 
 
A4. How long is it since you had a WHOLE MONTH WITHOUT any back pain? (tick ONE) 
 
  Less than 3 months 
  
 
3-6 months 
  
 
7-12 months 
  
 
1-2 years 
  
 
3-5 years 
  
 
6-10 years 
  
 
More than 10 years 
   
A5. Are you taking any MEDICATION (PAIN KILLERS) for your back pain? (tick ONE) 
Never Rarely Sometimes Every day 
 
 
 
 
 
 
 
 
 
A. The following questions are about you and your low back pain. 
Please answer ALL the questions below. Before answering each question, read 
through all the options and then tick the box or boxes that best describe(s) you.  
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B1.   I stay at home most of the time because of my back.   
B2.  
 
I change position frequently to try and get my back comfortable.    
B3.  
 
I walk more slowly than usual because of my back. 
B4.  
 
Because of my back I am not doing any of the jobs that I usually do around the house. 
B5.  
 
Because of my back, I use a handrail to get upstairs. 
B6.  
 
Because of my back, I lie down to rest more often. 
B7.  
 
Because of my back, I have to hold on to something to get out of an easy chair. 
B8.  
 
Because of my back, I try to get other people to do things for me. 
B9.   I get dressed more slowly than usual because of my back. 
B10.  
 
I only stand for short periods of time because of my back. 
B11.  
 
Because of my back, I try not to bend or kneel down. 
B12.  
 
I find it difficult to get out of a chair because of my back. 
B13.  
 
My back is painful almost all the time. 
B14.  
 
I find it difficult to turn over in bed because of my back. 
B15.  
 
My appetite is not very good because of my back pain. 
B16.  
 
I have trouble putting on my socks (or stockings) because of the pain in my back. 
B17.  
 
I only walk short distances because of my back. 
B18.  
 
I sleep less well because of my back. 
B19.   Because of my back pain, I get dressed with help from someone else. 
B20.  
 
I sit down for most of the day because of my back. 
B21.  
 
I avoid heavy jobs around the house because of my back. 
B22.  
 
Because of my back pain, I am more irritable and bad tempered with people than usual. 
B23.  
 
Because of my back, I go upstairs more slowly than usual. 
B24.  
 
I stay in bed most of the time because of my back 
 
 
B. When your back hurts, you may find it difficult to do some of the things you normally 
do.  
This list contains sentences that people have used to describe themselves when they have back 
pain.  When you read them, you may find that some stand out because they describe you TODAY. 
When you read a sentence that describes you TODAY, put a tick against it.  
 If the sentence does not describe you, then leave the space blank and go on to the next one.   
Remember, only tick the sentence if you are sure it describes you TODAY. 
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C1. Mobility  
 I have NO problems in walking about  
 
 I have SOME problems in walking about  
 
 I am CONFINED TO BED  
 
 
   
C2. Self-Care  
 I have NO problems with self-care  
 
 I have SOME problems washing or dressing myself  
 
 I am UNABLE to wash or dress myself  
 
 
   
C3. Usual Activities  
(e.g. work, study, housework, family or leisure activities) 
 
 I have NO problems with performing my usual activities  
 
 I have SOME problems with performing my usual activities  
 
 I am UNABLE to perform my usual activities  
 
 
  
C4. Pain/Discomfort  
 I have NO pain or discomfort  
 
 I have MODERATE pain or discomfort  
 
 I have EXTREME pain or discomfort  
 
 
  
C5. Anxiety/Depression  
 I am NOT anxious or depressed  
 
 I am MODERATELY anxious or depressed  
 
 I am EXTREMELY anxious or depressed  
 
 
 
D1. In the past week, how BOTHERSOME has your back pain been? (tick ONE) 
 
Not at all Slightly Moderately Very much Extremely 
          
C. By placing A TICK IN ONE BOX IN EACH GROUP BELOW, please indicate which statements  
best describe your own HEALTH STATE TODAY. 
 
D.  The following question is about your low back pain and how it has been  
IN THE PAST WEEK. 
 
 
  
E1. Over the past few days, on average, how would you rate your low back pain on a scale where ‘0’ is 
‘no pain’ and ‘10’ is ‘worst pain possible’? 
             0 1 2 3 4 5 6 7 8 9 10 
No pain                         
           
E2. Over the past few days, on average, how has your low back pain interfered with your daily activities 
(housework, washing, dressing, lifting, walking, driving, climbing stairs, getting in/out of bed/chair, 
sleeping) on a scale where ‘0’ is ‘no interference’ and ‘10’ is ‘completely unable to carry on with normal 
daily activities’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                         
           
E3. Over the past few days, on average, how much has your low back pain interfered with your normal 
social routine including recreational, social and family activities, on a scale where ‘0’ is ‘no interference’ 
and ‘10’ is ‘completely unable to participate in any social and recreational activity’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                        
           
E4. Over the past few days, on average, how anxious (uptight, tense, irritable, difficulty in relaxing/ 
concentrating) have you been feeling, on a scale where ‘0’ is ‘not at all anxious’ and ‘10’ is ‘extremely 
anxious’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all anxious                        
           
E5. Over the past few days, how depressed (down-in-the–dumps, sad, in low spirits, pessimistic, 
lethargic) have you been feeling, on a scale where ‘0’ is ‘not at all depressed’ and ‘10’ is ‘extremely 
depressed’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all depressed                        
           
E6. Over the past few days, how do you think your work (both inside the home and/or employed work) 
have affected your low back pain, on a scale where ‘0’ is ‘make it no worse’ and ‘10’ is ‘make it very much 
worse’? 
             0 1 2 3 4 5 6 7 8 9 10 
Make it no worse                        
           
E7. Over the past few days, on average, how much have you been able to control (help/reduce) and cope 
with your low back pain on your own, on a scale where ‘0’ is ‘I can control it completely’ and ‘10’ is  
‘I have no control whatsoever’? 
            
I have complete  
control over my pain 
0 1 2 3 4 5 6 7 8 9 10 
                      
 
THANK YOU FOR YOUR TIME IN COMPLETING THIS FORM. 
PLEASE RETURN THIS QUESTIONNAIRE TO THE PERSON WHO GAVE IT TO YOU. 
E. Please TICK ONE BOX FOR EACH OF THE FOLLOWING QUESTIONS about your low back pain         
and how it has affected you OVER THE PAST FEW DAYS. 
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FOR CLINIC STAFF USE ONLY 
Please state below whether or not this patient  
is receiving/will receive chiropractic care at  
your clinic: (tick one) 
 
Yes    
 
No   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFORMATION FOR CLINIC STAFF 
After the patient has completed and returned the questionnaire to you, please:  
 
 Check that the consent section of the questionnaire has been signed  
on page 1 of the questionnaire. 
 Check that the patient’s contact details have been completed  
on page 2 of the questionnaire. 
 Complete the box at the top of this page after the patient’s  
initial consultation (with or without treatment). 
 Place the questionnaire into one of the pre-paid envelopes supplied  
and return it to the AECC as soon as possible. 
PLEASE REMEMBER – only one questionnaire in a single envelope 
 
 
 
 CHIROPRACTIC 
PATIENT-REPORTED OUTCOME MEASURES 
 
If you would prefer to complete this questionnaire ONLINE, please go to: 
http://www.aecc.ac.uk/research/c-proms.aspx 
 
 
 
 
QUESTIONNAIRE 2 
AT FOLLOW-UP 
 
 
 
 
 
 
 
 
 
 
 
 
Code number: B     
 
 
 How am I today? How 
have I been over the past 
week and past 3 months? 
 
C H I R O P R A C T I C  
PATIENT-REPORTED OUTCOME MEASURES 
INFORMATION 
About three months ago, at the chiropractic clinic, you completed a questionnaire about your low 
back pain. As a follow up, we now ask you to complete this questionnaire and return it using the pre-
paid envelope provided. Please state today’s date and your name below. Your name is only required 
so we can match this questionnaire to the one you completed three months ago. None of the 
information you give here will be divulged to your chiropractor; it will only be used (anonymously) for 
the purpose of the research study. 
Today’s date: D D 
 M M  2 0 Y Y          
 
Your name: 
                   
 
Questionnaire Instructions 
The questions on the following pages are about your back pain and how it has been since you 
completed the first questionnaire, which in most cases will be about 3 months ago. The form starts by 
asking you to consider how your back pain is TODAY and then how it has been over the PAST WEEK AND 
PAST 3 MONTHS. Please think back and try to remember how your back pain has changed during this 
period of time. 
 
 
 
Ap
pr
ox
im
at
el
y 
3 
m
on
th
s a
go
 
  
 
 
1 
w
ee
k 
ag
o 
 
? 
 
 
 
Questionnaire 1  Questionnaire 2 
TODAY 
Want to know more? 
Mr Taco Houweling (Principal Investigator): Tel: 01202 436234 / 079 31444501;  
 Email: thouweling@aecc.ac.uk 
Professor Jennifer Bolton (Study Supervisor):  Tel: 01202 436200; Email: jbolton@aecc.ac.uk 
Dr David Newell (Study Supervisor):  Tel: 01202 436200; Email: dnewell@aecc.ac.uk  
Anglo-European College of Chiropractic (AECC), 13-15 Parkwood Road, BOURNEMOUTH BH5 2DF. 
THANK YOU FOR YOUR CO-OPERATION AND TIME. 
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A1.   I stay at home most of the time because of my back.   
A2.  
 
I change position frequently to try and get my back comfortable.    
A3.  
 
I walk more slowly than usual because of my back. 
A4.  
 
Because of my back, I am not doing any of the jobs that I usually do around the house. 
A5.  
 
Because of my back, I use a handrail to get upstairs. 
A6.  
 
Because of my back, I lie down to rest more often. 
A7.  
 
Because of my back, I have to hold on to something to get out of an easy chair. 
A8.  
 
Because of my back, I try to get other people to do things for me. 
A9.   I get dressed more slowly than usual because of my back. 
A10.  
 
I only stand for short periods of time because of my back. 
A11.  
 
Because of my back, I try not to bend or kneel down. 
A12.  
 
I find it difficult to get out of a chair because of my back. 
A13.  
 
My back is painful almost all the time. 
A14.  
 
I find it difficult to turn over in bed because of my back. 
A15.  
 
My appetite is not very good because of my back pain. 
A16.  
 
I have trouble putting on my socks (or stockings) because of the pain in my back. 
A17.  
 
I only walk short distances because of my back. 
A18.  
 
I sleep less well because of my back. 
A19.   Because of my back pain, I get dressed with help from someone else. 
A20.  
 
I sit down for most of the day because of my back. 
A21.  
 
I avoid heavy jobs around the house because of my back. 
A22.  
 
Because of my back pain, I am more irritable and bad tempered with people than usual. 
A23.  
 
Because of my back, I go upstairs more slowly than usual. 
A24.  
 
I stay in bed most of the time because of my back. 
 
 
A. When your back hurts, you may find it difficult to do some of the things you normally 
do.  
This list contains sentences that people have used to describe themselves when they have back 
pain.  When you read them, you may find that some stand out because they describe you TODAY. 
When you read a sentence that describes you TODAY, put a tick against it.  
 If the sentence does not describe you, then leave the space blank and go on to the next one.  
Remember, only tick the sentence if you are sure it describes you TODAY. 
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B1. Mobility  
 I have NO problems in walking about  
 
 I have SOME problems in walking about  
 
 I am CONFINED TO BED  
 
 
   
B2. Self-Care  
 I have NO problems with self-care  
 
 I have SOME problems washing or dressing myself  
 
 I am UNABLE to wash or dress myself  
 
 
   
B3. Usual Activities  
(e.g. work, study, housework, family or leisure activities) 
 
 I have NO problems with performing my usual activities  
 
 I have SOME problems with performing my usual activities  
 
 I am UNABLE to perform my usual activities  
 
 
  
B4. Pain/Discomfort  
 I have NO pain or discomfort  
 
 I have MODERATE pain or discomfort  
 
 I have EXTREME pain or discomfort  
 
 
  
B5. Anxiety/Depression  
 I am NOT anxious or depressed  
 
 I am MODERATELY anxious or depressed  
 
 I am EXTREMELY anxious or depressed  
 
 
 
C1. In the past week, how BOTHERSOME has your back pain been? (tick ONE) 
 
Not at all Slightly Moderately Very much Extremely 
          
B. By placing A TICK IN ONE BOX IN EACH GROUP BELOW, please indicate which statements  
best describe your own HEALTH STATE TODAY. 
C.  The following question is about your low back pain and how it has been 
 IN THE PAST WEEK. 
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D1. Over the past few days, on average, how would you rate your low back pain on a scale where ‘0’ is 
‘no pain’ and ‘10’ is ‘worst pain possible’? 
             0 1 2 3 4 5 6 7 8 9 10 
No pain                         
           
D2. Over the past few days, on average, how has your low back pain interfered with your daily activities 
(housework, washing, dressing, lifting, walking, driving, climbing stairs, getting in/out of bed/chair, 
sleeping) on a scale where ‘0’ is ‘no interference’ and ‘10’ is ‘completely unable to carry on with normal 
daily activities’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                         
           
D3. Over the past few days, on average, how much has your low back pain interfered with your normal 
social routine including recreational, social and family activities, on a scale where ‘0’ is ‘no interference’ 
and ‘10’ is ‘completely unable to participate in any social and recreational activity’? 
             0 1 2 3 4 5 6 7 8 9 10 
No interference                        
           
D4. Over the past few days, on average, how anxious (uptight, tense, irritable, difficulty in relaxing/ 
concentrating) have you been feeling, on a scale where ‘0’ is ‘not at all anxious’ and ‘10’ is ‘extremely 
anxious’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all anxious                        
           
D5. Over the past few days, how depressed (down-in-the–dumps, sad, in low spirits, pessimistic, 
lethargic) have you been feeling, on a scale where ‘0’ is ‘not at all depressed’ and ‘10’ is ‘extremely 
depressed’? 
             0 1 2 3 4 5 6 7 8 9 10 
Not at all depressed                        
           
D6. Over the past few days, how do you think your work (both inside the home and/or employed work) 
have affected your low back pain, on a scale where ‘0’ is ‘make it no worse’ and ‘10’ is ‘make it very much 
worse’? 
             0 1 2 3 4 5 6 7 8 9 10 
Make it no worse                        
           
D7. Over the past few days, on average, how much have you been able to control (help/reduce) and cope 
with your low back pain on your own, on a scale where ‘0’ is ‘I can control it completely’ and ‘10’ is  
‘I have no control whatsoever’? 
            
I have complete  
control over my pain 
0 1 2 3 4 5 6 7 8 9 10 
                      
 
 
D. Please TICK ONE BOX FOR EACH OF THE FOLLOWING QUESTIONS about your low back pain  
and how it has affected you OVER THE PAST FEW DAYS. 
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E1. Since completing the first questionnaire, have you at any time had A WHOLE MONTH free of 
YOUR BACK PAIN? (tick ONE) 
E. The following questions are about your low back pain and how it has been  
IN THE PAST 3 MONTHS OR SO (SINCE YOU COMPLETED THE FIRST QUESTIONNAIRE). 
 
 
 
No  
 
 
 
 
 
Yes 
 If yes, are you still in this  
pain-free period today? (tick one)   No   Yes 
 
  
E2. Since completing the first questionnaire, have you at any time been able to carry out YOUR 
USUAL ACTIVITIES (e.g. work; washing and dressing; housework; walking; sitting; exercise) 
without interference from your back pain AND this interference-free period lasted A WHOLE 
MONTH? (tick ONE) 
 
 
 
No 
 
 
 
 
 
Yes 
  If yes, are you still in this  
interference-free period today? (tick one)   No   Yes 
 
  
E3. Since completing the first questionnaire, have you at any time achieved an ACCEPTABLE  
QUALITY OF LIFE (e.g. socialising with family and friends; sleeping well; feeling well, energetic  
and confident) without interference from your back pain AND this interference-free period 
lasted A WHOLE MONTH? (tick ONE) 
 
 
 
No 
 
 
 
 
 
Yes 
  If yes, are you still in this 
interference-free period today? (tick one)   No   Yes 
 
 
 
E4. Since completing the first questionnaire, have you needed to take any  
TIME OFF WORK (PAID EMPLOYMENT) for your back pain? (tick ONE) 
 
 
 
No 
 
 
 
Yes 
 If yes, please state for how long you 
were/have been off work? (in DAYS) 
   
 
 
 
I am not in paid employment 
(e.g. at home and not looking for work, retired, student, unemployed) 
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 E5. Since completing the first questionnaire,  
how has your use of MEDICATION (pain killers) 
for your back pain changed? (tick ONE) 
E8. Since completing the first questionnaire, 
did you attend ANY of the following for your 
back pain? (tick AS MANY AS APPLY) 
 
  
I have NEVER, or HARDLY EVER,  
used any pain killers 
 
  GP  
 
 
 
I have REDUCED my use of pain killers 
 
 
 
Outpatient hospital visit to  
Accident and Emergency department  
 
 
 
I am taking about the SAME amount  
of pain killers 
 
 
 
Outpatient hospital visit to a 
physiotherapist 
 
 
 
I have INCREASED my use  
of pain killers 
 
 
 
Outpatient hospital visit to a  
medical specialist (e.g. pain clinic, 
orthopaedic surgery, rheumatology) 
    
 
 
Overnight stay in hospital 
E6. Since completing the first questionnaire, 
did you receive ANY of the following for your  
back pain? (tick AS MANY AS APPLY) 
   
E9.  How would you describe your  
back pain NOW compared to how you  
were about 3 months ago when you  
completed the first questionnaire? (tick ONE) 
 
  X-Ray 
  
 
MRI/CT scan 
  
 
Injections into spine (e.g. epidural)    Completely recovered  
  
 
Low back surgery   
 
Much improved 
     
 
Slightly improved 
   
 
No change E7. Since completing the first questionnaire,  
have you applied for DISABILITY/INCAPACITY 
BENEFITS for your back pain? (tick ONE) 
  
 
Slightly worsened 
 
  No 
  
 
Much worsened 
  
 
Yes   
 
Worse than ever 
 
E10. Please indicate whether you have made any CHANGES in the following in order to  
TAKE CARE OF YOUR BACK since you completed the first questionnaire? (tick ONE BOX PER LINE) 
  Increased No change Decreased 
Awareness of early warning signs of back pain       
Rest  
 
 
 
 
 
Specific exercises for your back  
 
 
 
 
 
General physical activity/exercise  
 
 
 
 
 
Care when lifting  
 
 
 
 
 
Awareness of posture  
 
 
 
 
 
 
Page 6 - CONTINUED OVERLEAF 
 
Please go to F5. 
 
 
 F. The following questions are about chiropractic care for your low back pain  
IN THE PAST 3 MONTHS OR SO (SINCE YOU COMPLETED THE FIRST QUESTIONNAIRE). 
 
F1. Since you completed the first questionnaire, HOW MANY visits have you made to the 
chiropractic clinic for your back pain (including your first visit)? (please write in NUMBER OF 
VISITS) 
 
 
   
 
 
F2. Did you experience any worsening of your back pain, stiffness, soreness and/or general 
discomfort IMMEDIATELY OR SHORTLY AFTER any of these chiropractic treatment visits?  
(tick ONE) 
   No 
  
 
Don’t know 
  
 
Yes, but I could carry on with my usual activities and/or work 
  
 
Yes and I could NOT carry on with my usual activities and/or work 
 
F3. Overall, how do you feel this chiropractic care helped your back pain? (tick ONE) 
Very helpful Helpful Don’t know Unhelpful Very Unhelpful 
 
 
 
 
 
 
 
 
 
 
 
 
 
THANK YOU FOR YOUR TIME IN COMPLETING THIS FORM. 
PLEASE RETURN THIS QUESTIONNAIRE IN THE PRE-PAID ENVELOPE. 
F4. Overall, how was the chiropractor at each of the following? (tick ONE) 
 Very 
good Good 
Don’t 
know Poor 
Very 
poor 
Giving you enough time  
 
 
 
 
 
 
 
 
 
Giving you an explanation for your back pain  
 
 
 
 
 
 
 
 
 
Involving you in decisions about your care  
 
 
 
 
 
 
 
 
 
G. Finally, we would like some FEEDBACK regarding the QUESTIONNAIRES you have completed 
for this study (tick ONE BOX FOR EACH STATEMENT). 
 Strongly 
agree Agree 
Don’t 
know Disagree 
Strongly 
disagree 
Overall, the questions were clear  
and easy to answer           
Overall, the questions were relevant  
to me and my back pain           
Overall, completion of the questionnaires  
was NOT too disruptive or time consuming           
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 22 November 2010 
 
 
 
Dear ..., 
RE: Chiropractic Patient-Reported Outcome Measures Study (C-PROMS) 
Thank you for agreeing to participate in the above study. 
Please find enclosed the following documents: 
 1 User guide 
 10 Pre-treatment questionnaires (Questionnaire 1) 
 10 Pre-paid return envelopes 
 
The first thing you should do is carefully read about the study and how it is conducted 
in the User Guide. This should take you no more than 5-10 minutes. The study has 
been designed to cause minimal disruption to your practice. The data collection 
process is straightforward, but it is important that you understand the procedures we 
ask you to follow. If you have any questions, please feel free to contact us, either by 
phone or email, using the contact details given on page 3 of the User Guide. Moreover, 
if you require additional questionnaires or pre-paid envelopes please do not hesitate to 
contact the Principal Investigator. 
 
Once you are familiar with the procedures of the study, you are ready to start. You can 
start at any time that is convenient to you, but once you do start you must 
consecutively recruit 10 patients who meet the eligibility criteria. It is important that 
you follow the instructions detailed in the User Guide so that all the data you collect 
are valid and complete. The credibility of this study is dependent on your efforts and 
diligence in this process, and for this we are very grateful.  
 
All participating chiropractors will automatically be entered into a prize draw unless 
we hear from you to the contrary. The results of the draw will be announced near the 
end of the study. 
 
Thank you for your time. 
 
Yours sincerely, 
 
 
Taco Houweling, DC, MRes (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton, PhD, MA (Ed.), FCC (Hon) 
 
David Newell, MSc, PhD 
 
 
 
 
 
 
 
 
 
 26 July 2011 
 
 
 
Dear Sir/Madam, 
RE: We need your views on chiropractic care 
About three months ago you completed a questionnaire about your low 
back pain at the chiropractic clinic; thank you for doing so. We now ask 
you to complete a final follow-up questionnaire for this study. Even if 
you have not visited the chiropractor recently, we still need your views.  
 
The information you provide in this questionnaire will help us improve 
patient care, from which you and others may benefit.  
  
The first thing you should do is read the information and instructions 
on page 2 of the enclosed questionnaire. Once you have done so, you are 
ready to complete the questionnaire, which should take you no more 
than 5-10 minutes of your time.  
 
Please do so and return it as soon as possible in the pre-paid 
envelope provided. If you would prefer to complete this 
questionnaire online, please go to http://www.aecc.ac.uk/research/c-
proms.aspx  
 
Thank you for your co-operation and time. 
 
Yours faithfully, 
 
 
 
Taco Houweling (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton (Study Supervisor) 
 
David Newell (Study Supervisor) 
 
 
 
 
 
 
 
 
 
 
  
 
Ref.  
 
Patient name 
 
Study period 
ends: 
 Total number of visits 
during study period 
(includes initial 
consultation visit) 
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
asdsdd  asdasdfa  asdasdf 
  
  
 
 
 
 
 
 
 
Please state below the TOTAL NUMBER OF VISITS each patient made to the 
clinic during the study period from the FIRST DAY THEY ATTENDED THE 
CLINIC (initial consultation) to the END OF THE STUDY PERIOD (INCLUSIVE).   
 
 
 1 July 2011 
 
 
 
Dear …, 
 
RE: Chiropractic Patient-Reported Outcome Measure Study (C-PROMS);  
 Number of visits to the clinic 
 
A few months ago, you participated in this study by administering questionnaires to 
a number of NEW low back pain patients presenting to your clinic; thank you for 
doing so. We now need to ask you the total number of visits (including the initial 
consultation visit) these new patients made to the clinic during the study period. 
This information can be gathered from your computer booking software. 
 
Please fill in the enclosed form and return it in the pre-paid envelope 
provided as soon as possible. These data will be kept completely confidential. 
Please find enclosed a copy of the signed informed consent forms of the participating 
patients to allow you to release this information. 
 
Thank you very much for your time and co-operation. 
 
Kind Regards,  
 
 
 
 
Taco Houweling (Principal Investigator) 
Tel: 01202 436234 / 079 31444501 
Email: thouweling@aecc.ac.uk 
 
Jennifer Bolton (Study Supervisor) 
 
David Newell (Study Supervisor) 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix 3: Ethics approval letter. 
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 Appendix 4A: Distribution of age of patients at baseline. 
 
 
Appendix 4B: Distribution of change scores. 
 
 Distribution of Bournemouth Questionnaire change scores. 
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Distribution of EQ-5D change scores. 
Distribution of Roland-Morris Disability Questionnaire change scores. 
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Appendix 4C: Distribution of continuous cost data. 
 
Distribution of bothersomeness scale change scores. 
Distribution of time off work. 
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Distribution of number of chiropractic visits as reported by patients. 
Distribution of number of chiropractic visits as reported in patient files. 
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 Appendix 5: Hypothetical example of a QALY calculation assuming linear utility change over time. 
Grey area represents QALY over the 3-month study period. 
 
 
 
 
 
 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
0 3 6 9 12 
EQ-5D score  
(utility) 
Months 
QALY calculation  
 
Utility at baseline: 0.40  
Utility at follow-up: 1.00 
 
=  [(((1.00 - 0.40) x 3) / 2) + 
    (0.40 x 3)] / 12 
 
=  0.175 
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 Appendix 6: Calculation of the accuracy between dichotomous 
measures using sensitivity and specificity. 
 
 
 
New measure 
External criterion (i.e. gold standard) 
Positive  Negative  
Positive True positive (TP) False positive (FP) 
Negative False negative (FN) True negative (TN) 
   
Sensitivity TP 
(TP+FN) 
   
Specificity TN 
(TN+FP) 
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 Appendix 7: Unit costs. 
Cost component Unit cost (£) Source Details 
Chiropractic 26.94 NICE costing report, 2009238 Cost of a visit to chiropractor adjusted for inflation (2% yearly, £25 in 2009) 
GP 36.00 Unit Cost of Health and Social Care, 2011290 Assumes one 11.7-minute consultation 
A & E 49.00 Unit Cost of Health and Social Care, 2011290 Cost of one visit to walk-in service 
Physiotherapy 90.00 Unit Cost of Health and Social Care, 2011290 
Assumes five 30-minute consultations. This assumption is 
based on the fact that low back patients receive an average 
of five physiotherapy sessions in the NHS. 
Medical specialist 127.00 NHS reference costs, 2010-2011291 Consultant led first attendance 
Overnight stay in hospital 549.00 Unit Cost of Health and Social Care, 2011 Mean cost per outpatient attendance (non-elective inpatient short stay) 
X-Ray 67.00 NHS reference costs, 2010-2011291 Cost of an X-Ray (direct access) 
MRI / CT Scan 162.00 NHS reference costs, 2010-2011291 Cost of an MRI or CT scan (one area of the body) 
Injection into spine 581.80 NICE costing report, 2009238 Cost of spinal injection adjusted for inflation (2% yearly, £540 in 2009) 
Low back surgery 9387.22 NHS study comparing surgical stabilisation to rehabilitation for low back pain, 2003292 
Mean total cost of a surgical stabilisation operation adjusted 
for inflation (2% yearly, £7610 in 2003) 
Cost of a day off sick 100.20 Office for National Statistics, 2011293 One-fifth of median weekly earnings weighted by age and gender 
All NHS costs include salary, on-costs, qualifications, overhead and capital costs.  
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 Appendix 8: Cut-off point determination using Received Operating 
Characteristics. 
 
Cut-off point determination for Roland-Morris Disability 
Questionnaire (cut-off point in bold). 
Cut-off  
point Sensitivity Specificity 
*Youden's  
index 
-11.000 1.000 0.000 0.000 
-8.500 0.994 0.015 0.009 
-6.500 0.994 0.030 0.024 
-5.500 0.994 0.075 0.069 
-4.500 0.994 0.090 0.084 
-3.500 0.988 0.090 0.078 
-2.500 0.988 0.119 0.107 
-1.500 0.988 0.179 0.167 
-0.500 0.964 0.313 0.278 
0.500 0.893 0.403 0.296 
1.500 0.738 0.582 0.320 
2.500 0.667 0.687 0.353 
3.500 0.589 0.761 0.350 
4.500 0.530 0.836 0.366 
5.500 0.458 0.881 0.339 
6.500 0.387 0.881 0.268 
7.500 0.339 0.881 0.220 
8.500 0.304 0.925 0.229 
9.500 0.262 0.925 0.187 
10.500 0.238 0.955 0.193 
11.500 0.196 0.985 0.182 
12.500 0.131 0.985 0.116 
13.500 0.095 0.985 0.080 
14.500 0.071 1.000 0.071 
15.500 0.042 1.000 0.042 
16.500 0.018 1.000 0.018 
17.500 0.012 1.000 0.012 
19.000 0.006 1.000 0.006 
21.000 0.000 1.000 0.000 
*Younden's index (sensitivity + specificity - 1) indicates 
the point that maximises sensitivity and specificity.  
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 Cut-off point determination for Bournemouth 
Questionnaire (cut-off point in bold). 
Cut-off  
point Sensitivity Specificity 
*Youden's  
index 
-30.000 1.000 0.000 0.000 
-28.000 1.000 0.016 0.016 
-22.000 1.000 0.032 0.032 
-15.500 1.000 0.048 0.048 
-12.500 1.000 0.063 0.063 
-9.500 1.000 0.111 0.111 
-7.500 1.000 0.143 0.143 
-6.500 0.994 0.206 0.200 
-5.500 0.988 0.238 0.226 
-4.500 0.982 0.238 0.220 
-3.500 0.982 0.254 0.236 
-2.500 0.976 0.270 0.246 
-1.500 0.964 0.286 0.249 
-0.500 0.964 0.317 0.281 
0.500 0.933 0.365 0.298 
1.500 0.921 0.365 0.286 
2.500 0.903 0.413 0.316 
3.500 0.897 0.429 0.326 
4.500 0.867 0.444 0.311 
5.500 0.848 0.460 0.309 
6.500 0.836 0.492 0.328 
7.500 0.806 0.492 0.298 
8.500 0.788 0.540 0.328 
9.500 0.770 0.587 0.357 
10.500 0.733 0.635 0.368 
11.500 0.709 0.651 0.360 
12.500 0.661 0.651 0.311 
13.500 0.624 0.683 0.307 
14.500 0.594 0.746 0.340 
15.500 0.582 0.746 0.328 
16.500 0.558 0.778 0.335 
17.500 0.545 0.810 0.355 
18.500 0.527 0.810 0.337 
19.500 0.497 0.857 0.354 
20.500 0.485 0.873 0.358 
22.000 0.473 0.905 0.377 
23.500 0.461 0.921 0.381 
24.500 0.442 0.952 0.395 
25.500 0.424 0.952 0.377 
26.500 0.406 0.952 0.358 
27.500 0.376 0.952 0.328 
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 28.500 0.364 0.968 0.332 
30.000 0.352 0.968 0.320 
31.500 0.333 0.968 0.302 
32.500 0.309 0.968 0.277 
33.500 0.303 0.968 0.271 
34.500 0.279 0.968 0.247 
35.500 0.267 0.968 0.235 
36.500 0.255 0.968 0.223 
37.500 0.230 0.984 0.214 
38.500 0.200 0.984 0.184 
39.500 0.182 0.984 0.166 
40.500 0.158 0.984 0.142 
41.500 0.133 0.984 0.117 
42.500 0.115 1.000 0.115 
43.500 0.109 1.000 0.109 
44.500 0.097 1.000 0.097 
45.500 0.085 1.000 0.085 
47.500 0.079 1.000 0.079 
49.500 0.073 1.000 0.073 
50.500 0.067 1.000 0.067 
52.500 0.042 1.000 0.042 
54.500 0.036 1.000 0.036 
55.500 0.030 1.000 0.030 
57.000 0.024 1.000 0.024 
59.000 0.018 1.000 0.018 
61.500 0.012 1.000 0.012 
63.500 0.006 1.000 0.006 
65.000 0.000 1.000 0.000 
*Younden's index (sensitivity + specificity - 1) indicates 
the point that maximises sensitivity and specificity.  
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 Cut-off point determination for EQ-5D  
(cut-off point in bold). 
Cut-off  
point Sensitivity Specificity 
*Youden's  
index 
-1.661 1.000 0.000 0.000 
-0.572 1.000 0.016 0.016 
-0.441 1.000 0.033 0.033 
-0.317 1.000 0.049 0.049 
-0.220 1.000 0.066 0.066 
-0.178 0.994 0.066 0.059 
-0.146 0.981 0.066 0.046 
-0.129 0.981 0.082 0.063 
-0.111 0.975 0.082 0.056 
-0.105 0.975 0.098 0.073 
-0.088 0.968 0.131 0.099 
-0.070 0.962 0.164 0.126 
-0.062 0.949 0.230 0.179 
-0.045 0.949 0.246 0.195 
-0.036 0.949 0.262 0.211 
-0.034 0.943 0.262 0.205 
-0.017 0.936 0.279 0.215 
0.006 0.758 0.492 0.250 
0.022 0.758 0.508 0.266 
0.033 0.758 0.525 0.283 
0.035 0.752 0.525 0.276 
0.044 0.701 0.607 0.307 
0.053 0.694 0.607 0.301 
0.056 0.688 0.607 0.294 
0.063 0.688 0.623 0.311 
0.070 0.656 0.721 0.377 
0.072 0.643 0.754 0.397 
0.080 0.643 0.770 0.414 
0.096 0.637 0.770 0.407 
0.105 0.637 0.787 0.424 
0.106 0.605 0.803 0.408 
0.124 0.599 0.820 0.418 
0.140 0.586 0.852 0.438 
0.146 0.580 0.852 0.432 
0.156 0.573 0.852 0.426 
0.166 0.567 0.852 0.419 
0.175 0.561 0.869 0.429 
0.181 0.548 0.869 0.417 
0.189 0.541 0.869 0.410 
0.198 0.529 0.869 0.398 
0.207 0.465 0.885 0.350 
0.225 0.459 0.885 0.344 
186 
 
 0.258 0.363 0.885 0.248 
0.292 0.338 0.885 0.223 
0.310 0.306 0.885 0.191 
0.319 0.287 0.885 0.172 
0.327 0.287 0.885 0.172 
0.347 0.274 0.885 0.159 
0.374 0.268 0.885 0.153 
0.389 0.229 0.885 0.115 
0.406 0.229 0.902 0.131 
0.438 0.217 0.902 0.118 
0.474 0.210 0.902 0.112 
0.502 0.197 0.902 0.099 
0.526 0.191 0.902 0.093 
0.532 0.191 0.902 0.093 
0.550 0.185 0.934 0.119 
0.568 0.178 0.934 0.113 
0.579 0.178 0.951 0.129 
0.599 0.172 0.951 0.123 
0.622 0.166 0.951 0.116 
0.637 0.153 0.967 0.120 
0.638 0.140 0.967 0.107 
0.649 0.140 0.984 0.124 
0.666 0.134 0.984 0.117 
0.672 0.134 1.000 0.134 
0.681 0.127 1.000 0.127 
0.691 0.121 1.000 0.121 
0.714 0.115 1.000 0.115 
0.738 0.102 1.000 0.102 
0.741 0.096 1.000 0.096 
0.785 0.083 1.000 0.083 
0.835 0.076 1.000 0.076 
0.842 0.064 1.000 0.064 
0.848 0.057 1.000 0.057 
0.865 0.051 1.000 0.051 
0.894 0.045 1.000 0.045 
0.964 0.038 1.000 0.038 
1.045 0.006 1.000 0.006 
2.074 0.000 1.000 0.000 
*Younden's index (sensitivity + specificity - 1) indicates 
the point that maximises sensitivity and specificity.  
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 Cut-off point determination for bothersomeness scale 
(cut-off point in bold). 
Cut-off  
point Sensitivity Specificity 
*Youden's  
index 
-3.000 1.000 0.000 0.000 
-1.500 1.000 0.015 0.015 
-0.500 0.994 0.152 0.146 
0.500 0.827 0.500 0.327 
1.500 0.524 0.909 0.433 
2.500 0.256 1.000 0.256 
3.500 0.071 1.000 0.071 
5.000 0.000 1.000 0.000 
*Younden's index (sensitivity + specificity - 1) indicates 
the point that maximises sensitivity and specificity.  
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 Appendix 9: Comparative analysis between the follow-up cohort and 
the validation sample. No significant differences were found. 
Variable   
 Follow-up cohort  
(n = 238) 
Sample cohort 
(n = 89) 
Age Mean (SD, range) number of years  
Missing 
 47.3 (14.45, 19-88) 
2 
46.3 (14.46, 19-88) 
1 
Gender Male 
Female 
Missing 
 104 (44) 
134 (56) 
0 
40 (45) 
49 (55) 
0 
Work status In paid (including self) employment  
At home and not looking for work 
Unemployed because of back pain 
Unemployed because of other reasons 
Retired 
Student 
Missing 
 183 (77) 
8 (3) 
1 (< 1) 
7 (3) 
35 (15) 
4 (2) 
0 
71 (80) 
2 (2) 
0  
3 (3) 
10 (11) 
3 (3) 
0 
Pain history < 3 months 
3-6 months 
7-12 months 
1-2 years 
3-5 years 
6-10 years 
> 10 years 
Missing 
 
84 (35) 
37 (16) 
29 (12) 
29 (12) 
23 (10) 
14 (6) 
21 (9) 
1 (< 1) 
29 (33) 
13 (15) 
14 (16) 
13 (15) 
7 (8) 
5 (6) 
7 (8) 
1 (< 1) 
Medication 
usage 
Never 
Rarely 
Sometimes 
Every day 
Missing 
 
50 (21) 
53 (22) 
83 (35) 
52 (22) 
0 
23 (26) 
23 (26) 
26 (29) 
17 (19) 
0 
Values are frequency (%) unless stated otherwise. N = number of observations. Statistical significance 
(p < 0.05) determined using chi2 test for categorical and independent t-test for continuous variables.  
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 Appendix 9 (continued): Comparative analysis between the follow-
up cohort and the validation sample. No significant differences were 
found. 
Variable   
 Follow-up cohort  
(n = 238) 
Sample cohort 
(n = 89) 
RMDQ Mean (SD) score 
Missing 
 
7.4 (5.13) 
0 
7.4 (5.14) 
0 
BQ Mean (SD) score 
Missing 
 
29.4 (15.41) 
5 
29.2 (15.65) 
2 
EQ-5D Mean (SD) score 
Missing 
 
0.59 (0.27) 
10 
0.62 (0.26) 
4 
Bothersomeness 
scale 
Mean (SD) score 
Missing 
 
3.5 (0.96) 
0 
3.5 (0.93) 
0 
RMDQ = Roland-Morris Disability Questionnaire. BQ = Bournemouth Questionnaire.  
EQ-5D = EuroQol-5D. 
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